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ABSTRACT 
Over the past few decades, recombinant protein therapeutics produced in cultured 
mammalian cells have fundamentally transformed modern medicine and improved 
millions of patients’ lives.  The drastic increase in product concentration and the number 
of products approved by the US Food and Drug Administration (FDA) have been 
attributed largely to the relentless efforts of the entire pharmaceutical community on 
multiple technological fronts.  The remarkable advances of high-throughput genomic and 
process analytical tools in recent years have allowed us to extensively characterize almost 
all steps along a typical cell culture process.  The massive amount of data generated by 
these technologies harbors vital information about the process, yet presents substantial 
challenges due to its exceptionally high dimensionality.  This thesis research has applied 
advanced multivariate approaches to explore these sets of data and comprehend profound 
cellular changes during various development and manufacturing stages. 
Through mining a large set of manufacturing data, we uncovered a “memory” 
effect, suggesting that the final outcome of a production culture is primarily affected by 
the early seed culture.  Several parameters related to lactate metabolism and cell growth 
were identified as having a pivotal influence on process performance.  Furthermore, 
transcriptome analysis of cells undergoing selection and amplification was performed 
using multiple statistical, clustering, and functional analysis methods.  Profound 
transcriptional changes were discerned, upon which a combined hyper-productivity gene 
set involving cell cycle control, signaling, and protein processing and secretion was 
derived.  These differentially expressed genes present promising targets for cellular 
modulation to enhance process performance.  We further developed a novel genetic tool 
to engineer the expression dynamics of these genes.  A large number of genes with time 
dynamic expression trends were identified through mining time-series transcriptome data.  
The promoters of these genes offer effective means to drive the expression profiles of the 
targets in a dynamic manner.  The systems approaches outlined in this research thus hold 
promise to deepen our understanding of process characteristics and open new avenues for 
process improvement. 
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1 INTRODUCTION 
1.1 MAMMALIAN CELL CULTURE FOR PRODUCTION OF RECOMBINANT PROTEIN 
THERAPEUTICS 
The advent of recombinant protein therapeutics more than three decades ago has 
profoundly impacted modern medicine with continued discoveries and deliveries of 
innovative therapies for a wide range of life-threatening and serious diseases.  The 
majority of these therapeutic proteins are produced in recombinant mammalian cells due 
to their unique ability to perform complex post-translational modifications, such as 
glycosylation, which are essential to the pharmacological activity of these biologics.  
Over 130 such products have gained approval by the US Food and Drug Administration 
(FDA) and thousands of candidate molecules are marching through different stages of the 
development pipeline (Leader et al. 2008).  With a growth rate of 6.5% and annual sales 
reaching $51.3 billion in the US in 2010, the biotech sector is expected to continue to 
grow strongly in the foreseeable future (Aggarwal 2011).  Therefore, there is an ever-
increasing drive to develop genuine breakthroughs in the field of mammalian cell culture. 
A typical mammalian cell culture process starts with cell line development, in 
which a product gene is introduced into the cells alongside other genes required for 
selection and amplification (Figure 1a).  Single clones with excellent product 
concentrations (titers) and growth characteristics are selected.  These clones are often 
subjected to amplification to increase the product gene copy number.  The best clones are 
characterized for multiple characteristics such as growth, titers, metabolic signatures, and 
stability in small-scale bioreactors.  During this process development step, process 
parameters and culture media are optimized before a few final clones with superior 
performance are frozen down in vials as the production cell bank.  For each production 
run, cells from a vial are thawed and expanded in shake flasks of increasing sizes before 
they are transferred to seed bioreactors, also of increasing sizes (Figure 1b).  At the 
production scale, the cells are often cultured in a fed-batch mode for approximately two 
weeks.  The secreted protein product is harvested from the supernatant and purified using 
a series of centrifugation, filtering, and chromatography steps. 
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Figure 1: Overview of a typical mammalian cell culture process, adapted from (Jayapal et al. 2007). 
a) Cell line and process development.  Recombinant cells are generated by transfecting a vector carrying the 
product gene and other supporting genes.  After selection and gene amplification, substantial screening is 
performed to identify the best clones, which are further characterized in small-scale bioreactors for growth, 
titer, and stability.  Process parameters and culture media are optimized for the selected clones before they are 
banked for production. 
b) After thawing and expansion in shake flasks of increasing sizes, the cells are expanded in a seed train 
comprising multiple bioreactors of increasing scales.  At the production scale, they are often cultured under a 
fed-batch mode for approximately two weeks before the secreted product is harvested from the supernatant and 
purified. 
3 
1.2 HIGH-DIMENSIONAL BIOLOGICAL DATA 
The rapid advancement of high-throughput genomic and process analytical 
technologies over the past few decades has enabled virtually every step along this product 
development and manufacturing pipeline to be extensively characterized at multiple 
levels.  Microarray- and deep sequencing (RNA-seq)-based transcriptome approaches can 
be used to perform global transcriptional analysis in recombinant cells undergoing 
genetic alterations in cell line development and changes in culture conditions over the 
course of process development and large-scale manufacturing.  The knowledge gained 
during this analysis is often extended by proteomics and metabolomics studies to 
investigate genome-wide changes at protein and metabolite levels, respectively.  At the 
process level, various process analytical technologies (PAT) have facilitated real-time 
monitoring, control, and analysis of large-scale manufacturing processes.  Each of these 
technologies generates a massive amount of data, which harbors valuable information 
about the physiological mechanisms of every step along the pipeline.  Consequently, 
advanced data analysis approaches need to be developed and implemented to fully 
explore the potential that these datasets currently hold. 
1.3 SCOPE OF THESIS 
This thesis research focuses on the development and application of advanced 
multivariate data analysis approaches to high-dimensional biological data in an effort to 
gain mechanistic insights into mammalian cell culture processes.  Two types of biological 
data were analyzed, namely large-scale temporal bioprocess and genome-wide 
transcriptome data. 
A significant part of this thesis is devoted to mining a vast dataset of nearly 250 
large-scale production runs acquired at a Genentech facility in Vacaville, CA, using 
support vector regression (SVR) and partial least square regression (PLSR).  For each 
run, more than one million data points from nearly 150 process parameters were recorded 
over the course of the seed train expansion and the production run.  Despite strict 
compliance with Good Manufacturing Practice (GMP) regarding process control and 
operation, there was inevitable variability in the final process outcome.  Thus, through 
4 
mining such a comprehensive set of manufacturing data, we sought to evaluate the 
“memory” effect of the seed cultures and obtain early prediction of the final process 
outcome.  Furthermore, we also identified critical process parameters which can 
potentially be used as indicators of process performance and points of intervention to 
render a process more robust. 
In the second part of the thesis, genome-wide transcriptome analysis of cells 
undergoing selection and amplification was performed using significance analysis of 
microarray (SAM) and gene set enrichment analysis (GSEA).  A custom Affymetrix 
microarray developed in our laboratory, with more than 61,000 probe sets representing 
over 15,000 unique genes, was used.  The gene sets significantly enriched in the antibody 
producing clones during this transformation process constitute alternative paths towards 
hyper-productivity.  Such mechanistic insights can potentially provide valuable 
guidelines for screening high-producers during the cell line development process. 
The third part of this thesis explores time-course microarray data obtained from 
seventy-two samples of twelve fed-batch cultures to identify genes with time dynamic 
expression trends.  A combination of principal component analysis (PCA) and k-means 
clustering was employed.  The promoters of such dynamic genes provide interesting tools 
to control the expression of any target gene following a desired expression trend.  A proof 
of concept has been demonstrated, and new experiments are ongoing to apply these 
promoters to engineering the expression dynamics of several target genes involved in 
regulation of central metabolism and cell growth.  Such dynamic control will potentially 
allow cells to switch to a more efficient metabolic state at the late stage of fed-batch 
cultures, to maintain high viable cell density and viability for a longer period, and thus to 
produce greater levels of the antibody product. 
1.4 THESIS ORGANIZATION 
This thesis is organized into seven chapters.  Chapter 2 provides a brief overview 
of mammalian cell culture processes used for the production of therapeutic proteins.  In 
particular, details about cell line and process development and large-scale manufacturing 
are presented.  In Chapter 3, background information on the characteristrics of high-
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dimensional transcriptome data and a large number of multivariate approaches was 
provided.  An example of the use of such approaches for analyzing large-scale 
manufacturing data is described in Chapter 4.  Multivariate regression models were 
constructed to predict the final process outcome and to identify critical process 
parameters.  In Chapter 5, transcriptome analysis was performed to investigate the 
physiological mechanisms underlying selection and amplification in a typical cell line 
development process.  Transcriptional responses of the exogenous genes as well as other 
genes which potentially confer hyper-productivity traits were examined.  Chapter 6 
describes a novel concept of dynamic cell engineering, in which endogenous promoters 
with time dynamic activities can be used to drive the expression of exogenous genes 
following a desired dynamic trend.  Such promoters were uncovered through multivariate 
analysis of time-series transcriptome data obtained from multiple fed-batch cultures.  
Finally, a brief conclusion and future directions are presented in Chapter 7. 
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2 BACKGROUND 
2.1 SUMMARY 
This chapter provides a summary of mammalian cell culture processes used for 
the production of recombinant protein therapeutics.  More details are focused on Chinese 
hamster ovary (CHO) cells, the current prominent workhorse of protein production.  
Background information about cell line development, process development, and cell 
engineering is briefly described.  Several aspects of these processes where opportunities 
for improvement exist are highlighted.  Finally, the characteristics of high-dimensional 
bioprocess data generated from large-scale manufacturing facilities are presented. 
2.2 HOST CELL LINES FOR PRODUCTION OF PROTEIN THERAPEUTICS 
Despite an abundance of cultured mammalian cell lines, only a few of them 
currently account for the majority of therapeutic proteins produced, notably Chinese 
hamster ovary (CHO), baby hamster kidney (BHK), human embryonic kidney (HEK), 
mouse myeloma, and mouse hybridoma.  The latter two were derived from in vivo 
professional antibody secretors, which are naturally equipped with fully developed 
secretory machinery.  Thus they often achieve high productivity with merely a single 
copy of the product gene.  In contrast, the first few, which were derived from tissues not 
specialized in secreting antibodies (ovary and kidney), generally required drastic gene 
amplification in order to produce antibody at high levels. 
Among these cell lines, CHO cells currently produce nearly 70% of all 
recombinant protein therapeutics (Jayapal et al. 2007).  Such a rise to prominence of 
CHO cells can be attributed to several factors.  First, CHO cells have been demonstrated 
to perform efficient post-translational modifications, resulting in protein products 
compatible with human immune responses.  Second, no adventitious pathogenic agents 
have been shown to effectively propagate in CHO cells, making them safe hosts for these 
products.  Finally, CHO cells are easily adapted to grow in suspension, which allows 
volumetric scaling to large bioreactors for industrial production. 
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2.3 DEVELOPMENT OF CELL LINES FOR PRODUCTION OF PROTEIN THERAPEUTICS 
2.3.1 Gene Delivery and Selection 
Cell line development follows a generally well established process.  First, a DNA 
molecule carrying the product gene and genes assisting selection and amplification is 
introduced into the host cells.  In some cases, these genes can also be arranged in separate 
vectors which are co-transfected in unequal amounts.  Typically the product gene is 
driven by a strong constitutive promoter, whereas the associated genes can be driven by 
either a similarly strong promoter or a weaker promoter to allow for more stringent 
selection.  This DNA delivery step in protein production is often achieved using a 
number of non-viral mediators such as calcium phosphate, electroporation, lipofection, 
and polymer-mediated gene transfer.  All of these methods generate a temporary 
disruption of the cellular membrane, allowing the DNA molecule to enter the cytoplasm.  
In order to generate a stable cell line, the DNA molecule has to enter the nucleus and 
stably integrate into the genome.  Since this event occurs at extremely low frequency 
(less than 10
-4
) (Mortensen and Kingston 2001), a selection step is often required to 
propagate stable transfectants and prevent non-transfected cells from taking over the 
culture. 
Gene integration is largely a random event, thus not all selected cells would have 
the same integration site of the product gene.  This variation in integration site has been 
known to result in profound differences in the expression level of the gene (Wilson et al. 
1990).  If this site resides within euchromatin, the gene is actively transcribed.  In 
contrast, heterochromatic surroundings will significant impair the expression level.  It has 
been shown that stably integrated transgenes can be rapidly silenced largely as a result of 
histone H3 and H4 hypoacetylation and loss of methylation at H3K4 (Mutskov and 
Felsenfeld 2004).  Due to this heterogeneity of gene expression levels in transfected cells, 
selection is often performed in parallel with dilution cloning to isolate homologous 
populations, i.e., single clones.  Normally, clones producing the highest antibody 
concentrations and growing at reasonable rates are selected. 
8 
A variety of selection systems exist, including dominant markers against 
antibiotics such as neomycin, blasticidin, puromycin, and hygromycin.  In addition, 
markers which require special phenotypes are also available such as dihydrofolate 
reductase (DHFR) and thymidine kinase (TK), which are transferred into cells deficient 
in DHFR and TK activity, respectively. 
2.3.2 Gene Amplification and Screening 
In order to increase the expression level of the product gene, the selected cells are 
often subjected to gene amplification.  This increase can be achieved using a number of 
systems, notably DHFR, glutamine synthetase (GS), adenosine deaminase, 
carbamylphosphate synthetase/aspartate transcarbmylase/dihydroorotase (CAD), 
multidrug resistance (MDR), and metallothionein.  Of those, DHFR is most commonly 
used in CHO cells.  By gradually increasing the concentration of methotrexate (MTX), 
which is an inhibitor of DHFR activity, the DHFR gene is amplified, resulting in co-
amplification of the product gene integrated nearby.  Upon MTX treatment, amplified 
cells frequently harbor several hundred to a few thousand copies of the product gene 
embedded in elongated chromosomes (Wurm et al. 1986).  This step inevitably leads to 
heterogeneity in mRNA and protein levels of the product gene within any selected clone, 
since each cell responds differently to the amplification pressure.  Thereby, additional 
dilution cloning and extensive screening are often performed to isolate the best 
performing clones. 
In an industrial setting, hundreds to thousands of clones are typically screened for 
superior growth and productivity in a high-throughput manner.  In addition, protein 
quality, metabolic behaviors, and especially stability in long-term culture are also taken 
into consideration.  Despite containing stably integrated product gene, these cells can 
experience a gradual loss of product titer over time.  This instability in some cases can be 
attributed to a decrease in the copy number of the product gene (Fann et al. 2000; 
Hammill et al. 2000).  Decreases in transcription efficiency (Chusainow et al. 2009) and 
translational/secretory capacity (Barnes et al. 2004) have also been reported.  Several 
mechanisms, including gene silencing and chromosomal rearrangement, have been 
suggested to possibly lead to long-term instability (Mutskov and Felsenfeld 2004; 
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Richards and Elgin 2002).  An integration site close to the telomeres was also shown to 
result in stability in the absence of MTX (Yoshikawa et al. 2000). 
Today, cell line development remains the most time- and resource-intensive step 
of an entire cell culture process.  As outlined in Figure 2, this step typically takes at least 
70 days with multiple empirical screenings.  Thus, substantial opportunities exist for 
greater understanding the underlying mechanisms, which hold promise to improve 
efficiency and shorten the development timeline. 
 
Figure 2: A typical cell line development timeline (Seth et al. 2007a). 
 
2.4 PROCESS DEVELOPMENT FOR PRODUCTION OF PROTEIN THERAPEUTICS 
2.4.1 Culture Formats 
After screening, a relatively small panel of clones with superior traits is further 
evaluated in small-scale bioreactors.  During this process development step, various 
parameters such as culture mode, pH, temperature, addition of supplements, especially 
media components, are experimented and optimized.  Further genetic engineering can 
also be performed to improve performance of these selected clones. 
Several culture modes, notably batch, fed-batch, and perfusion, are commonly 
used.  In a batch culture, cells are growing in a fixed volume of medium until a number of 
essential nutrients become depleted and the viability drops.  At that point, secreted 
product concentration reaches saturation for harvest.  In a fed-batch culture, concentrated 
feed medium is added several days after inoculation, which prevents nutrient depletion in 
the culture.  Thus higher cell concentration and product titer are achieved when the 
culture is terminated for harvest.  In a perfusion culture, cells are inoculated in a batch 
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mode until they reach a concentration close to the desired steady state.  Once 
concentrated medium is supplemented, an equal volume of the culture is also withdrawn 
to maintain the culture at a steady state.  Cells in the withdrawn volume can be 
concentrated and recycled back to the reactor.  This system allows continuous harvest of 
the product, yet presents a number of technical challenges that make it not as commonly 
used as the batch and fed-batch modes in the pharmaceutical industry.  One such 
challenge is due to the sub-optimal condition for cell growth in continuous cultures, 
which does not permit the cells to enter a rapid growth period in order to produce a large 
amount of product.  Concerns about mechanical failure and stability of the cells, 
especially when cell recycle is incorporated, also limit the use of continuous cultures.  
Thus, batch and fed-batch operating modes are still more commonly used. 
Media development and optimization is arguably still the most fundamental 
aspect of cell culture, affecting cell growth and productivity profoundly.  To date, the 
ranges of main components in most basal media are relatively well-defined.  Depending 
on the cell line, several components may need to undergo optimization, which usually 
required statistically designed experiments (Kim et al. 1998).  Serum and animal proteins 
are no longer widely used in cell culture media (Kallel et al. 2002).  Instead, protein-free 
and even chemically defined media are becoming more commonplace. 
2.4.2 Cell Engineering 
In addition to optimization of process parameters and media components, cell 
engineering is often applied to further improve process performance.  A number of 
functional pathways have been active targets of cell engineering, notably energy 
metabolism, amino acid metabolism, and apoptosis.  The ultimate goals are to enhance 
peak cell concentration, lengthen culture duration, and increase product titer. 
Cultured mammalian cells have been shown to uptake glucose, glutamine, and 
other nutrients in excess (Ronald Zielke et al. 1978).  As a result, metabolic by-products 
such as lactate and ammonia accumulate in the medium to levels that could negatively 
affect cell growth and productivity.  Thus, reducing lactate and ammonia accumulation 
has been one of the main focuses of cell engineering, and multiple efforts have been 
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reported.  In one study, low lactate production was achieved indirectly by decreasing 
sugar uptake via replacing glucose with fructose and overexpressing GLUT5, a fructose 
transporter with lower affinity compared to the most abundant glucose transporter 
GLUT1 (Wlaschin and Hu 2007b).  Lactate production can also be reduced by inhibiting 
lactate dehydrogenase A (LDH-A), an enzyme that converts pyruvate to lactate, using 
small interference RNA (siRNA) (Kim and Lee 2006; Le et al. 2010).  Another approach 
was to divert the flux of pyruvate into mitochondria for entry into the TCA cycle by 
overexpressing pyruvate carboxylase (PCX), an enzyme that converts pyruvate to 
oxaloacetate ( ogol  n et al      ; Irani et al. 1999; Kim and Lee 2007c).  A combined 
strategy was also demonstrated by knocking down LDH-A and pyruvate dehydrogenase 
kinase (PDHK), which inhibits the conversion of pyruvate to acetyl-CoA (Zhou et al. 
2011). 
Controlling glutamine or other amino acid metabolism has been slightly more 
challenging as multiple amino acids share the same transporter and vice versa.  To date, 
most of the efforts have been focused on overexpressing or de-silencing glutamine 
synthetase (GS) to make cells independent of an exogenous source of glutamine (Bell et 
al. 1995; Harris 1984). 
Delaying the onset of apoptosis, or programmed cell death, has also been a target 
of cell engineering for several decades.  Anti-apoptotic genes such as Aven, Bcl-xL, X-
linked inhibitor of apoptosis (XIAP), and E1B19K were overexpressed to improve 
culture performance (Figueroa et al. 2007; Figueroa et al. 2004; Sauerwald et al. 2006).  
Interestingly, altering apoptosis pathways was also shown to result in a metabolic switch 
to lactate consumption and lower production of ammonia (Dorai et al. 2009), indicating a 
tight link between apoptosis and metabolism. 
2.5 CHARACTERISTICS OF BIOPROCESS DATA FROM LARGE-SCALE 
MANUFACTURING FACILITIES 
Following cell line development, process optimization, scale-up, and cell banking, 
the production cell lines are transferred to large-scale manufacturing, at which point they 
are maintained in relatively small-scale bioreactors (rolling seed) to inoculate multiple 
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runs.  Each run starts with several bioreactors of increasing scales (seed train) before the 
cells eventually reach the final production scale, typically about 15,000 L.  These modern 
manufacturing facilities are highly automated in their operation and data acquisition.  
Hundreds of process parameters are routinely acquired and archived electronically, not 
only at the production scale but also throughout cell expansion in the seed train.  
Fluctuations in process productivity and product quality invariably occur in those 
production facilities.  Such fluctuations or variations may exist in the same plant over 
time or at different plants for the same product.  Understanding the root of such variations 
will have major economic implications for the product.  Historical bioprocess data 
archived from these large-scale manufacturing plants thus hold much potential to provide 
insights for enhancing the productivity and process consistency. 
Bioprocess datasets are unique in their heterogeneity.  The frequency of 
measurement and the parameter values vary widely among different types of process 
parameters.  Based on measuring frequency, bioprocess data can be categorized into 
several types, namely online, offline, raw materials, and product information.  Online 
parameters are recorded automatically using electronic probes at extremely high 
frequencies of a few seconds to less than a minute for the entire production run, which 
typically lasts at least 20 days.  Several online parameters are control parameters such as 
dissolved oxygen (DO), pH, and vessel temperatures, which are controlled at specific 
levels.  For instance, DO is often set at 30% of the saturation level of oxygen in liquid 
medium, pH at 7.0, and vessel temperature at 37
o
C under normal culture conditions.  In 
addition, control action parameters are also recorded online.  Examples include sparge 
rates of air and oxygen to control DO, and base addition and carbon dioxide sparge rate 
to control pH.  Online data also comprise other important parameters such as vessel 
volume, overlay gas flow rate, and states of different valves.  These valves control 
different ports for addition of cells, media, base, antifoam, and gas sparging. 
Offline parameters, on the other hand, are recorded manually by withdrawing 
samples from the bioreactors.  This measurement is often performed at 12 to 24 hour 
intervals.  Most of these parameters reflect the concentrations of different nutrients and 
metabolites such as glucose, lactate, sodium ion, and ammonium ion.  Physiological 
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parameters including viable cell density, viability, and packed cell volume are also 
measured offline. 
In addition to online and offline data, information about various components of raw 
materials such as basal medium, feed medium, and hydrolysate are also recorded.  This 
type of single-time point data includes lot number, the amount added from each lot, and 
the time stamps of each addition.  Besides, documents of cell source (bank and ampoule) 
and cell age (time period cells are maintained in the rolling seed before they are used to 
inoculate a seed train) are frequently available. 
The outcome of a cell culture process is often evaluated based on process quantity 
and quality.  These values are measured at the end of the production-scale reactors, when 
the viability drops below a certain threshold.  In addition to the secreted protein 
concentration in the supernatant (titer), the product quality is also a critical attribute.  
Commonly used criteria to assess glycoprotein quality include distribution of different 
glycans and charge variants. 
Not only do bioprocess data vary across a wide range of measuring frequency, 
they also differ drastically regarding parameter value.  Most parameters are quantitative 
with continuous values such as glucose and lactate concentrations.  Several others are 
quantitative with discrete values such as viable cell concentration.  A large number of 
parameters are categorical, especially lot number and valve state. 
Due to this highly heterogeneous nature, bioprocess data present great challenges 
to the mining practice.  Oftentimes, data have to be pre-processed extensively to smooth 
the time profiles and to estimate missing values.  Selection of parameters and 
dimensionality reduction are also important prior to analysis.  Several multivariate 
approaches which are commonly used for mining bioprocess data can be found in the 
next chapter (Multivariate Analysis of Microarray Data).  A general flowchart for 
analyzing bioprocess data was outlined in a recent review by (Charaniya et al. 2008) and 
is shown in Figure 3. 
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Figure 3: An approach for data-driven knowledge discovery in bioprocess databases (Charaniya et al. 2008). 
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3 MULTIVARIATE ANALYSIS OF MICROARRAY DATA 
3.1 SUMMARY 
In the past decade, DNA microarrays for transcriptome have fundamentally 
changed the way we study complex biological systems.  By simultaneously measuring 
the expression levels of thousands of transcripts, the paradigm of studying organisms has 
shifted from focusing on local phenomena involving a few genes to surveying the whole 
transcriptome.  DNA microarrays are used in a variety of ways, from simple comparisons 
between two samples to more intricate time-series studies.  With the unprecedentedly 
large number of genes being studied, the dimensionality of the problem is inevitably 
high.  The analysis of microarray data thus requires specific approaches.  In the case of 
time-series microarray studies, data analysis is further complicated by the correlation 
among successive time points in a series. 
This chapter provides a survey of the methodologies used in the analysis of static 
and time-series microarray data, covering data pre-processing, identification of 
differentially expressed genes, profile pattern recognition, pathway analysis, and network 
reconstruction.  When available, examples of their use in mammalian cell culture are 
presented. 
3.2 INTRODUCTION 
In the past decade, genome science has drastically changed our approaches to 
study biosciences and has broadened our ability to harness the potential of industrial 
organisms for technological applications.  Importantly, genome-wide gene expression 
profiling using DNA microarrays has become widely employed in biotechnological 
research.  Through DNA microarrays, we are able to look at the dynamics of the 
transcript levels of the entire set of genes to explore the intricate relationships among the 
biochemical reactions, the signaling and regulation, the physiological events in the cells, 
and the global gene expression.  In the next few years, we anticipate a greatly expanded 
reach of transcriptome analysis in cell culture research due to the dramatic advances in 
sequencing technology. 
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Until recently, the application of transcriptome analysis in cell culture bioprocess 
has been rather limited because the genome sequence information available for the most 
commonly used cell line, Chinese Hamster Ovary (CHO), was not extensive.  With the 
cost of DNA sequencing drastically reduced compared to even three years ago, and the 
readily accessible sequencing services, one can expect that genome sequences for 
reference species will become available in a very near future.  Furthermore, we can also 
expect that sequencing the genome of individual cell lines will become commonplace in a 
few years.  Therefore, the affordability of high throughput sequencing technology will 
push DNA microarrays to the forefront of cell culture bioprocess characterization, along 
with many routinely used quantitative tools such as HPLC and ELISA.  However, unlike 
the conventional variables typically measured in a cell cultivation process, transcriptome 
data are unique in its high dimensionality: each time point of measurement yields up to 
tens of thousands of transcript level data.  In some ways, the examination of the data is 
like looking for patterns in a starry sky; the comparison of different datasets is as if 
comparing the skies in different seasons or different days. 
This chapter summarizes commonly used microarray platforms and experimental 
design, and review methods used in differential expression analysis, profile pattern 
recognition, pathway analysis, and network reconstruction.  In each section, an overview 
of the basic methodology is provided, followed by a sequence of specific modifications 
and associated software.  Finally, several examples in which the methodology has been 
successfully applied are presented.  When available, examples in antibody producing 
recombinant cell lines are emphasized. 
3.3 PLATFORM OVERVIEW 
Several microarray platforms are currently available, each of them offering 
certain advantages.  As new platforms are introduced, a reduction in cost and an increase 
in flexibility have been observed.  Microarray platforms are generally classified into two-
dye or single-dye, referring to the number of fluorescently labeled samples applied to 
each chip. 
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3.3.1 Two-dye Microarrays 
Two-dye microarrays were first used by Schena et al. (Schena et al. 1995) to 
measure the expression level of 45 Arabidopsis genes, and were soon followed by studies 
at the genome-wide level in yeast (Lashkari et al. 1997).  Two-dye cDNA arrays are 
prepared by immobilizing long (>500 nt) cDNA probes prepared by PCR amplification 
onto a glass slide.  cDNA microarrays allow the direct comparison of genes in two 
samples, each labeled with a different fluorescent dye.  The raw intensities of the two 
dyes are indicative of the transcript levels in each sample.  The probes can be designed 
against the genome sequence of the organism to minimize the segments which may cause 
cross-hybridization with transcripts from other genes.  However, for mammalian cell 
applications, the large number of probes renders this approach very costly, as specific 
primers have to be designed for the amplification of specific segments of a sequence.  
Thus universal primers that amplify the entire cDNA region of an EST clone are more 
frequently used.  Yet they are prone to non-specific hybridization, especially for 
alternatively spliced transcripts.  cDNA microarrays also suffer from imprecise control of 
the amount of DNA immobilized on the surface, making it difficult to compare the levels 
of different genes in the same sample. 
With the much reduced cost in oligonucleotide synthesis, cDNA microarrays are 
used less frequently now.  In the past few years, many synthetic oligo-DNA based 
microarrays have evolved to be suitable for use as either single-dye or two-dye arrays.  
One such platform which can be used as either single-dye or two-dye is manufactured by 
Agilent.  Similar to cDNA microarrays, short (~ 60 nt) oligonucleotides synthesized in 
situ on a glass surface.  As few as individual slides are available for unique custom 
designs.  Multiplexing – that is, the availability of testing multiple samples in a single 
slide – is also available in Agilent’s microarrays  
3.3.2 Single-dye Microarrays 
In contrast to two-dye arrays, single-dye arrays are designed to provide “absolute” 
measurement of the relative transcript level of each gene within a sample.  With a 
“relative” measurement in two-dye arrays, a multiple sample comparison is cumbersome, 
requiring either a myriad of pairings of samples or the use of a common reference.  With 
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an absolute measurement and one sample for each array, even meta-analysis using 
hundreds of microarrays can be performed. 
An example of a single-dye array is that produced by Affymetrix, Inc.  
Affymetrix uses a photolithographic process for printing probes.  Gene expression is 
interrogated by probe sets, which consist of eight to eleven probe pairs.  Each probe pair 
consists of two 25-mers, one being a perfect match, the other containing a mismatch at 
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 base pair.  The photolithographic process, however, requires the creation of a set 
of masks for each array design (essentially 4 masks for each base position, thus each 25-
mer will require 100 masks).  The cost of generating a new set of masks limits the 
frequency of modifying or updating probes. 
Probes on another single-dye platform, commercialized by Roche NimbleGen, 
Inc., are synthesized by photo-mediated chemistry using a proprietary Maskless Array 
Synthesizer   The use of digital mirrors creates “virtual masks”, allowing for flexible 
designs that can be easily modified.  With their ability to control the area devoted to a 
probe to be very small, a very large number (in the millions) of probes can be placed on a 
single slide.  This presents an advantage for large genomes, such as those of mammalian 
species.  For smaller genomes or with a subset of genes, array multiplexing can be 
implemented.  Furthermore, without the use of mask, the cost of production is reduced.  
Making an array for only a small number of samples and frequent updating of probe 
design thus becomes affordable.  Unfortunately, this multiplex platform will not be 
offered beyond 2012. 
3.3.3 Other Platforms and Technologies 
In addition to the glass slide chip-based microarrays, other types of arrays have 
been developed   One such technology is Illumina’s BeadArray, which uses three micron 
silica beads that self-assemble in microwells with uniform spacing.  In this capture 
technology, each bead is covered with thousands of copies of specific oligonucleotides. 
With the rapid advances in DNA sequencing technologies and the decrease in 
sequencing cost, transcriptomes can now be analyzed by direct cDNA sequencing.  In 
RNA-Seq, a population of RNA is converted to a cDNA library, which is then 
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fragmented and sequenced using high throughput technology (Wang et al. 2009b).  The 
abundance level of a particular sequence fragment is indicative of the abundance level of 
the transcript from which it is derived.  Unlike DNA microarrays, which can be used only 
to probe the expression of genes represented on the arrays, RNA-Seq detects all RNA 
species, including novel RNAs and alternative transcripts.  It can also identify transcript 
boundaries, and has a much wider dynamic range, over several orders of magnitude as 
there is no saturation of highly expressed transcripts.  However, the bioinformatics can be 
challenging due to extensive mapping and assembly prior to analysis. 
3.4 STATIC STUDIES VS. TIME-SERIES STUDIES 
Although microarrays can be used to probe transcript profiles of a large array of 
genes in a cell sample, most applications involve the comparison of different cell 
samples, either the same cell line under different conditions or different cell lines.  In 
other words, most studies involve two or more cell samples.  The use of DNA 
microarrays to study cell culture processes can be categorized into static or dynamic 
(time-series) types according to how samples are taken and compared. 
Static studies compare two samples to identify differences in gene expression 
between them.  The samples may be different cells or tissues, such as the case of 
comparing cell lines of different levels of antibody production (Seth et al. 2007b).  In 
other cases, different process variables or culture conditions might be studied.  The 
following reports provided examples wherein microarrays were used to assess the effect 
of cell density (Krampe et al. 2008), to study cell proliferation in protein-free medium 
(Spens and Häggström 2009), and to analyze the effect of hypoxic stress (Swiderek et al. 
2008). 
Every cell culture process constantly evolves with time, entailing various stages 
of culture, from the early exponential phase and exponential phase to stationary phase.  In 
most cases, the environmental conditions change over time, either due to the culture’s 
evolution or due to process imposed culture condition alterations such as temperature or 
pH shift.  The gene expression profiles thus inevitably change with culture time.  Static 
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studies offer rich information on the difference in gene expression between two 
conditions or two cell populations but only as a snap shot at a point of a long process. 
Time-series studies sample different time points throughout the duration of the 
culture and aim at capturing the trends in gene expression changes originated by 
regulatory events and fluctuations in environmental conditions.  Furthermore, the 
temporal information harbored in microarray time-series data also enables one to infer 
causality in gene regulatory networks.  An aim of time-series data analysis is thus to 
identify genes which have different dynamic behaviors over time in the same sample or 
to identify the same genes whose transcripts follow different time trends under different 
treatments  (Tai and Speed 2006).  Time-series studies are particularly relevant for 
cellular processes exhibiting periodic behaviors, such as cell cycle and circadian rhythm, 
as well as other intrinsically dynamic processes such as development and differentiation.  
Although this type of study is abundant in yeast, roundworms, and stem cells, fewer 
examples have been demonstrated in antibody producing mammalian cells.  In one 
example, gene expression time-profiles were compared between fed-batch processes 
yielding high and low titers using the same CHO cell line (Schaub et al. 2010).  Dynamic 
regulation of transcription in a Human Embryonic Kidney (HEK) cell line in protein-free 
batch and fed-batch cultures was also unraveled (Lee et al. 2007).  In addition, time-
series transcriptome data was explored to elucidate cellular mechanisms leading to an 
increase in productivity in CHO cells under sodium butyrate treatment and temperature 
shift (Kantardjieff et al. 2010). 
In DNA microarray studies of mammalian cell cultures, the number of 
differentially expressed genes and the degree of their differential expression are often 
lower than typical changes observed in other systems such as developmental processes or 
microbial cultures (Schaub et al. 2010).  Using a fold-change cut-off of 1.4-2.0, and a p-
value cut-off of 0.05-0.1, it is common to identify much less than 10% of the genes as 
significant.  This number often decreases sharply when the fold-change cutoff is raised 
above 2.0 fold.  For example, in studying productivity in antibody-producing cell lines, a 
relatively small number of genes are consistently different between high- and low-
productivity clones (Seth et al. 2007b).  These modest changes in gene expression thus 
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require careful experimental design and subsequent data analysis.  This situation contrasts 
with most cases found in bacteria undergoing changes in nutritional or other 
environmental conditions, and stem cells under directed differentiation, in which often a 
large number of genes change their expression and many illustrate large differences in 
gene expression levels. 
3.5 MICROARRAY EXPERIMENT DESIGN 
Microarray and RNA-Seq studies can provide a wealth of information.  However, 
even with the decrease of cost in the past few years, it is still not bargain priced.  The 
number of conditions to be tested and the number of samples for each condition have to 
be planned.  When single-dye microarray platforms are used, there is no limitation to 
which comparisons among multiple samples can be made.  For two-dye arrays, however, 
the experimental design is crucial.  With two-dye microarray platforms, one aims to 
measure the ratio of each gene’s transcript level between two samples   When only two 
samples are involved, direct comparison is obtained using a single chip.  With three 
samples, loop designs in which three arrays are used to obtain direct pair-wise 
comparison of the three sample pairs (1-2, 2-3, 3-1) can be applied (Kerr and Churchill 
2001).  An alternative, often referred to as reference design, is to hybridize each of the 
three samples to a common reference, and obtain indirect comparisons for each sample 
pair in the experiment.  An often used reference is a pool of RNA, either from all 
samples, to ensure that the transcripts of all genes on the array are present, or from 
sample(s) external to the experiment.  An internal reference, for instance the first sample, 
can also be used to directly compare some of the pairs (1-2 and 1-3) and infer 
comparisons for the others (in this case 2-3).  The amount of available reference sample 
might limit the number of arrays that can be done. 
Time-series microarray studies present additional experimental design challenges.  
Frequently, the comparison is not only among data from different time points within the 
same treatment but also among series under different treatments.  The number of samples 
to be collected and their distribution in time will define the ability of the experiment to 
capture the gene expression dynamics.  Sample collection frequency should be high 
enough to capture the dynamics of genes with periodic behaviors or propensity for 
22 
sudden changes in expression.  This approach, however, might result in a very large 
number of samples, which is not always feasible due to the cost or the amount of work 
involved (Wang et al. 2008).  If critical changes are suspected between the originally 
analyzed time points, additional microarrays can be performed.  This is possible if 
samples were collected at intermediate time points.  Another possibility is to fill these 
gaps using quantitative PCR measurements of transcripts of the target genes. 
The general steps of analyzing gene expression data from microarrays is shown as 
a flowchart in Figure 4.  First, raw data are filtered to eliminate absent probes using 
intensity and/or detection p-value cutoffs.  Filtered data are further normalized to 
generate a baseline for comparison across samples.  Time alignment, log transformation, 
and scaling can be performed if necessary.  Once the data have been properly processed, 
genes exhibiting differential expression can be identified using multiple statistical 
approaches.  These significant genes are often further analyzed in a pathway/network 
context or using clustering tools to infer the biological meanings of differential 
expression. 
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Figure 4: General analysis flowchart for microarray data. 
Raw expression data are often filtered to eliminate absent probes.  The filtered data are subsequently 
normalized and processed using different methods if necessary.  Genes exhibiting differential expression are 
identified using statistical tools.  In addition to clustering, further analysis can be performed in a 
pathway/network context to finally interpret the biological meaning of differential expression. 
 
3.6 DATA PRE-PROCESSING 
3.6.1 Normalization, Transformation, and Scaling 
Gene expression levels measured using DNA microarrays are subject to a number 
of systematic biases, and hence should be globally adjusted (or normalized) to attain a 
common basis for all the microarrays to be compared.  These variations in gene 
expression measures are often the result of differences in starting amounts of RNA, 
labeling, hybridization, and scanning efficiency (Quackenbush 2002).  Normalization is 
thus a necessary step regardless of the platform used or whether the experiment involves 
static or time-series samples.  Different normalization methods (based on different sets of 
assumptions) often give different quantification.  Most normalization methods assume 
that the microarray contains a large and unbiased set of genes.  Furthermore, the number 
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of differentially expressed genes is considered to be relatively small compared to the total 
number of genes present on the array.  As a result, this differential expression does not 
affect the overall distribution of gene expression levels in each sample. 
Linear and quantile normalization are the most commonly used normalization 
methods in microarray data processing.  Linear normalization is often applied when gene 
expression measures in all arrays have similar distributions but different median values.  
Given the assumption that equal amounts of RNA are used in each sample, a 
normalization factor is calculated as the ratio of the median gene expression levels in two 
samples (Quackenbush 2002).  All gene expression measures are subsequently scaled 
using this factor such that these two samples have the same median gene expression level 
after normalization.  A target median value can also be defined to linearly scale multiple 
samples.  Thus linear normalization is conceptually simple, yet applicable to most cases 
wherein the assumptions stated above are satisfied.  However, possible lack of linearity 
between fluorescence intensity and the amount of DNA or RNA hybridized could 
introduce errors when linear normalization is applied. 
Quantile normalization, on the other hand, assumes that all samples have the same 
gene expression level distribution (Bolstad et al. 2003).  Gene expression measures are 
adjusted such that each sample follows the same distribution, which is assumed to be the 
average distribution of all samples.  This normalization method is frequently used to 
correct the gene expression level distribution in single-dye and two-dye arrays when 
genomic DNA is used in one channel.  Sometimes, a drastic change in cell physiology 
may occur, causing a major shift in gene expression profiles.  In such cases, the use of 
quantile normalization might not be appropriate.  For example, as stem cells differentiate 
or cells enter different phases of growth, their transcriptional responses or cellular RNA 
composition may change drastically.  Large variations in cellular RNA composition 
among samples violate the assumption that all samples have the same gene expression 
level distribution. 
It is important to note that, in most experimental protocols, the amount of total 
RNA (in the case of prokaryotic samples) or poly(A)-tailed transcripts (in the case of 
eukaryotic samples) applied to each array is kept equal, thus normalization methods only 
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adjust the data to equal quantities of RNA.  However, the RNA content per cell does not 
always remains constant under different conditions.  Fast growing cells have far more 
RNA than cells in stationary phase, thus total RNA content per cell varies.  It is thereby 
important to know whether differential expression calls are based on per cell or per unit 
amount of RNA. 
After normalization, the data are usually log-transformed.  The variance, which is 
inherently large in microarray data, is reduced in log-transformed data.  Normalized gene 
expression values can also be scaled to a mean or median value of zero.  This is 
equivalent to centering the gene expression level distribution over zero (mean- or 
median-centering).  Additionally, a standard deviation of one can be achieved using z-
transformation.  These data pre-processing steps can be performed using several software 
including Expressionist, GeneSpring, and R packages such as affy, limma, beadarray and 
oligo.  Although data normalization, transformation and scaling have become routine, 
these steps remain vital to all subsequent stages along the analysis pipeline for gene 
expression data. 
3.6.2 Time Alignment 
When comparing time-series experiments, it is important to ensure that the 
starting cell populations in different treatments are identical, or at least as similar as 
possible.  Under some conditions, variability is difficult to eliminate, resulting in 
somewhat different kinetic profiles even among biological replicate cultures.  When 
applying microarray to time-series studies, the aim is to identify genes whose transcript 
dynamics change beyond the fluctuations in biological replicate cultures, especially 
changes which can be attributed to experimental treatment.  In assessing the similarity or 
difference between two cultures under different treatments, a direct comparison of time 
profiles is an obvious first approach.  This is sound in the cases that the trends of growth 
and other growth-related variables (such as chemical profiles) are mostly identical.  Often 
growth and other culture indicators reveal difference, strongly hinting that the identical 
time points in two cultures may not correspond to identical “culture stages”   In other 
words, the time frame of one culture has shifted from the reference time frame of the 
other culture.  Direct comparison of time profiles of gene expression may give rise to 
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many falsely identified genes with different kinetic behaviors.  Thus these potential 
misalignments should be identified and corrected prior to analysis. 
The change in time dynamics could be global, i.e., all the transcripts change their 
temporal profiles similarly. This change may also be segmented and local, i.e., only some 
sets of genes change coordinately apart from the rest of genes or different sets of genes 
change their dynamics differently.  Such asynchronous behaviors need to be dealt with 
using some forms of time alignment.  Asynchronization between transcriptome time 
profiles appears in multiple forms, which can be largely divided into four types: frame 
shift, elastic compression or expansion, and time flip (Mehra et al. 2006). 
Frame shift occurs when one of the series experiences a lag phase with respect to 
the others.  If the growth rate differs significantly among the series, their gene expression 
profiles may display elastic compression or expansion.  Examples of frame shift and 
expansion are shown in Figure 5a.  These types of asynchronization are often adjusted 
globally.  In addition, changes in a few subsets of genes can result in a flip in time order 
between different subsets of genes (Figure 5b).  This time flip suggests the existence of 
multiple biological clocks controlling varied cellular processes in the experimental 
system and thus requires local alignment.  As a result, when multiple treatments are being 
compared, gene expression data sets should be examined and, if necessary, properly 
aligned before subsequent analyses can be performed. 
Conceptually, aligning time-series microarray data entails matching two patterns 
by locally compressing, expanding, or translating one with respect to the other such that 
their similar characteristics are aligned without altering the ordering of each sample.  This 
can be performed on either the continuous representation of each series or the discrete 
values of gene expression.  The alignment between time series can be achieved at a 
global level or at a local level to allow different subsets of genes to follow varied 
biological clocks. 
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Figure 5: Possible forms of time asynchronization in different series. 
a) Expression profile of gene ga in three different series.  The expression profile in series 2, ga2, shows a shift 
with respect to series 1, ga1.  The expression profile in series 3, ga3, shows an expansion with respect to ga1.  
These types of asynchronization can be adjusted globally. 
b) Expression profiles of two genes, ga and gb, in two different series.  Gene ga displays the same expression 
profile in the two series.  The peak observed in the expression profile of gene gb in series 1 appears at an 
earlier time point in series 2.  This time flip often requires local adjustment. 
 
An example of global alignment is the B-spline based alignment method, which 
represents each gene expression profile as a spline curve of multiple low-degree 
polynomials (Bar-Joseph et al. 2003).  To align different time series, one of the series is 
chosen as the reference, and the time points of the other series are mapped to the 
reference series by stretching and shifting the continuous representation of gene profiles.  
This method is particularly suited for long time series (e g , ≥ 10 time points) (Bar-Joseph 
2004).  The use of B-splines for alignment was demonstrated by aligning three yeast time 
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series that begin in different phases and occur in different time scales (Bar-Joseph et al. 
2003). 
A second example for global alignment, dynamic time warping (DTW), involves 
non-linear mapping between discrete time points of two series along the time dimension 
such that the distance between them is minimized (Sakoe and Chiba 1978).  In the case of 
transcriptome time series, the overall distance between the two series is computed as the 
weighted sum of distances contributed by all genes.  The use of a weighting factor for 
each gene allows higher contribution to the overall distance measure to be given to genes 
with consistent expression profiles across two treatments, or to genes important to the 
biological activities being considered.  In Figure 6, the algorithm is exemplified with two 
genes (ga and gb) in two different series.  The weighting factors (wa and wb) indicate the 
contribution of each gene to the final adjustment.  ga with a less dynamic profile thus has 
a lower weighting factor (wa < wb).  In addition to alignment of transcriptome data, DTW 
has also been used to synchronize offline and online data of batch processes (Kassidas et 
al. 1998; Ramaker et al. 2003). 
 
Figure 6: Alignment of gene expression profiles using DTW. 
Two genes (ga and gb) are shown in two different series.  For each gene, discrete time points in series 1 are 
mapped to those in series 2.  The weighting factors (wa and wb) indicate the contribution of each gene to the final 
global adjustment.  Gene ga with a relatively flat profile is given a lower weight (wa < wb).  The same alignment is 
imposed on both genes. 
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Global alignment algorithms assume that all genes share the same alignment, that 
is, that all genes were affected in the same manner.  The existence of multiple biological 
clocks within the same cell, however, can result in sets of genes affected independently.  
In other words, genes in one set correspond to genes that follow a particular biological 
clock, sharing the same alignment, but they need to be warped separately from the rest of 
the genes.  Recently, Smyth et al. (Smith et al. 2009) have proposed an algorithm capable 
of identifying sets of genes that present similar alignments when aligned independently.  
The resulting sets include genes that follow similar warpings, even though their 
expression profiles might be very different. 
3.7 IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES 
After transcriptome data have been pre-processed, a number of statistical 
approaches can be used to identify differentially expressed genes.  Commonly used 
analytical methods for static transcriptome data include t-tests, ANalysis Of VAriance 
(ANOVA), Significance Analysis of Microarray data (SAM), and LInear Models for 
MicroArray data (limma).  These methods are not all directly applicable for dynamic 
studies involving a chronological set of samples collected over time, since a change in the 
time order will result in a different statistical inference (Storey et al. 2005).  Recently 
several methods based on regression, ANOVA, and Bayesian models have been adapted 
to handle time-series microarray data.  In addition, a distance calculation approach has 
also been proposed for identification of kinetically differentially expressed genes. 
3.7.1 Statistical Analysis of Gene Expression Data 
The estimates of gene expression levels provided by microarray data are generally 
prone to two types of errors – systematic and random errors.  Systematic error resulting 
from several factors such as RNA concentration measurement or dye-labeling efficiency 
can give rise to a systematic bias in the expression level estimates of all genes on the 
same array.  This bias is often corrected using one of the normalization methods 
presented in the previous section of data pre-processing.  Random error in the 
measurement of gene expression levels arises from random fluctuations in other steps, for 
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instance array scanning.  Inferential statistics is used to ensure the observed change in 
gene expression did not occur by random chance. 
Inferential statistics is applied to microarray data by invoking a null hypothesis.  
The null hypothesis holds true when all samples have the same average expression value 
for the gene of interest.  Conversely, if the gene is expressed at a different level in at least 
one sample, the alternative hypothesis becomes valid.  In order to assess the validity of 
either hypothesis, a test statistic is often estimated as the ratio between the change in a 
gene’s expression values among samples and the variability in those measurements.  
Further, a p-value computed using this test statistic is compared to an acceptable 
significance level .  The smaller the p-value is compared to , the stronger the evidence 
is against the null hypothesis, and in support of the gene being differentially expressed in 
at least one sample. 
In a typical microarray experiment, tens of thousands of genes are tested 
simultaneously, and a large number of them are likely to be identified as differentially 
expressed.  Even with a small p-value such as 0.01, which is normally considered to be 
rather stringent, a significant number of those identified as differentially expressed might 
be called so by random chance.  For example, if 1,000 genes out of 10,000 in total are 
identified as differentially expressed, each with a p-value < 0.05, then 500 of these 1,000 
genes might be identified by chance.  One way to control the potentially high error rate is 
to set each gene’s p-value to an n-fold lower significance level, /n, where n is the total 
number of genes.  This method is often referred to as the Bonferroni correction for the 
family-wise error rate – (FWER) (Bonferroni 1936).  However, this correction imposes 
an extremely stringent criterion.  In the previous example, the p-value will have to be set 
at less than 0.0000005.  This strict criterion would likely result in failure to identify the 
majority of genes that are indeed differentially expressed.  An alternative is to control the 
number of false positives among the number of genes declared as differentially expressed 
rather than the total number of genes.  This statistic, referred to as false discovery rate 
(FDR), is less stringent than the FWER and thus offers more power than the FWER to 
detect differential expression (Benjamini and Hochberg 1995).  Therefore, in multiple 
hypothesis testing, FDR is often used in place of p-value. 
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3.7.1.1 Statistical Analysis of Static Gene Expression Data 
A variety of methods are available for hypothesis testing.  A t-test is often used 
when only two samples are compared to test for differential gene expression.  When three 
or more samples are involved, ANalysis Of VAriance (ANOVA) is recommended to 
avoid performing multiple t-tests, which will most likely result in an increased false 
positive rate.  Both methods assume the expression levels of a gene in different samples 
follow a normal distribution.  When this assumption does not hold true, non-parametric 
tests including the Wilcoxon rank-sum test and a permutation-based test are often the 
methods of choice. 
3.7.1.1.1 t-test 
t-tests are considered the simplest statistical methods to identify differentially 
expressed genes.  A t-statistic is calculated as the ratio between the difference in gene 
expression levels of two samples and the pooled variance.  Furthermore, a degree of 
freedom is calculated from the sample sizes – with more penalties if the two samples 
have unequal variances (Welch’s t-test), and no penalties if the assumption of equal 
variances holds true (Student’s t-test).  A p-value, which can be obtained using the t-
statistic and the degree of freedom, is compared to a pre-defined significance level  to 
detect differential expression.  t-tests can be easily performed in Microsoft Excel, several 
R packages, and a variety of software including Spotfire and Expressionist. 
Gene expression responses during metabolic shift in a hybridoma cell culture 
have been investigated using the Student’s t-test on cDNA microarray data (Korke et al. 
2004).  More than 120 probes were identified as changing their expression levels (fold-
change ≥ 1   and p-value ≤   1) when the cells were shifted to the lactate consumption 
state.  Another example involves the survey of global gene expression changes in a 
recombinant antibody producing Chinese Hamster Ovary (CHO) cell line and a mouse 
hybridoma cell line under sodium butyrate treatment (De Leon Gatti et al. 2007).  Using a 
fold-change cutoff of 1.4 and a p-value cutoff of 0.05, most transcripts were found to be 
expressed at similar levels in both cell lines, indicating the transcriptional responses 
under exposure to sodium butyrate are rather conserved. 
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3.7.1.1.2 Analysis of Variance (ANOVA) 
When more than two samples are involved, single-factor ANOVA is often used.  
The overall variance in gene expression among different samples is partitioned into 
separate sources of variations.  The total variation, as evaluated by sum of squares 
(SSTotal), arises from two sources – the actual differential expression among these samples 
(SSTreatment) and the random error (SSError).  The mean sum of square for treatment 
(MStreatment) and that for error (MSerror) can be estimated by dividing each SS by the 
corresponding degree of freedom.  The quotient of these two MSs is taken as the F-
statistic, which further provides a p-value for inference of differential expression. 
When the experiment involves several variables, or factors as they are known in 
ANOVA, and one wishes to segregate the effects of those factors, multiple-factor 
ANOVA is used.  Based on the same working principles described above, multiple-factor 
ANOVA also partitions the total variation into different sources – the actual effect of 
each experimental factor, their interactions, and the random error.  A p-value for each 
term can be derived similarly, and whether these factors significantly affect the change in 
gene expression can thus be concluded.  Both single-factor and multiple-factor ANOVA 
can be performed easily using Microsoft Excel, as well as several R packages. 
Variation in gene expression within and between two populations of the genus 
Fundulus was uncovered using ANOVA on log2 normalized microarray data of 907 
genes (Oleksiak et al. 2002).  More than 160 genes were differentially expressed among 
individuals within a population, whereas only 15 genes differ between populations, 
suggesting that substantial natural variation exists in gene expression.  A linear ANOVA 
model was also fitted to the expression levels of more than 3,000 genes expressed during 
embryonic development of six Drosophila species (Kalinka et al. 2010).  More than 80% 
of genes best fit to models incorporating stabilizing selection, and maximal similarity is 
observed during mid-embryogenesis rather than early or late stages of development.  This 
result thus supports the developmental hourglass model, and the hypothesis that natural 
selection acts to conserve gene expression patterns during the phylotypic period. 
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3.7.1.1.3 Significance Analysis of Microarray (SAM) 
Similar to t-tests, SAM also calculates a “relative difference” (d), which 
resembles the ratio between difference in average gene expression values and the pooled 
variance in two treatments for each gene (Tusher et al. 2001).  The expression levels in 
all replicated samples of these two treatments are then permuted, and an average “relative 
difference” over these permutations (dE) is estimated.  For the majority of genes, which 
are assumed not to be differentially expressed, the average difference obtained from 
permutation (dE) is largely the same as the observed one (d).  If the discrepancy between 
dE and d exceeds a threshold, the gene is considered differentially expressed.  In order to 
calculate the FDR for each gene, two horizontal cutoffs are defined – one as the smallest 
observed difference of up-regulated genes, and the other as the least negative of down-
regulated genes.  The average number of genes with dE exceeding these cutoffs in all 
permutations can be considered as the number of false positives, and is used to assess 
FDR.  A convenient Microsoft Excel-add-in for SAM is available, and the packages 
siggenes and samr in R are also publicly accessible. 
The advantage of SAM over other statistical methods was demonstrated when 
examining the transcriptional responses of the human lymphoblastoid cells under 
irradiation (Tusher et al. 2001).  Thirty-four genes were identified as significant at an 
FDR of 12% using SAM, compared to more than 60% using other methods.  In another 
example, SAM was used to identify about 400 genes contributing to the impaired 
differentiation capacity of murine neural stem cells (NSCs) defective in p53 and PTEN 
genes (Zheng et al. 2008).  The majority of genes involved in cell cycle regulation were 
also found to be significantly down-regulated when HeLa cells were transfected with 
siRNA against PHF8, an H4K20me1 demethylase (Liu et al. 2010a). 
3.7.1.1.4 Linear Models of Microarray Data (limma) 
In this approach, a linear hierarchical model with arbitrary coefficients and 
contrasts across multiple samples for each gene is developed (Lonnstedt and Britton 
2005; Smyth 2004).  Further, marginal distributions of the observed statistics are used to 
estimate the hyperparameters under consistent and closed forms.  In addition, the 
ordinary t-statistic can be replaced by a moderated one, which implicitly results in 
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shrinkage of all gene-wise variances into a common value.  This moderate t-statistic 
follows a t-distribution with augmented degrees of freedom, and thus can be extended for 
multiple-sample comparisons by using the corresponding F-statistics.  The R package 
limma is publicly available. 
Transcriptional responses upon restoration of p53 in adenocarcinomas were 
revealed using limma (Feldser et al. 2010).  p53-restored samples were shown to cluster 
with adenomas rather than carcinomas, suggesting that adenocarcinoma cells can be 
specifically removed from the tumors.  limma was also used to compare gene expression 
signatures between cultured thymic epithelial cells (TECs) and multi-potent hair follicle 
(HF) stem cells (Bonfanti et al. 2010).  About 120 genes were identified to be 
differentially expressed between these two samples with a fold-change cut-off greater 
than four and a p-value less than 0.001. 
3.7.1.2 Statistical Analysis of Dynamic Gene Expression Data 
Time-series transcriptome data offer a great advantage to explore transcription as 
a dynamic process, yet their analysis is more complicated than analyzing multiple 
samples unrelated in time.  Transcriptional responses at a certain time point often carry 
information about cellular behaviors in previous stages.  Thus samples within a series are 
mutually dependent, and should not be analyzed using traditional statistical approaches.  
Rather, methods taking this interdependency into consideration, such as Extraction of 
Differential Gene Expression (EDGE), Microarray Significant Profiles (maSigPro), 
ANalysis Of VAriance – Simultaneous Component Analysis (ANOVA-SCA), and 
multivariate Bayesian models, are more suitable.  The number of time points in each 
series, the number of series, and the availability of replicates will guide the selection of 
an algorithm to use in data analysis.  This analysis can become even more challenging if 
the sampling frequency is not uniform across multiple series. 
3.7.1.2.1 Extraction of Differential Gene Expression (EDGE) 
In EDGE, differential analysis is also approached as a hypothesis testing problem. 
The null hypothesis is that a gene’s expression does not change either over time within a 
single treatment or across multiple treatments (Storey et al. 2007; Storey et al. 2005).  
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The expression profile of each gene is modeled using a p-dimensional basis, usually a p
th
-
order polynomial, or a natural cubic spline function.  The parameters of these functions 
are then estimated by minimizing the sum of squared errors (SSE) between the model-
fitted expression values and the corresponding actual ones.  The parameterization of gene 
expression profiles allows the hypothesis testing to be performed by comparison of the 
fitted parameters.  As such, an F-statistic is calculated for each gene to reflect the relative 
difference in SSE of the model-fitted gene expression profiles under the null and the 
alternative hypotheses, respectively.  This statistic is used alongside a null distribution 
generated using a resampling method to estimate a q-value, which accounts for the FDR 
incurred in multiple hypothesis testing (Storey and Tibshirani 2003). 
The open-source software EDGE (Leek et al. 2006) has facilitated the use of this 
methodology in analyzing time-course gene expression data.  Differential expression can 
be surveyed along the time axis within each treatment or across multiple treatments.  
EDGE was used to define the transcriptomic signatures of aging in several tissues in 
Drosophila melanogaster (Zhan et al. 2007).  In a mouse model, a complex 
transcriptional hierarchy comprising more than one thousand genes regulated during 
endocrine differentiation was also identified using EDGE (White et al. 2008). 
3.7.1.2.2 Microarray Significant Profiles (maSigPro) 
Microarray Significant Profiles, maSigPro (Conesa et al. 2006), uses a two-step 
regression approach to identify differentially expressed genes in time-series microarray 
data.  Single or multiple time series can be analyzed, with multiple time series being 
analyzed directly instead of performing multiple pair-wise analyses.  This methodology 
not only detects kinetically differentially expressed genes, but also uncovers changes in 
gene expression trends.  In the first step of gene selection, expression data are fitted using 
a global regression model which considers all experimental variables and their 
interactions.  If there are n groups, (n – 1) dummy variables are defined.  Each dummy 
variable allows the distinction between each group and the reference group.  Further, an 
ANOVA table is generated for each gene.  If the gene shows differences between any 
group and the reference group, the regression coefficients will be statistically significant 
as determined by an F-statistic and its associated p-value.  In the second step of variable 
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selection, the best model for each gene is obtained using a stepwise regression approach.  
The variables that best fit the data represent the time effects and their interactions with 
the dummy variables.  For finding those genes with significant differences in group x 
with respect to the reference series, the genes with significant coefficients for the dummy 
variable (x – 1) are selected. 
The package maSigPro is available in R and includes several tools for result 
visualization.  In addition, it is part of the oneChannelGUI package (Sanges et al. 2007), 
which provides a graphical interface for the analysis of Affymetrix microarrays and was 
included in the popular software Gene Expression Pattern Analysis Suite (GEPAS) 
(Tarraga et al. 2008).  An extension of maSigPro, maSigFun (Nueda et al. 2009), is used 
to fit regression models for genes with the same functional class and for the functional 
assessment of time-course microarray data.  maSigPro has also been implemented in 
Corra (Brusniak et al. 2008), an R package devoted to the analysis of LC-MS-based 
proteomics.  maSigPro has been used to analyze data from intrinsically dynamic 
processes such as the spatial differentiation in fungi (Levin et al. 2007), and plant 
development (Pascual et al. 2009; Wong et al. 2009a; Wong et al. 2009b), as well as 
periodic responses such as the rhythmically expressed genes in mouse distal colon 
(Hoogerwerf et al. 2008). 
3.7.1.2.3 ANOVA-SCA 
ANOVA-SCA (or ASCA for short) is considered a combination of a statistical 
method (ANalysis Of VAriance, ANOVA) and a dimensionality reduction approach 
(Simultaneous Component Analysis, SCA) (Jansen et al. 2005; Smilde et al. 2008; 
Smilde et al. 2005).  ANOVA-SCA is particularly useful when two or more quantitative 
variables are involved, such as time and dose.  In the first step, an ANOVA model is 
applied for each gene expression measure to separate the variability caused by these two 
different variables.  The model parameters obtained for all genes under each experimental 
condition are subsequently organized into a matrix form.  The second step involves 
applying principle component analysis simultaneously on all matrices obtained under all 
experimental conditions.  A number of constraints can be further imposed such that the 
resulting matrices are mutually independent.  Such constraints on orthogonality enable 
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the ASCA model parameters to be estimated independently by solving a simple least-
square optimization problem.  Statistical significance of these experimental variables and 
their interactions can be further inferred using a permutation approach (Vis et al. 2007).  
In particular, all experimental conditions are permutated to obtain a no-effect distribution, 
thus providing a baseline to conclude whether the observed effect is indeed significant. 
One of the earliest applications of ASCA resides in analyzing a metabolomics 
experiment wherein the effects of time and vitamin C dose on the NMR spectra of guinea 
pig urine samples were delineated (Smilde et al. 2005).  Individual variations caused by 
time and doxorubicin dose on metabolite MS profiles were also uncovered using ASCA 
in a toxicology study on rats (Wang et al. 2009a).  Given the intrinsic generalizability of 
ASCA, it is not surprising to find this approach extended into discovery of kinetically 
differentially expressed genes (Nueda et al. 2007).  Two statistics – SPE (Squared 
Prediction Error) and leverage – were proposed to evaluate the goodness of fit of the 
ASCA model, and the degree of agreement by which a gene profile follows the main 
expression patterns, respectively.  This adapted version of the original algorithm, ASCA-
genes, has been implemented in the R language.  Furthermore, ASCA-fun was devised to 
perform functional analysis on time-series microarray data (Nueda et al. 2009).  In this 
method, genes ranked according to their correlation to the principal time components 
identified by ASCA were used to assess functional enrichment in the dataset following 
Gene Set Analysis (GSA) procedures. 
3.7.1.2.4 Bayesian Approaches 
A multivariate empirical Bayes model was applied to time-series microarray data 
by Tai and Speed (Tai and Speed 2006).  The algorithm, implemented in the R package 
timecourse, however, requires replicates of the full time-series.  This algorithm calculates 
multivariate versions of the log-odds, or B-statistic (MB-statistic), and the Hotelling 
statistic (T
2
).  When the numbers of replicates are the same for all genes, the MB-statistic 
is equivalent to the T
2
-statistic.  The algorithm can be used in one-treatment problems 
and multi-treatment problems.  Although this method ranks the genes, it does not provide 
a significance cutoff. 
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A fully Bayesian approach for microarray analysis was implemented in clustering 
(Heard et al. 2006) and later for the analysis of time series (Angelini et al. 2007).  This 
fully Bayesian approach can handle short series, non-uniform sampling and missing data 
and does take into consideration the temporal structure of the time series.  Gene 
expression profiles are modeled with Legendre or Fourier polynomials, and the 
coefficients and the degrees of these polynomials are estimated using a Bayesian 
approach.  The differentially expressed genes identified in this Bayesian multiple-testing 
procedure are ranked, and their expression profiles are estimated.  This estimation allows 
the visualization of each gene expression profile as a single smooth curve. 
The fully Bayesian approach was demonstrated when analyzing the time series 
obtained by stimulating human breast cancer cells with estradiol after different time 
periods.  The algorithm is implemented in the Bayesian user-friendly software for 
Analyzing Time Series (BATS) (Angelini et al. 2008), a graphic user interface written in 
Matlab.  The BATS package requires 5-6 time points and replicates are recommended but 
not required.  At the moment, however, BATS can only handle one-treatment time series.  
Its extension to multiple time series is under development. 
3.7.2 Calculation of Distances between Gene Expression Profiles 
Just as in the calculation of the geometrical distance between any two vectors, a 
distance value can be computed to quantitatively describe the difference between two 
expression profiles of the same gene.  By condensing all distance measures between the 
corresponding time points, the comparison of these two profiles is reduced into a single 
number.  Two frequently used metrics are Euclidean distance and Pearson’s correlation 
(Figure 7). 
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Figure 7: Calculation of distance between the expression profiles of a gene in two series. 
The distance between the expression profiles of gene ga in three series can be measured using different metrics.  
The Euclidean metric quantifies the absolute geometric distance between the profiles, whereas the Pearson 
metric evaluates the correlation of trends in expression.  Thus even though the Euclidean distance of ga between 
series 1 and series 3 (Eucl (ga1, ga3)) is much higher than that between series 1 and series 2 (Eucl (ga1, ga2)), their 
Pearson distances (Corr(ga1, ga2) and Corr(ga1, ga3)) are indeed the same. 
 
Euclidean distance, also known as L-2 norm, assesses the absolute difference 
between two time profiles.  As a result, genes with the highest Euclidean distance 
between two treatments are often the ones with a high expression level, and are most 
likely to be identified as differentially expressed despite having similar expression trends 
in these treatments.  Gene expression data can thereby be mean-centered or z-transformed 
to alleviate the dominance of these high-abundance transcripts.  On the other hand, 
Pearson’s correlation quantifies the overall similarity between the two trends regardless 
of the absolute values of gene expression.  Small fluctuations in gene expression between 
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low-abundance transcripts can thus be manifested as being markedly different since only 
expression trend is considered. 
The choice of distance metric therefore depends on the question being asked.  If 
the absolute values of expression measures are critical, the Euclidean metric is often 
preferred   Alternatively, the Pearson’s correlation coefficient is a more suitable 
similarity measure if the overall trend of expression is pertinent to the analysis.  A 
combination of both metrics is therefore recommended to integrate the differences in 
absolute expression magnitude and expression trend. 
Following selection of a proper metric and distance calculation, a distribution of 
this representative difference can be plotted, and a threshold is often set to declare 
differential expression.  Genes having distance measures between the expression profiles 
in two treatments above a certain threshold are considered differentially expressed.  
Manual inspection of gene expression profiles is often recommended to confirm the 
differential expression.  In addition, if both treatments were replicated, a statistic can be 
derived by permuting replicated samples between the two treatments.  An average 
distance over all permutations is calculated, and compared to the actual distance to infer a 
statistical significance level.  Yet optimizing the difference threshold between the average 
and the actual distance can be challenging. 
This approach was used in a number of studies conducted in Streptomyces 
coelicolor.  Genes involved in regulatory circuits related to antibiotic production were 
identified using Euclidean distance as a criterion for differential expression (Mehra et al. 
2006).  Euclidean distance was also used in conjunction with principal component 
analysis (PCA) to reveal genes kinetically perturbed when the Streptomyces coelicolor 
sigma-like protein AfsS was disrupted (Lian et al. 2008).  In a recent study, more than 
900 genes were identified as differentially expressed in an antibody-producing CHO cell 
line between the butyrate-treated 33°C culture and the non-treated culture (Kantardjieff et 
al. 2010). 
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3.8 PROFILE PATTERN RECOGNITION 
Microarray data, with their large size and high-dimensionality, are inherently 
complex.  Compared to the number of genes (i.e., dimensionality), the number of samples 
is almost always small, making it difficult to find an answer to the question being asked.  
Often, an objective in a microarray experiment is to identify genes with a certain profile 
or pattern.  Sometimes, however, which patterns are present in the data are not even 
known.  In order to identify patterns that exist in the data, two types of techniques can be 
used: unsupervised and supervised algorithms. 
3.8.1 Unsupervised Classification Methods 
Unsupervised pattern recognition consists of organizing data based on the 
properties of data themselves without reference to additional information (Gollub et al. 
2006).  Mathematical algorithms determine the search for natural patterns existing in the 
data (Morrison and Ellis 2003).  The goal of unsupervised pattern recognition is to 
identify small subsets of genes that display similar expression patterns (Boutros and Okey 
2005).  Instead of clustering genes, clustering samples based on their expression profiles 
can also be a goal in clustering analysis.  In this case samples with similar expression 
profiles might help identifying groups, or labels, that can be given to those samples.   
Although the term unsupervised pattern recognition is commonly used as a synonym for 
“clustering”, it actually encompasses other techniques, such as non-negative matrix 
factorization (NMF) and principal component analysis (PCA). 
3.8.1.1 Dimensionality Reduction Techniques 
Because microarray data often are obtained from only a small number of samples 
and entail thousands of genes, dimensionality reduction can be helpful for visualization, 
clustering, and classification.  When transcriptome data are represented as an n by m 
matrix, in which n is the number of genes and m the number of samples (n >> m), 
dimensionality reduction techniques can be used to identify a smaller number k of 
principle gene expression patterns (Figure 8).  This can be done by factorizing the 
original gene expression matrix (A) into two sub-matrices: one containing eigenarrays 
(W) and the other containing k eigengenes (H).  The expression level of each gene in 
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these m samples can be represented as a linear combination of the k eigengenes.  
Similarly, the overall expression pattern in each sample can be represented as a linear 
combination of the k eigenarrays. 
 
Figure 8: Matrix factorization in dimensionality reduction techniques: NMF and PCA. 
Microarray data are organized into a matrix (A) with each row representing the expression levels of a gene in m 
samples.  This original matrix can be decomposed into two sub-matrices: one containing k eigenarrays (W), and 
the other containing k eigengenes (H).  The expression levels of each gene in these m samples can be represented 
as a weighted combination of the k eigengenes.  Similarly, the overall gene expression pattern in each sample can 
be represented as a weighted combination of k eigenarrays. 
 
In principal component analysis (PCA), the data are transformed into a new set of 
variables called principal components (PCs).  The principal components are uncorrelated, 
and furthermore, they are ranked so that the first PCs contain most of the variation 
present in all of the original variables (Jolliffe 2005).  Since the first few PCs capture 
most of the variation in the original data, it is customary to use only the first few PCs 
(Yeung and Ruzzo 2001).  When the data are projected along the first few PCs (most 
commonly the first two or three), in many cases it is possible to identify groups. 
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In PCA, the gene expression values can be reconstructed by a weighted sum of 
the eigengenes, however there is no restriction on the sign of the weights.  This can cause 
some variability due to cancellations, if eigengenes with both negative and positive 
weights are added.  In a similar technique, Non-negative Matrix Factorization (NMF), the 
coefficients are forced to be non-negative, which ensures that the contributions from 
principal gene expression patterns are positive and thus additive (Brunet et al. 2004; Lee 
and Seung 1999). 
Both techniques, PCA and NMF, have been used in the identification of 
biomarkers, for example see (Schachtner et al. 2007).  PCA has been used to characterize 
the gene expression of stem cells in different phases (Aiba et al. 2006) and different types 
of stem cells (Ulloa-Montoya et al. 2007).  As NMF has been found superior to PCA in 
reducing microarray data (Liu et al. 2008), it has been used more extensively in the 
identification of cancer molecular patterns for gene expression data (Brunet et al. 2004; 
Frigyesi and Hoglund 2008; Han 2008). 
3.8.1.2 Clustering 
Clustering is one of the most widespread tools for grouping transcripts in 
microarray data.  The concept of clustering is based on the simple idea of grouping 
similar objects.  The goal is to maximize the similarity between objects in the same 
cluster, and minimize the similarity of objects in different clusters.  How similarity is 
measured is thus a key part of clustering algorithms.  In the case of microarray data, the 
expression profile of a gene, made up by the different samples, is seen as a series of 
coordinates that define a vector (Sherlock 2000).  Distance metrics can thus compare the 
similarity of the direction and/or magnitude of two or more vectors. 
Traditional clustering algorithms have existed since the 1950s and have been 
applied to a number of problems, including image analysis, marketing, document 
classification, and population studies.  These traditional algorithms have also been used 
to cluster transcriptome data.  In addition, specialized clustering algorithms have been 
developed for time-series data. 
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3.8.1.3 Clustering of Static Samples 
In the case of static sampling, transcriptome data can be represented as a matrix, 
with each row representing a gene, and each column representing a single condition.  The 
data can thus be represented as vectors and the distance between these vectors can be 
determined.  Note that there are two ways to organize the data.  One is to take the 
expression value of each gene across different samples as a vector.  The other one is to 
take the expression of all genes in a sample as a vector.  Clustering can thus be used to 
find genes behaving similarly in different samples or samples which are “similar” in 
overall gene expression.  In the following section, all examples are illustrated as 
clustering genes with similar transcriptional behaviors in different samples.  The 
alternative of classifying samples based on their overall gene expression data is 
demonstrated in the supervised classification topic. 
A distance measure (such as Euclidean, Manhattan, Chebyshev, Mahalanobis, 
Pearson, cosine, Spearman, or Kendall) is used to assess similarity and the data are then 
organized into clusters according to clustering rules.  These clusters can be of fixed size, 
(i.e. the number of clusters determined a priori), or natural clusters discovered in the 
data.  The most commonly used clustering algorithms broadly correspond to two 
categories: hierarchical clustering and partitional clustering. 
Hierarchical clustering can be bottom-up, starting with single-gene clusters and 
joining the most similar clusters until a single cluster with all genes is obtained; or top-
down, starting with all genes in a single cluster and dividing them into smaller clusters 
(Nugent and Meila 2010).  In both cases, the result is represented as a hierarchical tree, or 
dendogram.  Most commonly, the bottom-up approach is used (Figure 9).  Initially, two 
closest genes (1 and 2; 3 and 4) are joined using one of the distance metrics.  In the next 
iteration, a linkage or amalgamation rule is needed to join these multiple-gene clusters 
(Frades and Matthiesen 2010).  This rule can be single-linkage, complete-linkage, or 
average linkage.  In single linkage (aka nearest neighbor), the similarity of these two 
clusters is the shortest distance of all pair-wise comparisons of the genes in one cluster to 
the other; in this example, the distance between gene 1 and gene 3.  In complete linkage 
(aka furthest neighbor), the similarity of these two clusters is defined as the largest 
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distance of these pair-wise comparisons; in this case, the distance between gene 2 and 
gene 4.  In average linkage, the distance between these two clusters is that between their 
centroids (Gollub et al. 2006).  In this instance, the centroid of the first cluster is a 
hypothetical gene “in the middle of” gene 1 and gene  , and thus its expression level is 
taken as the average expression level of these two genes. 
 
Figure 9: Simple illustration of hierarchical clustering. 
The algorithm starts with each gene belonging to its own cluster, followed by joining the two closest genes: 1 and 
2.  Subsequently, individual genes or multi-gene clusters are joined using single linkage, complete linkage, or 
average linkage.  In this case, single linkage is used, i.e., the distance between two clusters is taken as the shortest 
distance between any two members of the clusters.  Thus the distance between cluster 1-2 and cluster 3-4 is the 
distance between genes 1 and 3.  The two closest clusters are joined accordingly, in this case cluster 1-2 and 
cluster 3-4.  This grouping is continued until all genes are joined into one cluster, and the whole process can be 
visualized as a dendogram. 
 
Hierarchical clustering has been used extensively to compare cell types and 
tissues, including diseased vs. healthy cells, and drug effects, for example (Ambrosi et al. 
2007; Anichini et al. 2003; Fortier et al. 2010; Secco et al. 2009; Vega et al. 2006).  
Hierarchical clustering has also been used to classify proteomic profiles of serum, 
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plasma, and modified media supplements used in cell culture (Ayache et al. 2006), and 
metabolomic profiles of extracellular metabolites in recombinant CHO fed-batch cultures 
(Chong et al. 2009). 
In partitional clustering, data points are separated into a pre-defined number of 
clusters.  In the first step of these iterative algorithms, data points are randomly assigned 
to clusters.  The distance between individual data points and the clusters is then 
calculated and used to reassign the data points to the cluster to which they are closest.  
This process continues until all data points are assigned to the closest cluster (De Bruyne 
et al. 2005).  K-means clustering, Self-Organizing Maps (SOM), and Fuzzy C-means 
(FCM) clustering are among the best known clustering algorithms in this category.  One 
limitation of these algorithms is that the number of clusters has to be fixed from the 
beginning, and thus the results are dependent on it (Dopazo et al. 2001). 
In k-means clustering (Everitt 1974b), k is the number of clusters and is a required 
input.  k random points are used as cluster centers (or means) at initialization.  All data 
points are assigned to these initial clusters by finding the one with the closest distance.  In 
iterative steps, the mean of each cluster is recalculated and the data points reassigned to 
new clusters (Do and Choi 2008).  This process continues until the assignment does not 
change considerably.  As the value of k greatly influences the final outcome, several 
algorithms include a procedure to determine the best k.  k-means clustering has been used 
to analyze transcriptome data of cancer cells (Liu et al. 2010b), and stem cells (Ulloa-
Montoya et al. 2007; Way et al. 2009) among others. 
Similar to k-means clustering, in the case of SOMs (Kohonen 2001), the number 
of clusters is also a required input.  In addition, their geometry must be specified (grid 
size).  Thus not only the number of clusters but also their geometry has an effect on the 
final clustering result.  A seed vector is first assigned to each cluster, and data assigned to 
these clusters in an iterative process.  In each iteration, gene expression data randomly 
selected is compared to the seed vectors.  The gene is assigned to the cluster that has the 
more similar seed vector.  The value of the seed vector is updated, so that it is more 
similar to the expression of the gene used in the comparison.  Because the cluster centers 
are part of a grid, the values of the other seed vectors are also modified although to a 
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lower extent.  SOMs have been used to analyze monolayers of cultured rat hepatocytes 
(Baker et al. 2001), to study hematopoietic differentiation (Tamayo et al. 1999), to 
investigate the saline osmotic tolerance in yeast (Pandey et al. 2007), and to investigate 
hepatic differentiation (Li et al. 2007b), among others. 
Whereas k-means and SOM assign each gene to a single cluster (hard clustering), 
FCM (Bezdek 1981) links each gene to all clusters using a series of values.  Values close 
to 1 indicate strong association to a cluster, and values close to 0 indicate absence of 
association.  These indexes define the membership of each gene with respect to all 
clusters (Dembele and Kastner 2003).  In addition to the number of clusters, the fuzziness 
parameter is also a required input.  Kim et al. (Kim et al. 2006) have reported that the 
fuzziness parameter is sensitive to the normalization method used, and thus the clustering 
results vary with the normalization method.  Recently, a method for the determination of 
the optimal parameters for FCM has been proposed (Schwammle and Jensen 2010).  
FCM has been used to analyze gene expression profiles in high-grade gliomas (Czernicki 
et al. 2007) and in tumor sample classification (Wang et al. 2003). 
3.8.1.4 Clustering of Dynamic Samples 
Clustering algorithms such as hierarchical clustering, k-means, and SOM, are also 
commonly used to analyze time-series data.  However, these algorithms do not take into 
account the sequential aspect of time-series data (Tchagang et al. 2009).  Thus clustering 
of time series requires specialized algorithms.  Some of the specialized algorithms require 
long series (> 10 time points), whereas others have been developed specifically for short 
time series. 
B-splines (Bar-Joseph et al. 2003; Gaffney and Smyth 2005; Luan and Li 2003), 
linear splines (De Hoon et al. 2002), ordered restricted inference (Peddada et al. 2003), 
hidden Markov models (Schliep et al. 2003), and gene expression dynamics using 
regression (Ramoni et al. 2002) are examples of clustering algorithms that can be used 
for long  time-series data.  Fuzzy C-Varieties with Transitional State Discrimination 
preclustering (FCV-TSD) (Moller-Levet et al. 2003), ASTRO and MiMeSR (Tchagang et 
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al. 2009), and Short Time-series Expression Miner (STEM) (Ernst and Bar-Joseph 2006) 
are examples of clustering algorithms developed specifically for short time series data. 
STEM selects a set of potential expression profiles, each representing a unique 
pattern.  Each gene is then assigned to the profile that best represents it.  The significance 
of each profile is determined using hypothesis testing.  The number of genes assigned to 
each profile under the true ordering is compared to the average number of genes assigned 
to each profile when permutated data are used.  The significant profiles can then be 
analyzed independently or grouped into clusters.  STEM has been used to cluster time-
course microarray data collected in the study of egg development in Drosophila 
melanogaster (Baker and Russell 2009), salt stress in Medicago truncatula (Lievens et al. 
2009), and muscle differentiation (Ozbudak et al. 2010). 
Biclustering takes clustering algorithms a step further.  It consists of simultaneous 
clustering of both genes (rows) and conditions (columns) (Cheng and Church 2000).  The 
goal in biclustering is to find submatrices (Madeira and Oliveira 2004), that is, to identify 
subgroups of genes and/or subgroups of conditions with highly correlated behaviors.  
Thus biclustering can find correlations in certain datasets where other algorithms cannot.  
Biclusters can be of constant row, constant column, or both constant row and column. 
Among the software that can perform biclustering are Gene Expression Mining 
Server (GEMS) (Wu and Kasif 2005), Expression Analyzer and DisplayER 
(EXPANDER) (Shamir et al. 2005), Phase-shifted Analysis of Gene Expression (PAGE) 
(Leung and Bushel 2006), Biclustering Gene Expression Time Series (BIGGEsTS) 
(Goncalves et al. 2009), Biclustering algorithm and Visualization (BiVisu) (Cheng et al. 
2007), and Biclustering Analysis Toolbox (BicAT) (Barkow et al. 2006), which 
integrates several biclustering algorithms. 
3.8.2 Unsupervised Classification Methods 
Unsupervised classification methods are used for the identification of naturally 
existing clusters within the data. Supervised approaches, on the other hand, are designed 
to address the following question – Given a set of samples categorized into pre-defined 
groups (training set); can we use the gene expression data of these samples to construct a 
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rule, or a function, to differentiate these groups?  This also implies the ability to use this 
rule for classification of new, uncategorized samples (test set) based on their expression 
data. 
Since the classification rule is built upon the training set, it may fit this dataset 
“too well” and thus have poor performance on unclassified samples in the test set (Figure 
10a).  In this example, the high producer clones (blue circles) and the low producer 
clones (black squares) can be simply separated by a linear model (solid line), allowing 
several samples to be misclassified (outliers).  Yet the model can become over-
complicated (dash line) when trying to classify correctly all outliers and thus often results 
in higher error rate in classifying regular samples   This is known as “overfitting”, and 
ideally should be assessed using an independent test set.  However, in situations where 
acquiring additional data is expensive or not feasible, various cross-validation schemes 
can be used.  The leave-one-out scheme allocates one sample for testing whereas the rest 
are used to train the classification model.  In the hold-out scheme, the data are split into 
two equal sets – one is used for training, and the other for testing.  Another frequently 
used method is the k-fold cross-validation, in which the data are divided into k sets – the 
first (k-1) sets are used for training, and the last one for testing (Figure 10b).  This 
process is repeated until all data have been used for testing.  Commonly used supervised 
classifiers for gene expression data include k-Nearest Neighbors (KNNs), decision trees, 
Artificial Neural Networks (ANNs), and Support Vector Machines (SVMs).  These 
algorithms have been implemented in several code libraries and various downloadable 
packages in Matlab and R. 
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Figure 10: Overfitting of training data and k-fold cross validation scheme. 
a) High producer clones (blue circles) and low producer clones (black squares) can be separated using a linear 
model (solid line) with a few outliers.  Yet the model can become complicated (dash line) when all outliers 
are taken into consideration.  This overfitted model will have high error rate when classifying new samples. 
b) The data are split into k subsets: (k-1) subsets are used for training the model, and testing is performed on 
the kth subset.  This process is repeated k times until all data have been used for testing. 
 
3.8.2.1 K-nearest Neighbors (KNNs) 
KNN is among the simplest and most fundamental of the classification methods, 
and is often the first choice when prior knowledge about the dataset is minimal.  Given 
that a set of samples has been classified into different groups, a new sample will be 
assigned into the group whose members constitute the majority in the neighborhood of 
the sample (Cover and Hart 1967; Tan et al. 2005).  The choice of distance metric thus 
becomes vital in this case – a new sample can be assigned to a different group when a 
different distance metric is applied.  In addition, if a certain group is dominated in size 
compared to the others, a bias in assigning new samples into that group is likely to occur.  
One way to circumvent this problem involves giving each “neighbor” a weight inversely 
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proportional to its distance to the new sample.  Furthermore, the distance threshold and 
the number of “neighboring” samples k also have an effect on the final classification, and 
thus should be optimized using cross-validation. 
In the FDA MicroArray Quality Control (MAQC) project, a KNN data analysis 
protocol was developed to predict the clinical outcome of about 500 new neuroblastoma 
patients (Parry et al. 2010).  These KNN models were built using a large gene expression 
dataset obtained from approximately 700 breast cancer, neuroblastoma, and multiple 
myeloma samples.  In another example, gene expression signatures from 4413 probes in 
37 colorectal cancer samples were also used to train a KNN model which was further 
validated using a leave-one-out scheme (Laiho et al. 2006).  This model successfully 
classified these samples into serrated and conventional colorectal cancer samples using 
the expression data of 10 genes. 
3.8.2.2 Decision Trees 
Decision trees are built using an iterative scheme wherein a question about the 
gene expression signatures of the training samples is posed at each node (Breiman et al. 
1984; Kingsford and Salzberg 2008; Quinlan 1993; Tan et al. 2005).  The entire tree is 
obtained by repeated splitting of those samples into two or multiple descendant subsets.  
The training samples will guide the choice of splitting rules such that each terminal node 
of the tree, i.e., leaf, is assigned a group label.  Thus decision trees are often more 
interpretable than other classifiers, and naturally support multiple-group assignment.  
Furthermore, multiple decision trees can be combined into an ensemble, e.g., random 
forest, to increase the classification accuracy (Breiman 2001; Tong et al. 2003).  When 
applying decision trees, it is critical to control the complexity of the tree, i.e., avoid 
overfitting the training data.  In addition to using cross-validation, one can also prune the 
tree by collapsing several internal nodes into one leaf, or stop branching the tree when 
there is no substantial improvement in the homogeneity of the final group assignment. 
Several decision tree algorithms were applied to 869 genes differentially 
expressed in earthworms in response to explosive compounds TNT or RDX (Li et al. 
2010).  Over 350 genes were subsequently selected by these algorithms as classifiers, and 
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ranked according to their significance in the assembled tree.  In another application, 
hierarchical clustering results of gene expression data from three different cohorts of 481 
breast cancer samples were further analyzed using decision trees (Ihnen et al. 2010).  
Four groups with different expression levels of osteopontin (OPN), activated leukocyte 
cell adhesion molecule (ALCAM), human epidermal growth factor 2 (HER2), and 
estrogen receptor (ER) were found.  Patients with high OPN and low ER, HER2 and 
ALCAM were placed in a particularly high risk group. 
3.8.2.3 Artificial Neural Networks (ANNs) 
ANNs were developed based on the computation principles occurring in the 
network of neurons within the human brain (Krogh 2008; Minsky and Papert 1969; Tan 
et al. 2005).  An ANN model can be considered as an assembly of interconnected nodes 
in which all input sources, in this case the expression values of all genes on the array, are 
weighted and combined.  This weighted average is compared to a threshold, yielding an 
output value based on a step function.  If the average exceeds the threshold, the output 
value will be one, corresponding to one group; otherwise it is zero, which corresponds to 
the other group.  During the training process, the weighting factors and the threshold can 
be estimated iteratively, and a linear decision boundary (i.e., separating hyper-plane) can 
be obtained.  Yet when the data are not linearly separable, hidden layers of intermediate 
nodes can be added to the network.  A partial classification is performed at each layer, 
and assembled to achieve the final classification at the output node.  Furthermore, 
alternative functions such as sigmoid or linear models can be utilized in place of the 
simple step function in these feed-forward neural networks. 
Using gene expression data obtained from 63 training samples of small, round 
blue cell tumors (SRBCTs), 3750 ANNs have been constructed and cross-validated 
(Khan et al. 2001).  Without over-fitting, these models successfully classified the samples 
into four diagnostic categories of tumors.  ANNs have also proven efficient in tracking 
transcriptional changes responsible for progression from the chronic stage to a highly 
aggressive acute stage of adult T-cell leukemia (ATL) (Choi et al. 2006).  Using gene 
expression data from more than 44,000 probe sets and 10-fold cross validation on 37 
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samples,    “predictor” genes could be identified, offering the possibility to diagnose 
different ATL stages. 
3.8.2.4 Support Vector Machines (SVMs) 
In binary SVM, two groups (for example, high producer clones and low producer 
clones) are separated in such a way that the distance between the training samples and the 
decision boundary is maximized (Boser et al. 1992; Noble 2006; Tan et al. 2005) (Figure 
11).  This optimization process results in the construction of a separating hyper-plane, 
e.g., a linear line in 2-dimensional space, which maximizes the margin between the two 
groups.  In several cases where the samples are not linearly separable in the original 
space, a kernel function can be chosen to transform the data to a higher-dimensional 
space in which a “linear” hyper-plane can be found.  Furthermore, a few anomalous 
samples are often allowed to be misclassified to achieve a larger margin.  Thus a cost 
function has to be selected and optimized such that the size of this “soft” margin is 
balanced with the allowable degree of hyper-plane violation. 
 
Figure 11: Support Vector Machines (SVMs) with soft margin. 
Binary SVM algorithms search for a separation hyperplane that maximizes the margin (or distance) between 
two groups: in this case, high producer clones and low producer clones.  Samples on the margins are referred to 
as “support vectors”.  A few samples can be misclassified in order to obtain a maximal margin (“soft margin”). 
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Gene expression data from 97,802 clones were used to construct several SVM 
models using the simple dot-product kernel and validated through the leave-one-out 
scheme (Furey et al. 2000).  Thirty-one human tissue samples were successfully 
classified by these models into cancerous ovarian and normal tissues.  Interestingly, an 
SVM model was also built using gene expression profiles from seven high and four low 
recombinant IgG-producing NS0 cell lines.  Through the leave-one-out cross-validation 
process, the transcriptomic differences between these high and low producers were 
indeed highlighted, supporting the molecular basis of productivity trait (Charaniya et al. 
2009). 
3.9 PATHWAY ANALYSIS 
Microarray analysis results in a list of differentially expressed genes or genes with 
a dynamic trend over time.  It is possible that the transcriptional changes seen on those 
genes might not be independent, but rather have occurred in a coordinated manner.  Thus 
understanding the physiological relevance of these changes requires analysis in a 
biological context, beyond what differential expression analysis can determine.  
Furthermore, examining genes in each pathway as a whole allows one to detect subtle, 
yet consistent, transcriptional changes that would otherwise be neglected by differential 
gene expression analysis. 
Pathway analysis involves mapping the list of differentially expressed genes onto 
known pathways in order to elucidate a whole chain of events which might have occurred 
during the experiment.  Depending on the microarray platform, probe IDs can be linked 
to different sources of annotation, for instance, Gene Ontology (GO), Kyoto 
Encyclopedia of Genes and Genomes (KEGG), and Gene Map Annotator and Pathway 
Profiler (GenMAPP).  This retrieval of pathway information allows all differentially 
expressed genes in a certain pathway to be highlighted.  Yet statistical tests need to be 
performed to confirm whether the entire pathway is indeed enriched or under-represented 
rather than occurring by random chance.  A number of methods and software have been 
developed to assess the statistical significance of this functional enrichment/under-
representation, including Ingenuity’s IPA, GeneGo’s MetaCore, GenMAPP’s 
MAPPFinder, Gene Set Enrichment Analysis (GSEA) (Subramanian et al. 2005), and 
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Gene Set Analysis (GSA) (Efron and Tibshirani 2007).  Those methods differ in the 
calculation of the enrichment score and the corresponding significance level, usually p-
value or FDR.  For illustrative purposes, two representative methods, MAPPFinder and 
GSEA, are described in the following section. 
3.9.1 MAPPFinder 
In order to assess the degree of enrichment for each pathway (or gene set), 
MAPPFinder calculates a z-score using the number of differentially expressed genes in 
the set, the number of genes in the set, the number of differentially expressed genes in 
total, and the total number of genes on the array (Dahlquist 2002; Dahlquist et al. 2002; 
Doniger et al. 2003).  A high positive z-score indicates that the pathway of interest is 
significantly enriched, and an extreme negative z-score suggests that it is under-
represented.  Furthermore, if a p-value is desired, a z-score of 1.96 or -1.96 can be 
converted to a p-value of 0.05 given that the data strictly follows a hyper-geometric 
distribution.  It is important to note that similar to several other pathway analysis tools, 
MAPPFinder also requires a pre-defined list of differentially expressed genes.  This is 
sometimes challenging since the list can vary considerably depending on the selected 
fold-change and the p-value cutoff. 
Prickett et al. have demonstrated the use of MAPPFinder in uncovering several 
immune-system pathways affected in chicken infected with a protozoan parasite (Prickett 
and Watson 2009).  About 1,175 genes, accounting for about 10% of total unique 
Ensembl genes present on the array, were mapped to 85 inferred chicken pathways in 
GenMAPP, 18 of which were either up- or down-regulated at a p-value cut-off of 0.05.  
In another study, functional enrichment information obtained from MAPPFinder was 
linked automatically to the original gene expression data to calculate the average intensity 
or ratio of all differentially expressed genes in each pathway (Yu et al. 2006).  This 
quantitative evaluation of dose- and time-dependent microarray data in rats exposed to 
toxicants thus allows one to calculate an effective dose (ED50) for each pathway, which 
plays an important role in risk assessment. 
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3.9.2 Gene Set Enrichment Analysis (GSEA) 
GSEA is a powerful tool for pathway analysis which calculates gene set 
enrichment using all genes present on the array instead of a pre-defined set of 
differentially expressed genes (Gene Set Enrichment Analysis ; Mootha et al. 2003; 
Subramanian et al. 2005).  An ordered list is first generated by ranking all genes in the 
dataset based on their signal-to-noise ratio (Figure 12). 
 
Figure 12: Gene Set Enrichment Analysis (GSEA). 
Genes are ranked based on their signal-to-noise ratios to create an ordered list.  A running sum statistic is 
calculated by walking down this list.  If the encountered gene is part of the gene set of interest, the running sum 
statistic is increased; otherwise, it is decreased.  The enrichment score of each gene set is chosen as the maximum 
deviation of this statistic from zero.  Genes with key contributions to the enrichment of the gene set are listed in 
the leading edge subset. 
 
This ratio is often the quotient between the difference in average expression levels 
and the overall variability of measurement.  In the second step, a running-sum statistic is 
measured for each pathway (or gene set) by travelling down the ordered list.  If the 
encountered gene is a part of the gene set of interest, the statistic is increased; otherwise it 
is decreased.  The magnitude of this change is set to be proportional to the signal-to-noise 
of that gene and the size of the gene set it belongs to.  The maximum deviation from zero 
of the running-sum statistic is chosen as the enrichment score (ES), and an associated 
statistical significance (p-value) can be calculated using a permutation scheme.  
Concurrently, a leading-edge subset of genes, which are key contributors to enrichment 
of the functional class represented by the gene set, can also be exported. 
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Deregulated functional categories in Ewing’s sarcoma family tumors (ES T) cell 
lines under hypoxia were identified by applying GSEA with three different gene sets 
(Aryee et al. 2010).  Hypoxia-related functions such as angiogenesis, vasculature 
development, and glucose metabolism were shown to be up-regulated under hypoxic 
conditions.  GSEA was also used alongside other pathway analysis tools to investigate 
the biological relevance of transcriptional differences between neurofibromatosis type 1 
(NF1)-haploinsufficient lymphoblastoid cell lines (LCLs) and mouse B lymphocytes 
(Pemov et al. 2010).  Despite the modest changes in gene expression detected using t-test, 
several pathways were revealed to experience perturbations including cell cycle, DNA 
replication and repair, transcription and translation, and immune response. 
3.10 NETWORK RECONSTRUCTION 
Gene network inference attempts to reconstruct gene networks reflecting their 
interactions from high-throughput data, especially microarray data.  Network 
reconstruction is a challenging task as gene interactions are dynamic and membership of 
particular elements in a network is not always permanent.  In this regard, the use of 
microarray data compiled under a wide range of conditions, or from a variety of mutants, 
can help unveil interactions.  Also, time-series microarray data are of particular relevance 
in reverse engineering regulatory networks.  In addition to algorithms for constructing 
regulatory networks using static gene expression data, special algorithms have also been 
developed for data obtained from time-series microarrays. 
3.10.1 Network Reconstruction from Static Gene Expression Data 
3.10.1.1 Information Theoretic Methods 
Several methods based on information theory have been used for reverse 
engineering cellular networks from microarray expression profiles.  These methods 
calculate mutual information (MI) between pairs of gene expression profiles.  An 
advantage of MI over other measures of relatedness is that it can detect non-linear 
interactions.  Although these algorithms can be used on time-series data, the sequential 
aspect is lost, as each sample time point would be considered a different condition. 
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The original algorithm, relevance networks (RELNET) (Butte and Kohane 2000), 
infers an interaction if MI for a pair is larger than a threshold.  RELNET has been applied 
to reconstruct networks in yeast (Butte and Kohane 2000), in cancer cell lines (Butte et 
al. 2000), in human hepatoma cells (Moriyama et al. 2003), and to identify hub cancer 
genes (Jiang et al. 2008).  This approach, however, can result in many false positives, 
thus extensions which discriminate between direct and indirect interactions have been 
developed. 
Extensions to RELNET proceed in two steps.  The first is common to all methods, 
and consists of calculating MI between pairs of gene expression profiles.  In the second 
step the MI values are assessed and compared, and interactions inferred.  The second step 
is unique to each method. 
Context Likelihood of Relatedness (CLR) (Faith et al. 2007) is an algorithm that 
removes false correlations by comparing MI for each pair with a background distribution 
of MI scores.  CLR was used to reconstruct parts of the transcriptional regulatory 
network of the pathogen Salmonella typhimurium (Taylor et al. 2009). 
A second algorithm based on relevance networks, the Algorithm for the 
Reconstruction of Accurate Cellular Networks (ARACNE) (Basso et al. 2005; Margolin 
et al. 2006a; Margolin et al. 2006b), eliminates indirect relationships by using data 
process inequality (DPI), a characteristic of mutual information.  ARACNE has been 
used in reverse engineering the regulatory networks of human B cells (Basso et al. 2005), 
in the identification of the targets of the transcriptional repressor BCL6 (Basso et al.), in 
the reconstruction of red blood cell metabolism from metabolic data (Nemenman et al. 
2007), and in the genome-wide reconstruction of the regulatory networks of Streptomyces 
coelicolor (Castro-Melchor et al. 2010), an antibiotic producer.  CLR and ARACNE were 
both used to identify genes regulated by Nrf2 in response to oxidative stress (Taylor et al. 
2008), and to infer the connectivity of phosphorylation sites in receptor tyrosine kinases 
(Ciaccio et al.). 
A third algorithm, Minimum Redundancy Networks (MRNET) (Meyer et al. 
2007), performs a series of maximum relevance/minimum redundancy (MRMR) 
59 
selection procedures for each gene and selects the genes having the highest MI with the 
target. 
RELNET, CLR, ARACNE, and MRMR are included in the R package minet (Mutual 
Information NETwork inference) (Meyer et al. 2008).  The networks resulting from these 
algorithms can be visualized using the R package Rgraphviz (Carey et al. 2005).  In 
addition, the Java implementation of ARACNE includes Cytoscape (Shannon et al. 2003) 
for network visualization. 
3.10.1.2 Bayesian Networks 
Bayesian networks have recently emerged as promising approaches for inferring 
gene regulatory networks using microarray data.  These methods are particularly suitable 
for the reconstruction of cellular networks due to their capability to capture the stochastic 
nature of gene regulation and allow causality inference (Kim et al. 2003; Murphy and 
Mian 1999).  Furthermore, prior knowledge can be incorporated to improve the accuracy 
of the final network structure. 
A Bayesian network can be represented as a directed acyclic graph, in which each 
node is a gene, and the edge between two nodes denotes the dependency between two 
corresponding genes (Heckerman 1998; Needham et al. 2006).  A joint probability for the 
network is thus calculated as a product of multiple conditional probabilities for each 
gene, given that it is regulated by a defined set of parent genes.  These probability 
functions can be either discrete, e.g., binomial distributions, or continuous, e.g., normal 
density function.  Among the several possible networks being reconstructed, an optimal 
network can be chosen by maximizing the corresponding posterior probability. 
Bayesian predictive networks were constructed using gene expression in 
combination with genotypic, transcription factor binding site, and protein-protein 
interaction data in yeast (Zhu et al. 2008).  These networks were shown to successfully 
predict regulators causing hot spots of gene expression activity in a dividing yeast 
population.  Molecular mechanisms underlying transcriptome reprogramming in 
cyanobacteria under altered environments were also revealed using Bayesian networks 
(Singh et al. 2010).  A large number of genes in the core transcriptional response (CTR) 
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are associated with oxidative stress under most perturbations, indicating the important 
role of reactive oxygen species in the regulation of these genes. 
3.10.2 Network Reconstruction from Dynamic Gene Expression Data 
3.10.2.1 Information Theoretic Method: TimeDelay-ARACNE 
Some of the algorithms originally used for network reconstruction using static 
sampling data have been extended to take advantage of the dependency information 
contained in time-series data.  One such example is an extension of ARACNE.  This 
extension, implemented in the TimeDelay-ARACNE algorithm (Zoppoli et al.), uses 
time-course data to retrieve time statistical dependencies between gene expression 
profiles.  This algorithm considers the possibility that the expression of a gene at a certain 
time could depend on the expression level of another gene at an earlier time point, that is, 
it detects time-delayed dependencies.  The algorithm performs three steps: first it detects 
the time point of the initial changes in the expression for all genes, second it constructs 
networks by calculating time-dependent MIs, and third it performs network pruning using 
DPI.  TimeDelay-ARACNE, which has been implemented in R, also attempts to infer 
edge directionality. 
3.10.2.2 Dynamic Bayesian Networks (DBNs) 
Built upon Bayesian networks, DBNs also calculate a joint probability using the 
conditional probability of each gene, and select the optimal network based on the 
posterior probability.  DBNs further allow time delay and modeling of feedback loops by 
incorporating temporal information associated with time-series data.  For instance, the 
cyclic regulation among genes ga, gc, and gd shown in Figure 13a can be represented by 
allowing these genes to cross-interact from time point i to time point (i+1) (Figure 13b).  
To further enhance the prediction accuracy and reduce the computational complexity of 
DBNs, a number of modifications have also been proposed (Zou and Conzen 2005).  For 
example, potential regulators are limited to those genes with either preceding or 
simultaneous expression changes.  Transcriptional time lags between regulators and 
target genes can also be estimated, and statistical analysis is thereby restricted within that 
time frame to improve the accuracy of the prediction. 
61 
 
Figure 13: Gene regulatory network with feedback loop deciphered using DBN. 
a) A regulatory network containing four genes (ga, gb, gc, and gd), three of which form a feedback loop (ga  gc 
 gd  ga). 
b) The feedback loop among ga, gc, and gd shown in the left panel is deciphered by allowing cross-interactions 
along the time axis.  For instance, the expression level of gc at time point (i+1) is dependent on that of ga at 
time point i.  Similarly, the expression level of gd at time point (i+1) is dependent on that of gc at time point 
i.  The loop is closed by allowing gd’s expression level at time point i to have an effect on that of ga at time 
point (i+1).  Note that each gene’s expression level at a certain time point is always dependent on its own 
expression level at the previous time point. 
 
DBNs have been used successfully to construct gene regulatory networks in yeast 
using cell cycle time-series microarray data in two independent studies (Kim et al. 2003; 
Zou and Conzen 2005).  Main regulatory nodes in the S.O.S. DNA repair network in 
E.coli were also extracted using DBNs (Perrin et al. 2003).  Compared to other methods 
for inferring gene regulatory networks such as Granger causality and probabilistic 
Boolean network, DBNs consistently displayed enhanced performance.  This was 
especially the case for short time series, as exemplified with data obtained from muscle 
development in fruit fly (Li et al. 2007a), normal and infected Arabidopsis leaves (Zou 
and Feng 2009), and food intake effect on human blood (Zhu et al. 2010).  Furthermore, 
the causality inference power of DBNs was substantially improved when time-series gene 
perturbation data was also incorporated (Dojer et al. 2006). 
3.11 CONCLUDING REMARKS 
In this chapter, methods for the analysis of microarray data were summarized, 
with a focus on their use in mammalian cell culture.  Whereas specific algorithms used 
for each step depend on the type of data and the question being asked, the general steps 
for microarray data analysis remain constant.  These steps include data pre-processing 
followed by identification of differentially expressed genes at a minimum, but greater 
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biological insight can be gained by using other types of analysis such as profile pattern 
recognition, pathway analysis, and network reconstruction. 
Even though the number of transcriptome studies of antibody producing cell lines 
has been relatively small compared to other cell types, the next few years will see an 
increase in the resources available for studying genomes and transcriptomes.  This 
expansion will greatly benefit the understanding of these relevant cell lines. 
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4 ANALYSIS OF LARGE-SCALE MANUFACTURING DATA FOR ENHANCED 
PROCESS PERFORMANCE 
4.1 SUMMARY 
Multivariate analysis of cell culture bioprocess data has the potential of unveiling 
hidden process characteristics and providing new insights into factors affecting process 
performance.  This chapter presents an investigation of time-series data from 134 process 
parameters acquired throughout the seed train and the production bioreactors of 243 runs 
at the Genentech’s Vacaville manufacturing facility   Two multivariate methods, kernel-
based support vector regression (SVR) and partial least square regression (PLSR), were 
used to predict the final antibody concentration and the final lactate concentration. 
Both product titer and the final lactate level were shown to be predicted 
accurately when data from the early stages of the production scale were employed.  Using 
only process data from the seed train, the prediction accuracy of the final process 
outcome was lower; the results nevertheless suggested that the history of the culture 
might exert significant influence on the final process outcome.  The parameters 
contributing most significantly to the prediction accuracy were related to lactate 
metabolism and cell viability in both the production scale and the seed train.  Lactate 
consumption, which occurred rather independently of the residual glucose and lactate 
concentrations, was shown to be a prominent factor in determining the final outcome of 
production-scale cultures. 
The results suggest possible opportunities to intervene in metabolism, steering it 
towards the type with a strong propensity towards high productivity.  Such intervention 
could occur in the seed stage or in the early stage of the production-scale reactors.  
Overall, this study presents pattern recognition as an important process analytical 
technology (PAT).  Furthermore, the high correlation between lactate consumption and 
high productivity can provide a guide to apply quality by design (QbD) principles to 
enhance process robustness. 
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4.2 INTRODUCTION 
In recent years, cell culture bioprocessing has seen a tremendous growth in data 
generation and collection.  In modern manufacturing facilities, it is not uncommon to 
encounter hundreds of process parameters being monitored and acquired automatically 
every few seconds throughout the entire production train.  This enormous volume of data 
further accumulates across multiple campaigns and at multiple manufacturing sites.  
Mining these historical data holds promise to gain insights into fluctuations in process 
performance, uncover hidden characteristics of high-performing cultures, and discern 
process parameters with pivotal contributions to the overall process performance. 
Cell culture bioprocess data, however, pose significant challenges to mining 
practices due to the inherent heterogeneities in time scale and data type (Charaniya et al. 
2008).  Yet many have successfully applied an array of classification and prediction 
techniques to investigate hidden process patterns.  Principal component analysis (PCA), 
partial least square regression (PLSR), and other unsupervised techniques, which have 
the advantage of capturing the interactions among process parameters, have been used for 
detecting state transitions related to product and lactate formation, online monitoring, 
fault detection and diagnosis, scale-up assessment, process characterization, and root 
cause analysis (Bachinger et al. 2000; Gunther et al. 2007; Kirdar et al. 2008; Ündey 
2004).  In other studies, powerful supervised approaches such as decision tree (DT), 
artificial neural network (ANN), and support vector regression (SVR) were used to 
optimize a control scheme incorporating time-course data, predict the final process 
outcome, and reveal key parameters (Buck et al. 2002; Charaniya et al. 2010; Coleman 
and Block 2006).  Among these multivariate analysis approaches, PLSR and SVR appear 
to be well-suited to handle the various challenges associated with bioprocess data, 
namely high-dimensionality and co-linearity between various parameters. 
Among the important contributors to differentiating between high- and low-
productivity runs of a cell culture process are parameters related to lactate metabolism, 
including pH, base addition, osmolarity, dissolved CO2, and lactate concentration 
(Charaniya et al. 2010).  Excessive lactate accumulation has long been known to be an 
impediment to achieving high cell concentration and superior productivity (Glacken et al. 
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1986; Hu et al. 1987).  Introducing metabolic shifts (i.e., controlling lactate production at 
low levels or, to a further extent, inducing lactate consumption) has been performed using 
various strategies.  These approaches include dynamic feeding to control glucose at low 
levels (Cruz et al. 1999; Zhou et al. 1997), using alternative carbon sources (Altamirano 
et al. 2006; Wlaschin and Hu 2007a), knocking down LDH-A (Chen et al. 2001; Kim and 
Lee 2007a), and enhancing glucose carbon flux into the TCA cycle (Irani et al. 1999; 
Kim and Lee 2007b).  Understanding the linkage between lactate metabolism and high 
productivity thus offers the opportunity to discover the metabolic signatures of these 
high-performing processes. 
In this study, we employed support vector regression (SVR) and partial least 
square regression (PLSR) methods to predict the final process outcome using process 
data from 243 production runs at a Genentech manufacturing facility.  This dataset 
comprises 134 temporal parameters acquired online and offline throughout the seed train 
(80 L, 400 L, and 2000 L) and the production-scale bioreactors (12000 L).  Parameters 
pivotal to prediction accuracy were assessed based on two criteria: the frequency of 
occurrence ( ) in the best parameter sets for SVR models and the magnitude of the 
regression coefficient ( ) in the optimal PLSR models.  Among these pivotal parameters, 
various aspects of the lactate consumption phenomenon at the production scale in high-
titer runs were further investigated. 
4.3 MATERIALS AND METHODS 
4.3.1 Overview of Mammalian Cell Culture Processes 
The large-scale manufacturing bioreactors from which bioprocess data were 
acquired were located at the Genentech’s Vacaville facility.  The recombinant hIgG-
producing CHO cells were thawed from a banked vial and expanded in shake flasks of 
increasing sizes before reaching 20 L bioreactors (Figure 14).  This rolling seed was 
maintained at 20 L scale to inoculate multiple seed trains, each of which comprises three 
scales: 80 L, 400 L, and 2000 L.  The cells were expanded step-wise throughout the seed 
bioreactors, each of which lasted for approximately 72 hr in a batch mode.  Subsequently, 
the cells were transferred to the production-scale bioreactors of 12000 L, in which they 
66 
were cultured for about 264 hr in a fed-batch mode with feeding and temperature shift at 
72 hr. 
 
Figure 14: Overview of a production train at the Genentech’s Vacaville manufacturing facility. 
After thawing and expansion in shake flasks, recombinant cells were maintained at 20 L to inoculate multiple 
production trains, each comprising a seed train (80 L, 400 L, and 2000 L) and a production (12000 L) 
bioreactor.  At each of the seed bioreactors, the cells were expanded in a batch mode for 72 hr.  At the 
production bioreactor, they were cultured in a fed-batch mode for 264 hr with feeding and temperature shift at 
72 hr. 
 
4.3.2 Collection of Large-scale Manufacturing Data 
For each runs, hundreds of process parameters were measured at various 
frequencies over the course of the production train.  The final hIgG antibody 
concentration, also known as final titer, was quantified at the end of the production stage 
and normalized to an average value of 1.00.  Hundreds of online parameters were 
recorded electronically every minute, whereas tens of offline parameters were determined 
by periodic withdrawal of samples from the bioreactors approximately every 24 hr.  In 
addition, several specific rates were calculated from these measured parameters.  A total 
number of 134 process parameters were selected for analysis as listed in Table 1. 
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Table 1: List of 134 temporal process parameters used in the analysis. 
Thirty-three parameters were collected at each seed scale (80 L, 400 L, and 2000 L), and thirty-five parameters 
at the production scale (12000 L). 
Offline parameters 
Ammonium ion concentration 
Dissolved CO2 (pCO2) 
Dissolved O2 (pO2) 
Glucose concentration 
Integrated packed cell volume (IntvPCV)
 
(12000 L only) 
Lactate concentration 
Osmolarity 
Packed cell volume (PCV) 
pH (offline) 
Sodium ion concentration 
Viability 
Viable cell density (VCD) 
Online parameters 
Air sparge rate 
Air sparge set point 
Backpressure
 
(12000 L only) 
CO2 sparge rate 
Dissolved oxygen (DO) controller output 
DO (primary) 
DO (secondary) 
Flowrate overlay 
Jacket temperature 
O2 sparge rate 
pH controller output 
pH (online) 
Pressure exhaust valve 
Reactor weight 
Total air sparged 
Total base added 
Total CO2 sparged 
Total O2 sparged 
Total gas sparged 
Vessel temperature 
Derived parameters 
Specific cell growth rate () 
Specific glucose consumption rate (qLac) 
Specific lactate consumption rate (qGlc) 
 
4.3.3 Data Pre-processing 
Online data acquired at each scale were smoothed using a moving window 
average method with a time window of 100 min.  At every time point, a parameter’s 
value was approximated as the average of all measurements of that parameter within the 
time window.  For instance, the pre-processed value at time t is the average of 
measurements at times t, t+1, t+2, …, t+99.  The raw and the pre-processed temporal 
profiles of CO2 sparge rate and DO controller output of one run at 12000 L scale are 
shown in Figure 15a as examples. 
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Figure 15: Pre-processing of cell culture bioprocess data. 
(a) Online parameters were pre-processed using a moving window average method: (_____) measured, (_____) pre-
processed. 
(b) Offline parameters were pre-processed using a linear interpolation scheme: () measured, (_____) 
interpolated. 
 
Due to differences in sampling frequency, offline parameters were linearly 
interpolated and extrapolated every 20 hr.  Figure 15b shows the temporal profiles of 
glucose concentration and osmolality in the production bioreactor for one example run.  
Furthermore, calculated specific rates of lactate production, glucose consumption, and 
cell growth were smoothed using third-order polynomials. 
4.3.4 Stage-wise Organization of Data 
Process data from all scales were organized into eight individual and seven 
cumulative datasets as shown in Figure 16 to investigate progression of the production 
trains.  The first individual dataset comprised process data from the 80 L scale 
bioreactors.  The second dataset contained data from the next scale of 400 L, and so on.  
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Since the run time at the production scale (260 hr) was much longer compared to that at 
each of the seed scales (70 hr), it was segregated into several stages: up to 70 hr, 120 hr, 
170 hr, 220 hr, and 260 hr.  In addition to these eight individual datasets, process data 
were also accumulated across scales with the largest dataset compiling data from 80 L, 
400 L, 2000 L, and up to 260 hr of the 12000 L scale. 
 
Figure 16: Stage-wise organization of process data into fifteen datasets. 
Eight individual datasets (from 1 to 8) comprised data from each seed bioreactor or each stage (up to 70 hr, 120 
hr, 170 hr, 220 hr, and 260 hr) of the production bioreactor.  Seven other datasets (from 9 to 15) incrementally 
accumulated data across time. 
 
4.3.5 Model Training and Evaluation Using 10-Fold Cross-Validation 
A 10-fold cross-validation scheme as shown in Figure 17 was used for training 
and evaluation of both support vector regression (SVR) and partial least square regression 
(PLSR) models.  Process data from 243 runs in each of the fifteen datasets described 
above were randomly divided into ten subsets of approximately equal sizes.  During each 
round of cross-validation, nine of the ten subsets were used as the training set on which 
model optimization was performed.  The best performing model on each training set was 
used to predict process outcome of runs in the corresponding, unseen test set (10
th
 
subset).  This process was repeated ten times on different pairs of training and test 
subsets. 
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Figure 17: Ten-fold cross-validation scheme with model optimization for both multivariate approaches. 
All n process runs (      in this study) were randomly separated into ten equal subsets.  Nine were used as 
the training set on which model optimization was performed.  The optimized model was used to predict the 
outcome of runs in the 10th subset (test set).  Model optimization involved further random separation of the 
training set into 10 equal groups.  Again, nine were used to train a model with a certain set of parameters (for 
SVR approach) or PLS factors (for PLSR approach).  The performance of this model was tested on the 10th 
group (validation set).  This process was repeated 10 times to obtain the average performance for each set of 
parameters/factors, which was later compared to identify the parameter/factor set that resulted in the best 
predictive (optimized) model.  The shaded box contains all steps in model optimization. 
 
Model performance was evaluated using the Pearson’s correlation coefficient ( ) 
and the root mean square error ( ) between the predicted and the actual final process 
outcome: 
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Equation 1: Pearson’s correlation coefficient   between predicted (     ) and actual outcome (  ). 
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Equation 2: Root mean square error   between predicted (     ) and actual outcome (  ). 
   √
∑           
  
   
 
  
where   is the number of runs, and    and       are the actual and the predicted titer 
values of run  , respectively.  The model performance was averaged across the 10 folds.  
As a baseline for evaluating model performance, a random predictor with one million 
simulations of randomized final process outcome was generated. 
To get a better estimate of the generalization error of the constructed models, 
model optimization (i.e. selection of model and process parameters) was further 
performed on each training set, also using 10-fold cross-validation, as shown in the 
shaded box in Figure 17.  Model optimization was performed for each round of the 10-
fold cross-validation.  This involved further partitioning of the training set randomly into 
ten smaller groups of about equal sizes.  The model was trained on nine groups using a 
different set of parameters for SVR approach or PLS factors for PLSR approach.  The 
performance of the resulting model was subsequently tested in the 10
th
 group, called the 
validation set.  This procedure was repeated ten times for each set of parameters or PLS 
factors.  The average performance of the model over these inner 10 folds was used to 
determine the optimal set of parameters or PLS factors for each round of the outer 10-
fold cross-validation.  Subsequently, the best model was selected and used to predict the 
outcome of runs in the corresponding, unseen test set. 
4.3.6 Construction of Partial Least Square Regression (PLSR) Models 
Partial least square regression (PLSR) models were constructed using the 
SIMPLS algorithm (Chong and Jun 2005; de Jong 1993).  Time-series data for each 
process parameter were extracted every 10 hr, resulting in multiple discrete “variables” 
originating from the same parameter.  These variables were concatenated over the run 
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time of each scale into a data matrix ( ).  Data in each column of this matrix were further 
autoscaled to a mean of zero and a standard deviation of one to give a new matrix   .  A 
similar transformation was also performed on the response vector ( ) to obtain the 
autoscaled final process outcome (  ) (either antibody titer or lactate concentration at the 
end of the 12000 L cultures). 
The autoscaled data matrix (  ) was projected onto mutually orthogonal PLS 
factors (  ), each of which is a weighted linear combination of the original variables 
in  .  A set of these PLS factors can be used to construct a regression function to 
predict the autoscaled final process outcome in    .  The SIMPLS algorithm for a 
univariate response in    can be simplified in the following equations: 
Equation 3: Projection of original data    into mutually orthogonal PLS factors   . 
                  
                 
           
Equation 4: Prediction of process outcome    using PLS factors in   . 
                            
such that the covariance between    and    is maximized. 
In these equations,   ,   , and  are the matrix of orthogonal PLS factors, the 
autoscaled data matrix, and the matrix of PLS weights, respectively.  The matrices    
and   contain loadings of the PLS factors and the residuals when factorizing    into a 
product of    and    , respectively.  The vectors   ,  , and    comprise the autoscaled 
response, the regression coefficients of    using   , and the residuals when regressing 
   using   , respectively.  The variables      and   are the number of process runs, the 
number of variables (in this case, a product between the number of process parameters   
and the number of time points  ), and the number of PLS factors used for regression, 
respectively. 
The plsregress subroutine, an implementation of the SIMPLS algorithm in the 
Matlab’s statistics toolbox, was used for constructing the PLSR models    or each of the 
fifteen datasets, a PLSR model was constructed and optimized as described in Model 
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Training and Evaluation Using 10-Fold Cross-Validation.  The number of PLS factors in 
each model was varied from one to the maximum possible (which is the rank of the data 
matrix   ).  For each fold of the outer 10-fold cross-validation, an optimal set of PLS 
factors, and thus variables, could be identified.  Furthermore, as each original parameter 
was discretized into multiple variables, the average magnitude of the regression 
coefficients of all variables which originated from the same parameter was used to assess 
the importance of that parameter. 
4.3.7 Construction of Support Vector Regression (SVR) Models 
LIBSVM (Chang and Lin 2001), an implementation of the SVR algorithm in C, 
was used to construct  -SVR models.  This algorithm utilized the similarity measure 
between runs, which were calculated using the following two-step approach, as the input.  
In the first step, the Euclidean distance over time between any two runs   and   was 
computed for each individual parameter   : 
Equation 5: Euclidean distance between run   and run   for parameter   . 
   
   √∑                  
Subsequently, this distance was scaled to 0 – 1 and converted into a similarity 
value: 
Equation 6: Similarity measure between run   and run   for parameter   . 
   
        
  
  
All pair-wise similarity values between runs were organized into an     matrix, 
where   is the number of runs. 
In the second step, the similarity matrices of all parameters were linearly 
combined to form a final similarity matrix, which was used as a pre-defined kernel in the 
 -SVR algorithm.  Upon combination, each parameter was either given equal weights of 
  ⁄  (where  is the number of process parameters) or weighted according to how well 
it correlates to the final process outcome using the non-linear Spearman’s rank 
correlation coefficient: 
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Equation 7: Overall similarity measure between run   and run   taking all parameters into consideration. 
    ∑      
  
   
where        for equal weighting or             
         with      denotes the 
difference in the final process outcome between run   and run  .  Thus all entries in the 
final similarity matrix were maintained between 0 and 1.  The objective function ( ), 
either the final titer or the final lactate concentration, was also scaled to the same range of 
0 – 1. 
A  -SVR model seeks to identify a regression function           that 
minimizes the prediction error   (Equation 2).  Differences exceeding   are penalized by 
a slack variable (   or   
 ) and an a priori chosen cost function (C).  The parameters (   ) 
of the regression function are obtained by solving the following constrained optimization 
problem: 
Equation 8: Optimization problem formulated in  -SVR. 
      {
 
 
‖ ‖   (   
 
 
∑       
      )}  
subject to the following inequality constraints: 
Equation 9: Inequality constraints of  -SVR optimization problem. 
                    
               
      
where   ,   
 , and    . 
The parameter   is a non-negative constant that determines the balance between 
the complexity of the model and the extent of the prediction error  .  The default value of 
      was used.  In addition, a simple grid search within the range of 0 – 1 with 0.1 
intervals was performed on the cost function.  The best value was used in the subsequent 
steps of model optimization and identification of pivotal process parameters. 
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 -SVR models were constructed and optimized for each of the eight individual 
datasets as described in Model Training and Evaluation Using 10-Fold Cross-Validation.  
For the seven cumulative datasets, due to computational constraints imposed by the large 
number of parameters, SVR models were built using the best performing sets of 
parameters obtained for the corresponding individual datasets. 
4.3.8 Identification of Pivotal Process Parameters Using SVR Approach 
A greedy parameter selection approach based on the wrapper feature-selection 
method (Liu and Hiroshi 1998) was used to find the best performing set of parameters for 
the SVR models.  This approach determined the suitability of a set of features (i.e., 
process parameters) by first building an SVR model using these features and then 
assessing its performance on a subset of the data that was not used for training (i.e., 
validation set).  The set of features whose model achieved the best performance on the 
validation set became the set of selected parameters.  Since each of the eight individual 
datasets contains either 33 parameters at the seed scales or 35 parameters at the 
production scale, a direct application of the wrapper feature-selection method will require 
an evaluation of       or       (excluding the      set) possible parameter subsets, 
which is prohibitively large.  For this reason, we employed a greedy strategy that only 
considers a substantially smaller number of parameter subsets. 
In this approach, the different parameter subsets were organized into a lattice 
structure, whose     level contained all the subsets of size        where   is the 
number of parameters.  All nodes at each level were connected to the nodes of the 
preceding level that were its supersets.  The algorithm started by evaluating the 
performance of the subsets at levels 0 and 1 (i.e., the entire set of   parameters and the 
  subsets that were obtained by removing one parameter, respectively).  Among the  
subsets at level 1,   subsets whose models achieved the best performance on the 
validation set were retained.  The algorithm then proceeded to evaluate the performance 
of subsets at level 2 that are descendants of at least one of the   nodes retained at level 1.  
Among those subsets, it also retained the   best performing ones.  This process 
continued until the last level of the lattice.  Note that, by setting   to a small value (in our 
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experiments,                    and by considering only subsets whose supersets 
were among the   best performing subsets of the previous level, the total number of 
subsets being considered became computationally feasible.  In addition, since the subsets 
that were pruned are those that did not perform well, this approach could still identify 
good performing parameter subsets. 
Since a 10-fold cross-validation scheme was performed, each fold generated an 
optimal set of parameters.  Thus the occurrence frequency ( ) of each parameter over all 
10 folds can be used as an estimate of its contribution to the overall model performance. 
4.4 RESULTS 
4.4.1 High- and Low-Performing Runs Exhibit Distinct Process Characteristics 
The 243 production runs investigated in this study exhibited considerable 
variation in a number of process parameters and outcome as shown in Figure 18.  The 
pre-harvest recombinant antibody concentration, also known as the final titer, varied 
across a wide range from 0.70 to 1.25 (Figure 18a).  These runs were categorized into 
three classes: top 20% (in blue), middle 60% (in grey), and bottom 20% (in red), with 
their final titer approximately over 1.10, between 1.10 and 0.90, and below 0.90, 
respectively.  Because of measurement error of recombinant antibody concentration, it is 
possible that runs within the middle 60% class have a high degree of similarity.  In 
contrast, comparison of the top 20% and the bottom 20% runs should bear distinct 
characteristics of high-titer cultures. 
As shown in Figure 18b, both the top and bottom 20% cultures started with a 
similar range of cell concentration in the production-scale bioreactors.  There was a 
substantial spread of cell concentration at peak growth and at the end of the culture, even 
among runs within the top or bottom 20% class.  In general, the top 20% runs reached 
higher peak cell concentrations (between 100 and 150 hr) although the range was rather 
wide.  It is apparent that more runs of the bottom 20% class had lower peak cell 
concentrations, and all bottom 20% runs had lower viable cell concentrations at the end 
of the production run. 
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Figure 18: Differences in process performance as indicated by the final antibody concentration (titer), viable cell 
density (VCD), and lactate concentration across 243 production runs. 
a) Distribution of the final titer (normalized such that the average across all runs is 1.00).  Roughly 20% 
of runs have final titers greater than 1.10 (top 20% - in blue); 20% of runs have titers less than 0.90 
(bottom 20% - in red); and 60% of runs have titers between 0.90 and 1.10 (middle 60% - in grey) 
b) Variation in viable cell density at 12000 L scale between runs in the top 20% (blue) and the bottom 
20% (red) 
c) Variation in lactate concentration at 12000 L scale between runs in the top 20% (blue) and the bottom 
20% (red) 
d) High correlation (-0.87) between the final lactate concentration and the final titer across all runs 
 
The lactate concentration profiles also showed profound differences between the 
top 20% and bottom 20% runs (Figure 18c).  Although lactate concentrations were in 
similar ranges in all cultures initially, by the time cell concentration reached the peak, 
they had become higher in the bottom 20% runs.  Despite a period between 100 and 130 
hr during which lactate production subsided, all bottom 20% runs proceeded to return to 
the lactate production state whereas nearly all top 20% runs switched to the lactate 
consumption state.  Many of these top 20% runs resulted in complete exhaustion of 
lactate previously produced during the exponential growth stage.  As expected, the final 
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lactate concentration was found to be highly correlated to the product yield in all runs 
with a Pearson’s correlation coefficient of −  87 (Figure 18d), indicating a close 
connection between cellular metabolic activities and product titer. 
4.4.2 Process Outcome is Predicted Accurately Using Multivariate Models 
Two multivariate regression approaches, support vector regression (SVR) and 
partial least square regression (PLSR), were employed.  Time-series process data were 
acquired for 134 online, offline, and derived parameters throughout the seed train (80 L, 
400 L, and 2000 L) and the production-scale bioreactors (12000 L).  To investigate the 
importance of these parameters at each scale, process data were organized into fifteen 
different datasets as shown in Figure 19.  In addition to the final titer, the final lactate 
concentration was also used as an objective function because of the indication of its being 
an attribute of a culture’s performance   The prediction accuracy of these models was 
assessed based on the Pearson’s correlation coefficient ( ) and the root mean square error 
    as described in Model Training and Evaluation Using 10-Fold Cross-Validation. 
In constructing SVR models, a grid search of the cost function in the range of 0 – 
1 with 0.1 intervals yielded an optimal value of 1, which was used for constructing 
subsequent SVR models.  Both differential and equal weighting schemes as described in 
Construction of Support Vector Regression (SVR) Models were employed to combine all 
similarity matrices.  Since the equal weighting scheme resulted in slightly better model 
performance (data not shown), it was used for the subsequent step of feature selection.  A 
wrapper-based feature selection algorithm as described in Identification of Pivotal 
Process Parameters Using SVR Approach in Methods was further employed to identify 
the optimal combination of parameters that result in the lowest root mean square error 
   .  The top 35 nodes (i.e.,      ) were expanded at each level.  Three additional 
values of               were also evaluated, and resulted in similar performances for 
the 8
th
 dataset (12000 L up to 260 hr).  Thus, for the other individual datasets, the 
maximum number of nodes to be expanded at each level was fixed at 35. 
Similarly, in constructing PLSR models, a 10-fold cross-validation scheme 
(Figure 17) was used to find the optimal number of PLS factors to be incorporated in 
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each model that gives the best predicted final process outcome.  As described in Model 
Training and Evaluation Using 10-Fold Cross-Validation, the number of PLS factors was 
varied from one to the rank of the data matrix   .  The optimized number of PLS factors 
in each training set was used to construct a PLSR model for the corresponding test set. 
It is interesting that prediction trends across different datasets were considerably 
similar irrespective of the multivariate approach as shown in Table 2.  Overall, the PLSR 
approach appeared to result in slightly better models than those constructed using the 
SVR approach.  However, when the input data were noisy (400 L and 2000 L), these 
PLSR models failed to maintain good performances whereas SVR models built using the 
same datasets were still robust.  Furthermore, similar correlations between the predicted 
and the actual final process outcome were observed across all datasets regardless of 
whether the final titer or the final lactate concentration was used as the objective 
function.  This result indicates that product yield and cellular metabolic activities are 
indeed closely interconnected, confirming the high correlation between these two 
characteristics as previously shown in Figure 18d.  Due to this considerable similarity in 
prediction accuracy, results are presented for SVR models predicting the final titer herein.  
It is noteworthy that a random predictor generates a root mean square error of 0.17 and 
7 8  for the final titer and the final lactate concentration, respectively, and a Pearson’s 
correlation coefficient of zero in both cases. 
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Table 2: Prediction accuracy of PLSR and SVR models using process data acquired at different stages. 
Model performance was evaluated using the Pearson’s correlation coefficient (r) and the root mean square error 
() between the predicted and the actual final process outcome. 
Dataset 
Final antibody 
concentration (titer) 
Final lactate 
concentration 
PLSR SVR PLSR SVR 
r  r  r  r 
80 L 0.42 0.10 0.40 0.10 0.44 4.18 0.43 4.15 
400 L 0.21 0.12 0.43 0.10 0.33 4.79 0.43 4.15 
2000 L 0.28 0.11 0.35 0.10 0.28 4.63 0.37 4.30 
12000 L up to 70 hr 0.73 0.07 0.73 0.07 0.72 3.18 0.77 2.93 
12000 L up to 120 hr 0.80 0.06 0.77 0.07 0.85 2.41 0.78 2.84 
12000 L up to 170 hr 0.88 0.05 0.86 0.06 0.95 1.47 0.92 1.98 
12000 L up to 220 hr 0.92 0.04 0.91 0.04 0.97 1.09 0.96 1.56 
12000 L up to 260 hr 0.92 0.04 0.92 0.04 0.97 1.13 0.98 1.33 
80 L+400 L 0.41 0.10 0.47 0.09 0.50 3.97 0.48 4.00 
80 L+400 L+2000 L 0.45 0.09 0.48 0.09 0.45 4.10 0.50 3.94 
80 L+400 L+2000 L+12000 L up to 70 hr 0.71 0.07 0.68 0.08 0.73 3.13 0.68 3.39 
80 L+400 L+2000 L+12000 L up to 120 hr 0.77 0.07 0.72 0.08 0.76 2.94 0.73 3.24 
80 L+400 L+2000 L+12000 L up to 170 hr 0.88 0.05 0.83 0.06 0.90 1.97 0.87 2.65 
80 L+400 L+2000 L+12000 L up to 220 hr 0.91 0.04 0.91 0.05 0.97 1.18 0.95 2.00 
80 L+400 L+2000 L+12000 L up to 260 hr 0.92 0.04 0.92 0.05 0.97 1.14 0.96 1.82 
 
Data acquired at the smallest scale of the seed train (80 L) were moderately 
indicative of the final titer with a correlation coefficient ( ) of 0.40 and a root mean 
square error ( ) of 0.10 (Figure 19a).  The SVR model constructed using data from the 
next scale of 400 L performed slightly better with          and         .  Data from 
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2000 L scale bioreactors, surprisingly, were less informative than data from the two 
smaller scales.  The correlation coefficient dropped to 0.35 and the error remained at 0.10 
as shown in Figure 19b.  This reduced performance appeared to be circumvented by 
concatenating data across these scales.  The SVR model built upon data concatenated 
from 80 L and 400 L scales exhibited a slight improvement than did those built using data 
from each individual scale (      ,       ).  Similarly, cumulative data across all 
three scales of the seed train resulted in a correlation coefficient of 0.48 and an error of 
0.09. 
When data from the first 70 hr of the production scale was used, the prediction 
accuracy increased sharply to 0.73 with a root mean square error of 0.07 (Figure 19c).  
By the time most runs reached peak growth at 120 hr, the performance improved to 
       and       .  As the runs approached the end, the final titer could be predicted 
with higher correlation coefficients of 0.86 (        ) by 170 hr, and 0.92 (  = 0.04) 
upon completion at 260 hr (Figure 19d).  Interestingly, the regression models built upon 
data acquired at the production scale alone were slightly more predictive compared to 
those with the addition of data from the seed train.  Concatenating data from the seed 
train to the first 70 hr of the production scale actually reduced the prediction accuracy 
from        and        to        and       .  At around peak growth (~120 
hr), addition of seed data did not result in a better model (      ,        compared 
to       ,       ).  Similarly, concatenating seed data with data from the late stage 
of the production scale also did not improve prediction accuracy.  The model built upon 
concatenating all data showed little to no improvement (      ,       ) over the 
model built on data from the production scale only (      ,       ).  This result 
suggests that the seed data are rather noisy relative to the production-scale data and 
incorporation of these data may not help increase model prediction accuracy. 
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Figure 19: SVR models’ prediction accuracy of the final titer using different datasets. 
The correlation coefficient ( ) between the predicted and the actual titer is shown for each dataset.  The dashed 
lines indicate the separation of the top 20%, middle 60%, and bottom 20% of runs based on the predicted titer 
(y-axis) or the actual titer (x-axis).  Runs in the top 20% class are colored in blue; runs in the middle 20% class 
are colored in grey; and runs in the bottom 20% class are colored in red. 
a) 80 L scale 
b) 2000 L scale 
c) Up to 70 hr of 12000 L scale 
d) Up to 260 hr of 12000 L scale 
e) The progression of predicted titer is shown over the course of the cultures for the top and the bottom 
20% runs 
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Furthermore, as evident from Figure 19a and b, using data from the 80 L and 
2000 L scales, only a few runs predicted to be in the top 20% class (above the horizontal 
grid line of         ) actually fell to the bottom 20% class of the actual titer (on the left 
of the vertical grid line of         ).  Similarly, the number of runs predicted to be in 
the bottom 20% class (below the horizontal grid line of         ) that ended up in the 
top 20% class (on the right of the vertical grid line of         ) was also small.  Once 
data from the production scale, even as early as the first 70 hr was used, this class switch 
was not observed in any runs (Figure 19c and d).  This result indicates that process 
characteristics at the early stage of the production scale are already indicative of the final 
outcome, and no runs are inclined to switch between the top and the bottom classes after 
this stage. 
We next examined those few runs which switched classes by tracking their 
performance over the course of the run.  The performance as judged by titer predicted 
using each of the eight individual datasets is shown in Figure 19e.  For better 
visualization, the titer values predicted using each dataset were linearly scaled such that 
they were in the same range as the actual titer values throughout.  Again red and blue 
colors indicate the bottom and the top 20% of runs, respectively.  It is interesting to note 
that class switch occurred relatively gradually over different stages of the seed train (80 
L, 400 L, and 2000 L).  By 70 hr of the production scale, switching has virtually 
completed.  This result clearly points out that any intervention means should be carried 
out during the seed train or at least by the first 70 hr of the production scale. 
4.4.3 Majority of Pivotal Parameters are Related to Cell Growth and Lactate 
Metabolism 
The contribution of each parameter to the prediction of the final process outcome 
was assessed using two criteria: the magnitude of the regression coefficient ( ) in the 
optimized PLSR models and the frequency of occurrence ( ) in the selected parameter 
sets for SVR models.  As described in Materials and Methods, a wrapper-based feature 
selection algorithm was employed to identify the minimum combination of parameters 
that results in an SVR model with the lowest validation error.  Shown in Figure 20 is this 
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error as a function of the number of parameters incorporated into SVR models at each 
scale. 
 
Figure 20: Variation of validation error as a function of the number of parameters used in SVR models. 
a) Final titer as the objective function 
b) Final lactate concentration as the objective function 
 
Initially, the SVR models appeared to perform better with the gradual removal of 
parameters, indicating that most of these parameters are indeed redundant or even noisy.  
In most cases, the best model was constructed using a set of six to eight parameters as 
indicated by the valley in the validation error profile.  The immediate, sharp rise of error 
following the removal of parameters in this selected set from the model suggests that they 
play a pivotal role in model prediction accuracy.  Thus the occurrence frequency ( ) of 
each parameter in all selected sets represents its relative contribution to the SVR models’ 
performance. 
As shown in the previous section of Process Outcome is Predicted Accurately 
Using Multivariate Models, class switch appeared to occur either during the seed train or 
by 70 hr of the production scale.  We thus focused on identifying pivotal parameters at 
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these two stages to search for possible hints of intervention.  Figure 21 shows the relative 
importance of 33 process parameters acquired at the smallest scale of the seed train (80 
L) using PLSR and SVR approaches. 
 
Figure 21: Contribution of process parameters to prediction accuracy of the final titer ( ) and the final lactate 
concentration ( ) using data acquired at 80 L scale bioreactors as evaluated using: 
a) Magnitude of regression coefficient (   ) of each parameter in optimized PLSR models 
b) Frequency of occurrence ( ) of each parameter in optimized SVR models 
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Both criteria of   and   led to a common conclusion that the majority of 
parameters pivotal to prediction of the final titer appeared to be related to cell growth and 
lactate metabolism by different degrees.  These parameters include viable cell density, 
viability, specific cell growth rate, specific lactate production rate, total base added, 
lactate, and osmolarity.  It is noteworthy that when the final lactate concentration was 
used as the objective function, similar parameters were identified as pivotal, supporting 
the notion that product yield and cellular metabolism are indeed strongly correlated. 
The time profiles of several pivotal parameters in the top 20% and bottom 20% 
runs at the 80 L scale are shown in Figure 22.  Although the differences between runs in 
these two classes were rather modest, a general trend could still be discerned.  Runs in 
both classes appeared to be inoculated at similar cell concentrations, yet cells in most top 
20% runs grew at relatively faster rates, giving rise to consistently higher viable cell 
density in these runs (Figure 22a and b).  Cell viability was also largely remained high (> 
90%) in these cultures (Figure 22c).  Surprisingly, the majority of the top 20% runs 
experienced somewhat higher lactate concentration at this scale as shown in Figure 22d.  
However, the specific lactate production rate was lower (Figure 22e) and less base was 
added to maintain a constant pH (Figure 22f). 
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Figure 22: Time profiles of several pivotal parameters at 80 L scale. 
Runs in the top 20% are colored in blue; those in the bottom 20% are in red. 
a) Viable cell density 
b) Specific cell growth rate 
c) Viability 
d) Lactate concentration 
e) Specific lactate production rate 
f) Total base added 
 
It is interesting that these pivotal parameters identified during the seed train 
continued to be critical at the early stages of the production scale (Figure 23). 
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Figure 23: Contribution of process parameters to prediction accuracy of the final titer ( ) and the final lactate 
concentration ( ) using data acquired up to 70 hr of 12000 L scale bioreactors as evaluated using: 
a) Magnitude of regression coefficient (   ) of each parameter in optimized PLSR models 
b) Frequency of occurrence ( ) of each parameter in optimized SVR models 
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Furthermore, the subtle differences between runs in the top and bottom 20% 
classes observed at the 80 L scale were significantly magnified at the production scale 
(Figure 24). 
 
Figure 24: Time profiles of several pivotal parameters at 12000 L scale. 
Runs in the top 20% are colored in blue; those in the bottom 20% are in red. 
a) Specific lactate production rate 
b) Specific glucose consumption rate 
c) Glucose concentration 
d) Total base added 
e) Osmolarity 
f) pH controller output 
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As early as 60 hr, a number of high-titer runs already had a metabolic shift to 
lactate consumption as indicated by negative specific lactate consumption rates, whereas 
most low-titer runs continued to produce lactate (Figure 24a).  The majority of runs in the 
top 20% class eventually shifted to the lactate-consuming state.  In contrast, runs in the 
bottom 20% class produced lactate at elevated rates, resulting in substantially high lactate 
concentrations in most cultures (Figure 18c). 
Specific glucose consumption rates also differed significantly between the two 
classes (Figure 24b).  High-titer runs consumed glucose at much reduced levels 
throughout the cultures than did those with low titer.  Thus, high-titer runs did not appear 
to require multiple additions of glucose after the main feed at 70 hr (Figure 24c). 
The low lactate concentration in the top 20% runs reduced or even eliminated the 
need for base addition whereas large amounts of base were added to the bottom 20% runs 
(Figure 24d).  This base addition in turn led to accumulation of sodium ion to 
significantly higher concentrations (Figure 24e), and therefore osmolarity (data not 
shown), in these low-titer runs.  The difference in lactate concentration between the two 
classes was also reflected in the pH controller output as shown in Figure 24f.  The 
opposing behaviors of parameters related to lactate metabolism in the two classes further 
strengthened the findings that this set of parameters played an important role in 
predicting the final process outcome. 
4.4.4 Lactate Consumption at Production Scale Emerges as Process Indicator 
The analysis presented so far indicates a high correlation of cell growth and 
lactate metabolism to the final titer.  The majority of parameters identified as pivotal for 
prediction of the final process outcome, using data from the seed train or the early stage 
of the production scale, are related to cell growth and lactate metabolism (Figure 21 and 
Figure 23).  Runs with high viable cell concentration and low final lactate concentrations 
or consumed lactate at the production scale yielded high levels of recombinant antibody 
(Figure 18c and Figure 24a).  Runs with low lactate production rates and high cell growth 
rates at the beginning of the seed train often had high final titer (Figure 22).  Indeed, 
when specific lactate production rate was plotted against viable cell concentration or 
91 
specific glucose consumption rate at 80 L scale (Figure 25), two clusters of the top and 
the bottom 20% runs could be seen, albeit with a high degree of overlap.  These 
metabolic indicators of the final process outcome thus hint at possible means to intervene 
with the process as early as the seed stage. 
 
Figure 25: Relationship between several parameters related to cell growth and lactate metabolism for runs in 
the top 20% (blue) and the bottom 20% (red) classes at 80L scale. 
Each data point represents one time point from 20 hr to 70 hr of 80 L cultures with 10 hr intervals. 
a) Specific lactate production rate (qLac) vs. viable cell density (VCD) 
b) qLac vs. specific glucose consumption rate (qGlc) 
 
To gain more insights into the metabolic shift occurring at the production scale, 
which is highly correlated to hyper-productivity, the specific rates of lactate production, 
glucose consumption, and cell growth in the top and bottom 20% of runs at the late stage 
of the production scale (from 120 hr to 240 hr with 10 hr intervals) were further analyzed 
as shown in Figure 26. 
92 
 
Figure 26: Relationship among several parameters related to cell growth and lactate metabolism for runs in the 
top 20% (blue) and the bottom 20% (red) classes in the late stage of the production scale. 
Each data point represents one time point from 120 hr to 240 hr of 12000 L cultures with 10 hr intervals.  The 
dashed line represents qLac = 0. 
a) Specific lactate production rate (qLac) vs. lactate concentration 
b) qLac vs. glucose concentration 
c) qLac vs. specific glucose consumption rate (qGlc) 
d) qGlc vs. glucose concentration 
e) qLac vs. specific cell growth rate () 
f) qGlc vs. specific cell growth rate () 
 
In low-titer runs, specific lactate production rate spanned over a wide range from 
a very low value to as high as 0.6 mmol/10
9
 cells/hr (Figure 26a).  In contrast, specific 
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lactate production rate in high-titer runs spanned a much narrower range from 0.05 to – 
0.05 mmol/10
9
 cells/hr (consumption).  Lactate consumption at the production scale, 
strikingly, occurred even when lactate was almost depleted in the cultures.  This suggests 
that once cells start to consume lactate, they have a propensity to continue consuming it 
regardless of the low level of this metabolite.  Likewise, cells in a lactate-producing 
culture appeared to remain in that state despite the extensive accumulation of lactate.  In 
other words, high concentration of lactate alone is not sufficient to trigger lactate 
consumption, nor does it completely inhibit lactate production. 
Interestingly, glucose concentration does not dictate lactate metabolism; both 
lactate production and consumption can occur over the same wide range of glucose 
concentration (Figure 26b).  In other words, the abundant presence of glucose does not 
deter lactate consumption.  It is evident that lactate consumption occurs only when the 
specific glucose consumption rate is low (below 0.07 – 0.1 mmol/109 cells/hr) (Figure 
26c).  There also seems to be a minimum specific glucose consumption rate that cells 
sustain, as the value never reaches zero.  Furthermore, glucose concentration alone does 
not determine glucose consumption, as can be seen in Figure 26d.  There is virtually no 
difference in the range of glucose concentration between metabolically shifted cultures 
(qLac ≤   and low qGlc) and “typical” cultures (high qLac and high qGlc).  It should be noted 
that the glucose concentrations in all cultures were maintained at more than 3 g/L, 
substantially higher than the reported Km of the GLUT1 transporter for glucose 
(approximately 0.18 g/L). 
It is interesting to observe that lactate consumption did not depend on how much 
cell growth slowed down during the late stage of the production scale (Figure 26e).  Both 
lactate-consuming and lactate-producing cultures appeared to have similar ranges of 
specific cell growth rate.  Likewise, glucose consumption rate can vary vastly regardless 
of specific cell growth rate (Figure 26f).  Taken together, these observations indicate that 
the potential of cells to consume lactate in the late stage is largely a function of reduced 
glycolytic flux rather than of glucose or lactate concentration or cell growth. 
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4.5 DISCUSSION 
The immense volume of cell culture bioprocess data in historical archives 
certainly holds valuable insights into manufacturing processes and product 
characteristics.  This resource has begun to be explored to generate process insights using 
multivariate data analysis tools in recent years.  This study employed two such tools, 
SVR and PLSR, to investigate process data from more than two hundred production-scale 
cultures.  Both methods could predict process performance with similar high accuracies if 
data from the production bioreactors were used with the objective function being either 
the final titer or the final lactate concentration.  Data acquired at the seed train alone (80, 
400 and 2000 L reactors) were somewhat less predictive of the final process outcome 
compared to the production-scale data.  However, only a few of the predicted top 20% 
runs switched class to the bottom 20% in the actual outcome, even using only data from 
the seed train.  Such lack of switching also holds true for the bottom 20% runs. 
The pivotal parameters identified both at the seed train and at the production scale 
are mostly associated with cell growth and lactate metabolism, indicating the prominent 
role of cellular metabolism in determining product titer.  Previous analysis of a subset of 
runs used in this study (Charaniya et al. 2010) and data from another manufacturing 
process (Kirdar et al. 2008) also led to a similar conclusion.  The results from this study 
further indicate that lactate consumption at the production scale serves as an indicator of 
high productivity.  However, the conditions that induce lactate consumption in the high 
titer runs at this scale are still unknown. 
The pivotal parameters identified in the seed train possibly impart a longer lasting 
effect on the process outcome.  Such potential occurrence of a “memory” effect reiterates 
our previous findings (Charaniya et al. 2010) and the results from another study (Ündey 
et al. 2010).  This effect also has a strong implication for process operation during early 
stages as it appears to have a profound impact on the final process outcome.  However, it 
is also important that the predicted class does change in some cases as evident in Figure 
19e.  For some runs, even though the pivotal process parameters (indicators) indicated 
that their process characteristics placed them in the low-titer class, they gradually 
switched to the high-titer class.  Since those pivotal parameters are metabolism related, it 
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thus indicates that metabolic characteristics can be altered, but the alteration is relatively 
gradual.  A better understanding of the relationship between the culture environment and 
metabolic characteristics may enlighten our approach of intervention.  Or for the cases 
that the class switched from high-titer to low-titer, a better understanding of prevention of 
such a shift will be critical. 
A key correlated factor of low lactate production and lactate consumption at the 
production scale appears to be low specific glucose consumption.  Thus controlling 
glycolytic flux seems to be the key to modulating lactate metabolism and therefore the 
final product yield.  Such a conclusion has also been reached through a metabolic study 
in conjunction with modeling (Mulukutla et al. 2011), which showed that the switch to 
the lactate consumption mode could be attributable to a moderate attenuation of 
glycolytic genes’ expression and differential activities of the Akt and p53 signaling 
pathways.  Indeed, inhibition of the Akt pathway by addition of its inhibitors in the late 
growth stage was shown to facilitate lactate consumption. 
The analysis presented in this work may hint at possible routes of intervention to 
steer the low titer runs to higher productivity.  One possible approach is by early 
intervention, as metabolic indicators at even the 80 L scale show a correlation to the final 
titer.  An inverse relationship between viable cell concentration and specific lactate 
production, as well as a positive correlation between glucose consumption and lactate 
production, point to the possible benefit of rearranging seed train scheduling strategy and 
of selective use of 80 L runs for subsequent inoculation into 400 L runs. 
Since the predictability at 80 L scale is only tentative, some production runs will 
inevitably have a propensity towards becoming low performers.  Remedial corrective 
measures at the production scale will need to focus on manipulating cell metabolism prior 
to 70 hr, the point at which the correlation between predicted and actual titer still hints at 
some flexibility in the outcome.  Many possible approaches of suppressing glucose 
metabolism and eliciting metabolic shift to lower lactate production or lactate 
consumption have been reported, including reducing glucose concentration (Cruz et al. 
1999; Zhou et al. 1997), employing alternative sugars (Altamirano et al. 2006; Wlaschin 
and Hu 2007a), supplementing copper ion (Qian et al. 2011), and adding inhibitors of the 
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Akt pathway (Mulukutla et al. 2011).  Conceivably interventive measures can be taken by 
then if necessary.  Whether those possible interventions will be effective can only be 
answered by experimentation.  Whether the intervention methods, if proven effective, 
should be implemented in a manufacturing setting will largely depend on the operating 
protocols of each individual plant and the nature of the interventions. 
With the increasing emphasis on the concept of Quality by Design (QbD) in the 
production of therapeutic biologics, we foresee such practices of mining bio-
manufacturing data being extended to analyze Critical Quality Attributes (CQAs).  
Recently, clustering of glycosylation profiles of an antibody product has revealed a high 
correlation between product quality attributes and process characteristics (Le et al.).  As 
both process and product quality data continue to accumulate, the likelihood of 
identifying process characteristics which affect product quality will also increase.  
Harnessing the power of data mining will greatly strengthen our capability to produce 
high quality products through high-productivity processes. 
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5 ANALYSIS OF TRANSCRIPTION DYNAMICS OF SELECTION AND GENE 
AMPLIFICATION 
5.1 SUMMARY 
The dihydrofolate reductase (DHFR)-based amplification system is the most 
commonly used method in CHO cells for increasing the expression level of a product 
gene following selection for production of recombinant protein therapeutics.  This 
approach has enabled the transformation of host cells from non-producers to professional 
secretors.  However, three decades after the advent of recombinant DNA technology, we 
still have little understanding of the mechanisms of this transformation process. 
To gain mechanistic insights into this process, a parental CHO cell line deficient 
in DHFR activity was transfected with a vector expressing a mouse dihydrofolate 
reductase (mDHFR) gene, a hygromycin resistance marker (HPT), and transgenes 
encoding for a human immunoglobulin G (hIgG) antibody product.  A control experiment 
using a similar vector without the antibody transgenes was also carried out.  Following 
transfection and initial selection in hygromycin, methotrexate (MTX) treatment was 
applied.  Single clones at different stages were isolated, and representatives of varying 
productivities were subjected to transcriptome analysis.  Amplified populations were 
further sub-cloned, and samples from isolated single sub-clones were also characterized 
in fed-batch cultures. 
The integration and amplification of the vectors under the pressure of hygromycin 
and MTX was confirmed by an increase in mRNA levels of the hIgG, the exogenous 
DHFR, and the HPT genes.  Surprisingly, more profound transcriptional changes were 
seen upon selection than amplification.  The transcript levels of these transgenes showed 
a tremendous surge upon selection and only a moderate or even no increase upon 
amplification.  Functional analysis revealed several signaling pathways, aminoacyl tRNA 
biosynthesis, cell cycle, DNA replication, and amino acid metabolism which were 
commonly enriched upon selection and amplification.  The results suggest that the 
development of cellular machineries required for hIgG production occurred even prior to 
amplification. 
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The notable clonal variability during selection and amplification continued to 
occur among different sub-clones during fed-batch cultures.  Two classes of sub-clones 
regarding product titer and cell growth, namely high-producers with slow growth and 
low-producers with fast growth, were discerned.  Among cellular functions enriched in 
the high-producers were protein processing, cell cycle, cytoskeleton function, ECM 
receptor interaction, ABC transporter, and several signaling pathways. 
We hypothesize that the selection process, with the forced expression of a 
secretory protein hIgG, enriched survivors with superior secretion machineries.  The role 
of the amplification process is less about further enhancement of the transgene expression 
level than further reinforcement of other cellular characteristics which favor high 
productivity, including protein processing, cell cycle, and signaling pathways.  The 
mechanistic insights gained through such systems analysis will allow for a rational 
screening strategy of robust production cell lines. 
5.2 INTRODUCTION 
The past few decades have witnessed a tremendous increase of more than 100 
fold in product titer achieved in recombinant protein-producing cells (Wurm 2004).  In 
addition to downstream optimization, this achievement can be attributed to relentless 
improvement in the most upstream process of cell line development, which includes 
product gene delivery, selection, amplification, and screening.  The transformation of 
protein secretion capability of these host cells during the cell line development process, 
from none to levels which rival professional secretors in vivo, entails profound changes in 
gene regulation which are poorly understood.  Empirical selection of cells with high 
productivity and desired growth characteristics has been the key to this success.  
However, as the demand for recombinant protein therapeutics continues to grow, it is 
necessary to gain better understanding into the physiological mechanisms underlying this 
transformation process. 
Typically, a plasmid DNA molecule(s) carrying a product gene and a selection 
marker can be introduced into the host cells using a multitude of DNA delivery methods 
such as calcium phosphate, electroporation, lipofection, and polymer-mediated gene 
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transfer.  Subsequently, this exogenous DNA fragment would integrate into the host 
genome, by and large randomly via chromosomal rearrangement and non-homologous 
recombination, providing cells with a survival advantage under the selection pressure 
(Finn et al. 1989).  Due to variability in integration site and plasmid copy number, 
substantial screening is often performed following selection to isolate single clones with 
exceptional growth characteristics and titer. 
To further increase productivity, the selected clones are often subjected to gene 
amplification, which co-amplifies the product gene along with the selection marker.  The 
most commonly used amplification system is dihydrofolate reductase (DHFR) and its 
chemical antagonist, methotrexate (MTX) (Bendig 1988; Gandor et al. 1995; Pallavicini 
et al. 1990).  By using a host cell line deficient in DHFR activity and by introducing an 
exogenous DHFR alongside the product gene, one can achieve co-amplification via 
adding MTX at increasing concentrations.  It has been shown that MTX-mediated gene 
amplification could result in hundreds to thousands copies of the plasmid in tandem 
repeats in the host genome (Wurm et al. 1986).  Thereby, specific productivity could 
increase up to 10- to 20-fold (Wirth et al. 1988). 
Both selection and amplification processes, upon which the host cells are 
completely transformed from non-secretors to professional secretors, are likely to confer 
drastic changes in multiple cellular functions.  These changes are essential to cope with 
the expansion of the transcription, mRNA processing, translation, protein processing, and 
secretory machineries.  However, there has been a lack of studies investigating the 
transcriptional changes in the host cells undergoing such transformations.  Such 
understanding could be achieved at the transcriptome level through the use of DNA 
microarrays, providing a mechanistic guide to the screening process. 
In this study, we isolated a panel of hIgG-producing clones through transfection 
with both chains of the hIgG gene, the hygromycin resistance marker (HPT), and the 
DHFR gene.  Following selection in hygromycin, these clones were further subjected to 
MTX-mediated amplification.  Transcriptome analysis using microarrays was performed 
on each stage of the process: host, post-selection, and post-amplification.  This study 
therefore represents the first example of applying transcriptome analysis to study the 
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mechanisms underlying selection and amplification.  Furthermore, several single sub-
clones spanning a wide range of titer were generated from the amplified hIgG-producing 
populations.  Samples from day 4 and day 7 of fed-batch cultures of these sub-clones 
were also analyzed using microarrays.  As a result, a set of genes potentially conferring 
hyper-productivity traits could be compiled from these analyses and several previous 
studies. 
5.3 MATERIALS AND METHODS 
5.3.1 Generation of hIgG-producing Clones and Non-producing Pool 
CHO DXB-11 cells (host, H) were cultured in MEM medium supplemented 
with 10% fetal bovine serum (FBS) at 37
o
C and 7.5% CO2 in a humidified environment.  
Cells at 80% confluency in T75 flasks were transfected with 4 g each of two expression 
vectors, pHC and pLC, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).  The pHC 
vector carries a hIgG heavy chain driven by a CMV promoter and a hygromycin 
resistance marker (HPT) driven by a TK promoter.  The pLC vector contains a hIgG light 
chain driven by a CMV promoter and an mDHFR gene driven by an LTR promoter. 
Forty-eight hours following transfection, the cells were diluted in 96-well plates 
in MEM supplemented with 10% FBS and 400 g/mL hygromycin.  After three weeks, 
ELISA was used to measure hIgG concentration (titer) in the supernatant of isolated 
single clones.  The three best clones in terms of titer, namely P1, P2, P3, were selected for 
further analysis. 
In addition to these hIgG-producing clones, a transfection with a control vector 
carrying only the HPT and the mDHFR genes was performed in parallel.  The transfected 
cells were selected and expanded in T75 flasks as a control pool (C).  The absence of 
hIgG heavy chain and light chain in this control pool allowed us to evaluate the effect of 
the hIgG genes alone. 
5.3.2 MTX-based Gene Amplification 
The three hIgG-producing clones and the control pool generated as described 
above were treated with 20 nM of MTX (Sigma Aldrich, St. Louis, MO) for 15 days in 
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duplicate cultures in T75 flasks.  Cell samples were taken immediately before MTX 
treatment (P1,0, P2,0, P3,0, and C0) and after MTX treatment (P1,M, P2,M, P3,M, and CM) for 
microarray analysis.  In addition, duplicate samples of the host cells (H) were also 
analyzed.  The experiment design is briefly illustrated in Figure 27. 
 
Figure 27: Experiment design of selection, MTX-mediated amplification, and fed-batch cultures. 
a) Host cells were transfected with hIgG, mDHFR, and HPT.  The transfected cells were selected in hygromycin 
and single cell cloned.  The three best clones were picked and subjected to MTX treatment for 15 days.  A 
control pool was generated through a similar process. 
b) Amplified hIgG-producing populations were further sub-cloned.  Nine sub-clones were picked and used to 
run fed-batch cultures.  Duplicate samples of host, hIgG-producing clones and control pool before and after 
amplification, and nine sub-clones at day 4 and day 7 of fed-batch cultures, were analyzed using Affymetrix 
microarrays. 
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Following MTX treatment, the three hIgG-producing populations were sub-
cloned in 96-well plates.  A panel of nine sub-clones (SC) spanning a wide range of hIgG 
concentrations in the supernatants was selected.  These sub-clones were adapted to 
growth in suspension prior to inoculation of fed-batch cultures at 2 L scale.  Cell lysates 
collected on day 4 and day 7 of these sub-clones were used for microarray analysis. 
5.3.3 Transcriptome Analysis 
Total RNA was isolated using the RNeasy Mini kit (Qiagen, Valencia, CA) 
according to the manufacturer’s protocol with on-column DNase I treatment for removal 
of genomic DNA.  First-strand and second-strand synthesis and labeling were performed 
using 5 g of total RNA following a protocol recommended by Affymetrix (Santa Clara, 
CA).  Ten micrograms of labeled, fragmented cRNA was hybridized onto custom 
Affymetrix microarrays with 61,223 probe sets.  Microarrays were washed using the 
Affymetrix GeneChip Fluidics Station 450 and scanned using the Affymetrix GeneChip 
Scanner 3000. 
For mDHFR and HPT, which were not represented by any probe sets on the array, 
quantitative real-time PCR (qRT-PCR) was used to measure mRNA levels.  First-strand 
cDNA was synthesized from 2.5 g of total RNA using Superscript III Reverse 
Transcriptase (Invitrogen, Carlsbad, CA) with 1 mM oligo dT primers in a total volume 
of 50 L.  A no reverse transcriptase control was performed in parallel to assess the 
extent of genomic DNA contamination.  The primers used for qRT-PCR are listed in 
Table 3. 
Table 3: List of qRT-PCR primers used for quantification of mRNA levels of mDHFR, HPT, and -actin. 
Gene Left primer Right primer 
mDHFR TCTGTTTACCAGGAAGCCATGA AATTCCTGCATGATCCTTGTCA 
HPT GATGTTGGCGACCTCGTATT GATGTAGGAGGGCGTGGATA 
-actin GTCGTACCACTGGCATTGTG AGGGCAACATAGCACAGCTT 
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The mRNA levels of these two genes were quantified using the Brilliant II SYBR 
Green qPCR Master Mix (Agilent, Santa Clara, CA).  Each 12.5 L reaction mixture 
contained 6.25 L of the master mix, 50 ng of the cDNA template, and 0.2 M of each 
primer (forward and reverse).  qRT-PCR was performed using the Stratagene Mx3000P 
instrument (Agilent, Santa Clara, CA).  The thermal cycling profile was set as follows: 
initial denaturation at 95
o
C for 10 min, followed by 40 cycles of 95
o
C for 10 sec, 57
o
C 
for 1 min, and 72
o
C for 30 sec.  The dissociation curves of the PCR products were 
generated by ramping from 57
o
C to 95
o
C after a denaturation step at 95
o
C for 1 min and 
an annealing step at 57
o
C for 30 sec.  All cDNA samples were run in triplicates alongside 
a no reverse transcriptase control and a no template control.  -actin was used as a 
reference for comparison across samples. 
5.3.4 Microarray Data Processing and Analysis 
Expressionist software (GeneData, San Francisco, CA) was used to process all 
array image (.CEL) files.  The raw intensities were condensed using the Microarray 
Analysis Suite (MAS 5.0) Statistical Algorithm (Affymetrix, Santa Clara, CA).  After 
background removal, a linear normalization was performed to scale the average intensity 
value of all probe sets within each array to 500.  Probe sets with a minimum detection p-
value ≥ 0.04 or a maximum intensity value ≤ 70 in all samples were called absent and 
removed from further analysis. 
Hierarchical clustering of microarray data was performed using Spotfire 
DecisionSite 9.1.2 (Somerville, MA).  Default settings of the distance metrics 
(Euclidean) and the clustering method (unweighted average) were used. 
Differentially expressed genes were identified using Significance Analysis of 
Microarray (SAM) (Tusher et al. 2001).  Genes with a fold-change ≥ 1 5 and a q-value ≤ 
10% were considered statistically differentially expressed. 
Functional analysis was performed using Gene Set Enrichment Analysis (GSEA) 
(Subramanian et al. 2005).  Approximately 550 curated gene sets from the Broad Institute 
were used (http://www.broadinstitute.org/gsea/downloads.jsp).  Gene sets with a nominal 
p-value ≤ 0.07 were considered significantly enriched. 
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5.4 RESULTS 
5.4.1 Profound Transcriptional Changes of Transgenes Imposed by Selection and 
Amplification 
A panel of three hIgG-producing clones (P1, P2, P3) and a control pool (C) were 
subjected to MTX treatment following selection in HT-minus medium supplemented with 
hygromycin (Figure 28a).  Duplicate samples were taken for transcriptome analysis 
immediately before MTX treatment (post-selection) and 15 days following treatment 
(post-amplification).  Host cells were also sampled in duplicate to serve as a baseline for 
evaluating the magnitude of transcriptional responses induced by selection and 
amplification. 
 
Figure 28: Changes in mRNA levels of transgenes in hIgG-producing clones and control pool after selection and 
amplification compared to host cells. 
a) hIgG heavy chain (microarray intensity) 
b) hIgG light chain (microarray intensity) 
c) mDHFR (fold-change with respect to host using qRT-PCR) 
d) HPT (fold-change with respect to host using qRT-PCR) 
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As evident in Figure 28a, all three hIgG-producing clones displayed a tremendous 
surge in hIgG heavy chain mRNA level.  After selection, this level increased from almost 
none in host cells to approximately 20,000-30,000 of normalized microarray intensity.  
Note that the average intensity of all genes in an array is 500.  The change in hIgG heavy 
chain expression level following amplification, surprisingly, was rather modest.  In clone 
1 (P1), this level stayed relatively constant at 28,000.  In clones 2 (P2) and 3 (P3), a 1.3-
1.6 fold increase to 30,000-40,000 was observed.  As a side note, no signal of hIgG heavy 
chain was detected in the control pool (C), indicating that the probe set designed for hIgG 
heavy chain on the Affymetrix microarray was specific. 
hIgG light chain expression level also experienced a similar trend following 
selection and amplification (Figure 28b).  After a surge from almost zero to 30,000-
40,000 of normalized microarray intensity upon selection, the expression level of hIgG 
light chain in P2 and P3 moderately increased 1.2-1.3 fold upon amplification.  P1 even 
experienced a slight decrease in hIgG light chain expression level of 1.1 fold. 
As mDHFR and HPT are not represented by any probes on the array, qRT-PCR 
was performed and a fold-change with respect to the host cells was reported.  The change 
in mDHFR mRNA level upon selection and amplification appeared to be more 
consistent, albeit slightly smaller in magnitude (Figure 28c).  The DHFR expression level 
was approximately 6-12 fold higher in the three clones post-selection compared to that in 
the host cells.  Upon amplification, the gene underwent another 5-10 fold increase in 
expression.  Thus, compared to the host cells, the amplified populations expressed DHFR 
30-80 fold higher.  The change of DHFR expression level in the control pool was more 
significant: 35-fold increase upon selection and a further 3.5 fold increase (to an overall 
fold-change of 125) upon amplification. 
Compared to DHFR, the hygromycin resistance marker (HPT) displayed a more 
drastic change following selection and amplification (Figure 28d).  All selected clones 
expressed HPT at a level 3,000-6,000 fold higher than the host cells.  Up to 3-fold 
increase was further induced upon amplification, which led to a total fold-change of 
6,000-17,000 in the amplified populations.  In the control pool, the fold-change was 
25,000 upon selection, and 43,000 upon amplification. 
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In most cases, selection surprisingly appeared to induce more drastic change in 
the expression levels of the four transgenes than did amplification.  The fold-change upon 
selection could be tens of thousands, whereas the change upon amplification was limited 
below ten. 
5.4.2 Global Transcriptional Changes Following Selection and Amplification 
To characterize transcriptional dynamics in response to selection, we compared 
the expression levels in post-selection samples of hIgG-producing clones (P1, P2, and P3) 
and control pool (C) to host cells.  As shown in Table 4, in P1, P2, and C, a large number 
of genes (on the order of 700 – 900) were considered differentially expressed upon 
selection with a fold-change ≥ 1 5 and a q-value ≤ 1 % using Significance Analysis of 
Microarray (SAM).  This number was rather small in P3 – only 64 genes were 
differentially expressed. 
When the same criteria were applied to compare samples before and after 
amplification, only about 200 – 500 genes were given differential calls in P1, P3, and C.  
Surprisingly, P2 experienced a relatively modest change – only 22 genes changed their 
expression levels upon amplification. 
Table 4: Number of differentially expressed genes in hIgG-producing clones and control pool upon selection and 
amplification. 
                   Processes 
 
Samples 
Selection Amplification 
Up-regulated Down-regulated Up-regulated Down-regulated 
P1 426 500 187 123 
P2 263 366 12 10 
P3 35 29 261 270 
C 
397 417 112 133 
P1∩P2∩P3 9 6 0 0 
 
Functional analysis using Gene Set Enrichment Analysis (GSEA) was performed 
to identify cellular functions which are statistically enriched among all genes present on 
the microarray (Table 5).  Unlike several other functional analysis approaches wherein 
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only differentially expressed genes were taken into consideration, GSEA is not affected 
by differential analysis results.  Instead, it takes all genes into account by calculating a 
signal-to-noise ratio (Subramanian et al. 2005).  Thus it allows small yet concerted 
changes within a functional pathway to be detected. 
Gene sets enriched with a nominal p-value ≤ 0.07 in the selected clones compared 
to the host cells include several signaling pathways, cell cycle, DNA replication, mRNA 
processing, amino acid metabolism, amino-acyl tRNA biosynthesis, and glutathione 
metabolism.  Of those, glutathione metabolism, mRNA processing, and a few signaling 
pathways were unaltered in the control pool. 
Upon amplification, the EDG1, PDGF, and Ras signaling pathways, glycolysis, 
the TCA cycle, protein processing, amino acid metabolism, and amino-acyl tRNA 
biosynthesis were enriched in the amplified populations.  Among them, glycolysis, the 
TCA cycle, and several signaling pathways were unchanged in the control pool. 
Table 5: List of functional classes enriched in hIgG-producing clones and control pool upon selection and 
amplification. 
Gene sets enriched upon selection Gene sets enriched upon amplification 
EDG1 signaling pathway*  EDG1 signaling pathway*  
PDGF signaling pathway*  PDGF signaling pathway*  
Aminoacyl tRNA biosynthesis Aminoacyl tRNA biosynthesis 
Cell cycle  Cell cycle  
DNA replication  DNA replication  
Amino acid metabolism  Amino acid metabolism  
mTOR signaling pathway*  Ras pathway  
Toll-like receptor signaling pathway  Extracellular matrix receptor interaction*  
Cytokine-cytokine receptor interaction  Ribosome 
mRNA processing* Proteasome  
Glutathione metabolism* Glycolysis and TCA cycle*  
 
* Unchanged in control pool. 
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5.4.3 Significant Clonal Variability upon Selection and Amplification 
As seen in Figure 28 and Figure 29, all four transgenes were expressed at 
significantly different levels among the three hIgG-producing clones.  P3 appeared to 
consistently express both hIgG heavy chain and light chain at higher levels compared to 
P1 and P2 following amplification.  For mDHFR and HPT, notable differences among the 
three clones were also observed although no consistent trend could be discerned.  It is 
important to note that the difference in expression of the transgenes among these clones 
upon selection was rather modest.  However, this difference appeared to be widened 
following amplification. 
 
Figure 29: Variability among different clones in expression levels of hIgG heavy chain, hIgG light chain, 
mDHFR, and HPT before amplification (bottom panel) and after amplification (top panel). 
 
In addition, as shown in Table 4, even though a large number of genes were 
differentially expressed following selection and amplification in each individual clone, 
the overlap among them seemed to be marginal.  Instead of hundreds, only 15 genes were 
commonly differentially expressed among the three clones upon selection, and none upon 
amplification.  This result indicated that these clones may have responded to the pressure 
of selection and amplification in considerably different ways. 
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Furthermore, hierarchical clustering was performed to assess the transcriptional 
similarity present amongst all analyzed samples (Figure 30).  A greater degree of 
similarity was found within individual clones and the control pool, rather than before and 
after MTX treatment.  In other words, amplification did not appear to greatly alter the 
transcription signature that had been established upon selection.  This result suggests that 
each clone isolated following selection continued to carry distinct transcriptome 
characteristics over the course of MTX treatment. 
 
Figure 30: Variability among different clones revealed by hierarchical clustering of transcriptome data. 
H: host, C: control pool, P: hIgG-producing clones, R: replicate, subscript zero: before MTX treatment, 
subscript M: after MTX treatment. 
 
5.4.4 Wide Range of Titer and Growth Characteristics in Fed-batch Cultures 
Each of the three hIgG-producing clones described above was further sub-cloned 
following amplification.  Two sub-clones were picked from each of the first two clones 
(P1 and P2), and five sub-clones from the third one (P3).  Duplicated fed-batch cultures at 
2 L scale were performed on the nine sub-clones.  As shown in Figure 31, these sub-
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clones produced hIgG at substantially different levels and displayed various growth 
characteristics.  The final titer in these cultures varied within a wide range, from 200 to 
900 mg/L (Figure 31a).  The peak viable cell concentration (VCC) ranged from 6 to 
11x10
6
 cells/mL (Figure 31b).  It is interesting to note that the sub-clone with highest 
final titer (in blue) had the lowest peak VCC, and vice versa, the culture with highest 
peak VCC (in red) produced the lowest final level of hIgG.  A similar inverse correlation 
could also be seen between the final titer and the final VCC.  In addition to having higher 
peak and final VCCs, this low-producing sub-clone also maintained substantially higher 
viability during the first half of the fed-batch cultures (Figure 31c).  However, shortly 
after the cells reached peak VCC at day 8, the viability in this culture dropped sharply.  In 
contrast, the best producing sub-clone maintained a steady and slow rate of decreasing 
viability over the course of the fed-batch cultures, and thus ended with the highest final 
viability.  The plot shown in Figure 31d indicated that the high titer cultures also had 
higher specific productivity.  Thus all correlations derived above for high and low titer 
cultures could also be applied for cultures with high and low specific productivity. 
 
 
111 
 
Figure 31: Various titer values and growth characteristics of sub-clones in fed-batch cultures. 
The red to blue color gradient corresponds to low to high final titer. 
 
Furthermore, the difference in product titer among sub-clones at day 4 and day 7 
of the fed-batch cultures appeared to be well correlated to the difference in hIgG heavy 
chain mRNA levels (Figure 32).  The correlation coefficient between them was 0.76 at 
day 4 and 0.69 at day 7.  In contrast, the light chain mRNA level did not seem to dictate 
the titer, as their correlation coefficient was almost zero at day 4 and only 0.32 at day 7.  
Surprisingly, the DHFR mRNA level was inversely correlated to the hIgG titer.  This 
correlation coefficient was – 0.47 and – 0.65 at day 4 and day 7, respectively. 
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Figure 32: Variability amongst different sub-clones in expression levels of the transgenes and the hIgG titer at 
day 4 (bottom panel) and day 7 (top panel) of fed-batch cultures. 
 
5.4.5 Transcriptome Analysis of High vs. Low IgG-producing Sub-clones in Fed-
batch Cultures 
Transcriptome analysis was performed on samples at day 4 and day 7 of fed-batch 
cultures to investigate the underlying transcriptional differences among the nine sub-
clones.  When the hIgG titers of these sub-clones at the two time points were re-arranged 
as shown in Figure 33, two classes of producers emerged: a high-producing class of five 
sub-clones (SC1_2, SC3_4, SC3_3, SC3_5, and SC3_1) and a low-producing class of four sub-
clones (SC1_1, SC3_2, SC2_1, and SC2_2).  Subsequently, an approach similar to the one 
applied to analyzing transcriptional responses upon selection and amplification, including 
statistical analysis (SAM) and functional analysis (GSEA), was taken to explore the 
differences between the two classes at transcription level. 
113 
 
Figure 33: Two classes of sub-clones: high-producers and low-producers with regard to hIgG titer at day 4 (left 
panel) and day 7 (right panel) of fed-batch cultures. 
 
As presented in Table 6, approximately 1,800 genes were identified as 
differentially expressed between the five high-producers and the four low-producers at 
day 4 with a fold-change ≥ 1 5 and a q-value ≤ 1 %   At day 7, this number reduced 
drastically to only 107 genes.  Between the two time points, only one gene (Rit2) was 
commonly up-regulated in high-producers, whereas 41 genes were commonly down-
regulated. 
Table 6: Number of differentially expressed genes between high and low producing sub-clones at day 4 and day 
7 of fed-batch cultures. 
             Time points 
 
 
Comparison 
Day 4 Day 7 
Up-regulated Down-regulated Up-regulated Down-regulated 
High vs. Low Sub-
clones 
1153 629 4 103 
 
Functional analysis identified a large number of cellular pathways which were 
enriched in the high producers at day 4 and day 7 as listed in Table 7.  Among the gene 
sets commonly enriched between these two time points are protein processing (Golgi 
apparatus and glycan structure biosynthesis), cell cycle, ABC transporter, cytoskeleton 
function, and signaling pathways (ECM receptor interaction, neuroactive ligand receptor 
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interaction, HCMV pathway, and TNFR1 pathway).  In addition, a few other pathways 
appeared to be enriched in the high producers only at day 4 such as phenylalanine 
metabolism, aminoacyl tRNA biosynthesis, DNA replication, cell adhesion, ribosome, 
MPR and JAK-STAT signaling pathways.  At day 7, pyrimidine metabolism, steroids 
biosynthesis, and FMLP pathway were enriched in the high-producing sub-clones. 
Table 7: List of functional classes enriched in high vs. low sub-clones at day 4 and and day 7 of fed-batch 
cultures. 
Gene sets enriched at day 4 Gene sets enriched at day 7 
Golgi apparatus Golgi apparatus 
Glycan structure biosynthesis Glycan structure biosynthesis 
Cell cycle Cell cycle 
Cytoskeleton function Cytoskeleton function 
ECM receptor interaction ECM receptor interaction 
ABC transporters ABC transporters 
Neuroactive ligand receptor interaction Neuroactive ligand receptor interaction 
HCMV pathway HCMV pathway 
TNFR1 pathway TNFR1 pathway 
Phenylalanine metabolism Pyrimidine metabolism 
Aminoacyl tRNA biosynthesis Biosynthesis of steroids 
MPR pathway FMLP pathway 
DNA replication  
Cell adhesion molecules  
Ribosomal proteins  
JAK-STAT signaling pathway  
 
5.4.6 Multiple Routes to Hyper-productivity 
Given that each clone isolated following selection and each sub-clone isolated 
following amplification possessed a unique transcriptome signature, it appeared that these 
cells have developed multiple routes to achieve hyper-productivity.  Thus it becomes 
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critical that a union among the gene sets representing these routes is derived to serve as a 
universal indication of hyper-productivity traits.  To this end, we employed a filtering 
strategy outlined in Figure 34 to compile a final hyper-productivity gene set. 
A set of 349 genes (F) was identified as differentially expressed in high-producers 
compared to low-producers at day 4 and day 7 of fed-batch cultures using a q-value ≤ 
10%.  This set could subsequently intercept with each of the following three sets to arrive 
at a final gene list.  The first set (S) comprised of 1,996 genes which were differentially 
expressed in at least one hIgG-producing clone upon selection but not in the control pool.  
The second set (A) of 988 genes was derived by compiling a union of differentially 
expressed genes in the three hIgG-producing clones following amplification, also not in 
the control pool.  In these two sets, a slightly stricter q-value cutoff of less than 5% was 
used to identify differential expression in the clones, whereas genes with q-values passing 
a commonly used cutoff of 10% were considered unchanged in the control pool.  The 
third set (Q) of 451 genes was compiled from several previous studies of high vs. low-
producing NS0 clones (Charaniya et al. 2009; Seth et al. 2007c) and of productivity 
enhancing culture conditions such as temperature shift and sodium butyrate treatment 
(Kantardjieff et al. 2010; Yee et al. 2008; Yee et al. 2009). 
The intersection between F and S, F and A, and F and Q comprised 58, 13, and 15 
genes, respectively.  The combined list of these genes is shown in Table 8.  The majority 
of these genes are involved in gene expression and signaling activities (Figure 35). 
116 
 
Figure 34: Compilation of hyper-productivity gene sets from multiple sources. 
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Table 8: List of genes conferring hyper-productivity traits compiled from multiple sources. 
Gene symbols Gene symbols Gene symbols 
2410001C21Rik Gpatch3 Sar1b 
AB370295.1 Gps2 Scamp2 
Abcb6 H2afy Slu7 
AC016791.23 Hmgcr Smc6 
AC132224.3 Hsd17b12 Smurf1 
Acsl4 Hspd1 Snrpc 
Adam9 Ing1 Snx21 
AL611927.21 Jmjd4 Stk25 
AL824707.7 LOC680531 Stt3b 
Arfrp1 Mrps24 Stx7 
Arhgap29 Ncapd2 Tdrd3 
Atp11b Nde1 Tfdp1 
Ckap4 NM_008350.4 Timp2 
CS391352.1 Nt5dc2 Traf6 
Cstf2t Papola Trim28 
Ctbp1 Parp1 Twsg1 
Cyp20a1 Pask Ube2s 
D17Wsu104e Pax3 Ubr1 
Dagla Pcolce2 Ufm1 
Dnpep Pin4 Utp11l 
Dpm1 Prpf31 Wtap 
E2f6 Ptpn14 Xrcc5 
Fam3a Ptrf Ythdf1 
FI847326.1 Pxk Zfand5 
Fn1 Rac1 Zfp128 
FQ075827.1 Rpe Zfp346 
GH511842.1 Rps20 Zfp600 
GH524702.1 
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Figure 35: Distribution of functional enrichment in the hyper-productivity gene set. 
 
5.5 DISCUSSION 
The process of initial selection followed by amplification has been used widely in 
the past few decades for generating recombinant protein producing cell lines.  However, 
very limited information is currently available regarding the transcriptional changes 
incurred by this transformation process.  To our knowledge, this is the first study that 
employed a genome-scale transcriptome approach to investigate these changes.  
Hundreds of genes were identified as differentially expressed upon selection and 
amplification, most of which are related to signaling, cell cycle, DNA replication, and 
amino acid metabolism. 
A moderate variability was observed among the three hIgG-producing clones 
following selection, which harbored the plasmid at random locations in the host genome.  
Following amplification, this difference was expanded significantly.  This is likely a 
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result of the “position effect”, in which the integration site of the plasmid would 
significantly affect the expression of the transgenes (Wilson et al. 1990).  Integration of 
the plasmid into a heterochromatin region can lead to little or no expression, whereas 
integration into a euchromatin region often allows active expression of the transgenes.  
Another contributing factor could be a difference in the copy number of plasmid 
integrated into the genome.  In a different study, it was shown that the range of plasmid 
copy number can be between 20 and 400 in six randomly chosen clones (Wurm and 
Petropoulos 1994).  Furthermore, from hierarchical clustering results, different samples 
appeared to cluster amongst clones rather than across time.  This result suggests that each 
clone may possess a unique transcription signature which could dictate the cells’ 
propensity to amplify and which was well retained even after amplification. 
Given the assumed roles of selection and amplification, it is surprising to find that 
selection conferred more drastic transcriptional changes of the transgenes than did 
amplification.  Except for DHFR, which was induced at comparable levels, the other 
three transgenes (namely HPT, hIgG light chain, hIgG heavy chain) experienced a more 
than one-thousand-fold increase upon selection relative to amplification.  This result 
indicated that selection was not simply selecting for cells with stable integration of the 
selection marker.  Indeed, during the selection process, cells might have been forced to 
expand other cellular functions to cope with the selection pressure such as cell cycle, 
DNA replication, and amino acid metabolism.  A comparison between hIgG-producing 
clones and the control pool further revealed several aspects of the cellular machinery 
which are potentially required for secreting hIgG at high levels.  Such cellular functions 
encompass glutathione metabolism, mRNA processing, and several signaling pathways 
such as mTOR, EDG1, and PDGF.  Not only does amplification appear to incur modest 
changes in the expression levels of the transgenes, it also induces minor changes at a 
global level with respect to selection.  Almost identical cellular pathways were shown to 
be enriched following amplification.  Thus, amplification seems to play a role in further 
reinforcement of transcriptional changes which have already occurred during selection 
rather than giving rise to new and unique changes. 
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A comparison between high and low-producing sub-clones derived from 
amplified populations in fed-batch cultures uncovered additional cellular pathways 
necessary for secreting hIgG efficiently.  In high-producing sub-clones, Golgi apparatus, 
glycan structure biosynthesis, cell cycle, cytoskeleton function, ECM receptor 
interaction, ABC transporter, and several signaling pathways were significantly enriched 
compared to low-producing sub-clones.  Among these pathways, protein processing, cell 
cycle, and cytoskeleton-related elements were also identified in a previous transcriptome 
study of seven high- and four low-producing clones of NS0 cells (Charaniya et al. 2009).  
In another study, combined transcriptome and proteome analysis of CHO cells revealed 
enrichment of secretory pathways, including Golgi apparatus, cytoskeleton protein 
binding, and small GTPase-mediated signal transduction under temperature shift and 
sodium butyrate treatment (Kantardjieff et al. 2010). 
Given that there is such a high degree of dissimilarity among different clones, 
each of which has altered a large number of genes and functional classes to become high-
producers, it becomes evident that hyper-productivity can be achieved via multiple 
routes.  Indeed, this concept has been articulated previously (Seth et al. 2007a).  As 
shown in Figure 36, hyper-productivity can be considered a complex trait that requires a 
collection of many positive characteristics encompassing a wide range of functions, 
including energy metabolism, protein secretion, redox balance, and growth/death control. 
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Figure 36: Multiple routes to hyper-productivity (Seth et al. 2007a). 
 
The surprisingly modest role of amplification relative to to selection observed in 
this study suggests that selection itself may suffice to generate a wide range of clones to 
screen for high-producers.  Furthermore, it would be interesting to explore the long-term 
stability of such high product titers achieved upon cell line development.  It has been 
shown that transgene mRNA levels can potentially decline over time in culture, possibly 
due to repeat-induced silencing of the amplified product gene (Chusainow et al. 2009).  
Thus more mechanistic insights would be required to derive a conclusive guide for cell 
line development process.  As more genomic tools for CHO cells are becoming available, 
we can anticipate an abundance of such studies characterizing different aspects of hyper-
productivity traits in the years to come. 
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6 ENGINEERING GENE EXPRESSION DYNAMICS OF MAMMALIAN CELLS IN 
CULTURE 
6.1 SUMMARY 
Cultured mammalian cells are the major hosts for the production of recombinant 
protein therapeutics.  Genetic engineering has been used to transform these cells from 
non-producers to hyper-producers, which harbor superior phenotypic traits related to 
metabolism, protein secretion, and growth control.  Many of these efforts have been 
performed using strong and constitutive expression systems.  However, cellular needs are 
dynamic, responding to various environmental perturbations as well as cellular processes, 
rather than being static.  Inducible systems enable time dynamics through external 
manipulation of inductive conditions.  Ideally, a transgene’s expression should be 
synchronous with the host cell’s own rhythm    urthermore, depending on the cellular 
process to be manipulated and the transgene’s function, the expression level should be 
controlled at the correct modulating level. 
To that end, we surveyed the transcriptome profiles obtained from time-course 
experiments spanning various stages of cell growth and encompassing different fed-batch 
culture conditions.  Clustering of gene expression patterns revealed thousands of genes 
with varying dynamics across a wide intensity range.  The promoters of these genes can 
potentially provide a more flexible and dynamic means to control the expression of the 
transgene. 
In this study, we focused on several genes which exhibit low expression levels in 
the mid-exponential phase and significantly higher expression levels in the late-stationary 
phase.  We demonstrated that, under the control of these dynamic promoters, a blasticidin 
resistance (BSD) gene and an enhanced green fluorescent protein (EGFP) gene can be 
expressed in concert with cell growth.  This approach illustrates a novel concept in 
metabolic engineering which can potentially be used to achieve dynamic control of 
cellular behaviors for enhanced process characteristics. 
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6.2 INTRODUCTION 
Recombinant mammalian cells are used extensively for the production of 
therapeutic proteins, accounting for tens of billions per annum of product value and 
benefiting tens of thousands of patients (Aggarwal 2011).  Their rise to such prominence 
largely has been attributed to genetic manipulations which enable cells to produce high 
levels of recombinant proteins.  Substantial efforts in genetic engineering have focused 
on introducing metabolic, secretory, and growth control genes.  Significant progress has 
been reported, including down-regulation of lactate dehydrogenase A (LDH-A) and 
pyruvate dehydrogenase kinases (PDHK) to reduce lactate production (Zhou et al. 2011), 
functional disruption of an -1,6-fucosyltransferase (Fut8) to produce nonfucosylated 
hIgG1 (Malphettes et al. 2010), and over-expression of anti-apoptotic genes E1B19K and 
Aven to delay the onset of apoptosis (Figueroa et al. 2007). 
Typically, genetic engineering of these target genes in cultured mammalian cells 
involves the use of either constitutive or inducible promoters.  Constitutive promoters 
such as those derived from Cytomegalovirus (CMV), Simian virus 40 (SV40), or the 
elongation factor 1 (EF1) are virtually always active regardless of environmental 
conditions.  Such strong and constitutive expression of the transgenes may not be suitable 
in several cases wherein the transgenes have negative impacts on cellular behaviors.  
Inducible promoters, alternatively, are activated upon addition of the corresponding 
inducers such as tetracycline, isopropyl-b-D-thio-galactoside (IPTG), or hormones; thus, 
inducible systems allow more flexibility in modulating gene expression.  However, the 
presence of these inducers could potentially trigger undesirable cellular responses.  
Furthermore, gene expression is a dynamic process by nature, which is constantly 
adjusting to cope with various perturbations.  Consequently, endogenous promoters with 
intrinsic dynamic activities represent attractive tools to control the expression dynamics 
of the transgenes. 
The vast increase of time-course transcriptome data in recent years, mainly 
through microarray and deep sequencing approaches, presents unprecedented 
opportunities to discover genes with dynamic expression profiles.  Indeed, analysis of 
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time-course deep sequencing (deepCAGE) data revealed the time-dependent dynamics of 
the 30 most significant regulatory motifs in a human cell line (Suzuki et al. 2009).  Such 
variety of time dynamics was also observed in an hIgG-producing CHO cell line 
undergoing temperature shift and sodium butyrate treatment (Kantardjieff et al. 2010).  In 
these studies, the major expression trends of hundreds of regulatory motifs or genes were 
distinguished from the background noise either by model fitting or principal component 
analysis (PCA).  These trends subsequently could be classified into several groups by 
clustering based on their similarity.  The promoters of these genes, once isolated, would 
serve as potential tools for dynamic control of gene expression. 
Recent advent of genome sequences for the most important industrial cell lines, 
Chinese Hamster Ovary (CHO) and Baby Hamster Kidney (BHK) cells, has permitted 
further avenues for dynamic cell engineering (Broad Institute 2011; Jacob et al. ; Xu et al. 
2011).  Although not as completed as the human or mouse genomes, it would be expected 
that regulatory elements in these cells can be identified and isolated.  Pioneering work by 
the ENCODE and the FANTOM consortiums have revealed that transcriptional 
regulation in mammalian cells is much more complex than previously known.  Gene 
expression is regulated by an intertwined network which include histone modifications; 
dispersed enhancers, silencers, and insulators; and alternative promoter usage, splicing, 
and polyadenylation (The ENCODE Consortium 2007; The FANTOM Consortium 
2005).  The concept of a promoter region thus becomes fuzzy, as it may encompass 
thousands of base pairs (bp) and contain a large number of regulatory elements.  In the 
scope of this study, we focused on the commonly known core and proximal promoter 
regions, which are the most well-defined regions that can be routinely isolated.  The core 
promoter often resides within a few hundred bp of the minimum portion required for 
transcription initiation, which involves binding sites of the RNA polymerase and general 
transcription factors (TFs) (Butler 2002).  The proximal promoter region, typically 
extended up to a few thousand bp, contains the core promoter and most of the specific TF 
binding sites. 
In this study, we surveyed historical time-course microarray data from multiple 
fed-batch cultures to identify genes with time dynamic expression trends.  The promoter 
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of several candidate genes were isolated from Chinese hamster liver genomic DNA, and 
used to drive the expression of a fusion transgene following the expected dynamic 
manner.  Thus this study represents the first proof-of-concept in dynamic cell 
engineering. 
6.3 MATERIALS AND METHODS 
6.3.1 Time-series Transcriptome Data Processing 
Transcriptome data obtained from 72 samples from twelve fed-batch cultures of a 
recombinant CHO cell line producing IgG were used in this study.  RNA samples of six 
time points in each culture were obtained and assayed with Affymetrix microarray.  Raw 
data (.CEL) files were processed using the GeneData Expressionist Refiner module 
(GeneData, San Francisco, CA).  The Microrray Analysis Suite Statistical Algorithm 
(MAS 5.0) was used to assess the overall quality and to condense the intensities of all 
probes within each probe set to a single value.  The average intensity value of all probe 
sets within each array was linearly scaled to 500.  Quantile normalization was further 
applied to align the intensity distributions of all arrays (Bolstad et al. 2003).  Probe sets 
with a minimum detection p-value greater than 0.04 or a maximum intensity value less 
than 70 in all samples were called absent and removed from further analysis.  Since we 
were only interested in transcripts which are dynamically expressed, “invariant” probe 
sets with a coefficient of variation (CV) across time less than 20% in all samples were 
also excluded.  If a gene is represented by multiple probe sets, the one with highest CV 
was selected. 
6.3.2 Time Profile Patterns of Transcriptome Data  
Log2-mean centered intensity values for each gene were arranged into a 12 x 6 
matrix, representing the twelve fed-batch cultures, each with six time points.  Principal 
component analysis (Alter et al. 2000) was performed on each matrix (Spotfire, 
Cambridge, MA).  Genes for which the first principal component (PC1) captured more 
than 80% of the total variance were retained for further analysis.  These genes were 
grouped into clusters with similar expression time profiles using k-means clustering 
(Everitt 1974a) (k = 6) with their first principal components as the input.  Genes within 
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each of the six clusters were furthered categorized into high, mid, and low intensity 
ranges with the maximum intensity across samples (Imax) greater than 10000, between 
10000 and 5000, and less than 5000, respectively.  Finally, functional classes enriched 
amongst each of the six clusters (i.e., enrichment p-value less than 0.05) were identified 
using gene ontology enrichment analysis implemented in GenMAPP’s MAPP inder 
(Doniger et al. 2003). 
6.3.3 Fed-batch Cultures 
The transcript dynamics of the candidate promoter was verified in a second 
recombinant CHO cell line prior to promoter isolation.  The same cell line was used as 
the host cell line for expressing the promoter-reporter construct.  The cultures were 
initiated by inoculating cells at 2.5 x 10
5
 cells/mL into 20 mL of DMEM-F12 medium in 
each 125 mL shaker flask (Thermo Scientific, Rochester, NY) and incubated at 37
o
C on a 
shaker rotating at 130 rpm, in 5% CO2 environment in a humidified incubator.  One mL 
of a ten-fold concentrated feed medium (10 X) was added daily starting from day 2.  Cell 
concentration and viability were determined by counting with a hemacytometer using 
trypan blue staining.  One million cells were withdrawn each day for RNA extraction 
starting from day 2. 
6.3.4 Quantitative Real Time PCR (qRT-PCR) 
Total RNA was isolated using the RNeasy Mini kit (Qiagen, Valencia, CA) 
according to the manufacturer’s protocol with on-column DNase I treatment for removal 
of genomic DNA.  Reverse transcription was performed with 2.5 g of total RNA using 
Superscript III Reverse Transcriptase (Invitrogen, Carlsbad, CA) with 1 mM oligo dT 
primers in a total volume of 50 L.  A no reverse transcriptase control was performed in 
parallel to assess genomic DNA contamination. 
qRT-PCR primers for several dynamic genes, listed in Table 9, were designed 
using the Primer3 website (http://frodo.wi.mit.edu/).  The mRNA levels of these genes 
were quantified using the Brilliant II SYBR Green qPCR Master Mix (Agilent, Santa 
Clara, CA).  Each 12.5 L reaction mixture contained 6.25 L of the master mix, 50 ng 
of the cDNA template, and 0.2 M of each primer (forward and reverse).  qRT-PCR was 
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performed using the Stratagene Mx3000P instrument (Agilent, Santa Clara, CA).  The 
thermal cycling profile was set as follows: initial denaturation at 95
o
C for 10 min, 
followed by 40 cycles of 95
o
C for 10 sec, 57
o
C for 1 min, and 72
o
C for 30 sec.  The 
dissociation curves of the PCR products were generated by ramping from 57
o
C to 95
o
C 
after a denaturation step at 95
o
C for 1 min and an annealing step at 57
o
C for 30 sec.  All 
cDNA samples were run in triplicates along with a no reverse transcriptase control and a 
no template control.  -actin was used as a reference for comparison across samples. 
Table 9: List of qRT-PCR primers used for quantification mRNA levels of candidae genes, -actin, BSD, and 
EGFP. 
Gene 
symbol 
Ensembl ID of mouse 
homolog 
Left primer Right primer 
Mmp12 ENSMUSG00000049723 CAGCCATCTTTGACCCATCT GAGCCTTTTGGTGACACGAT 
Sppr1a ENSMUSG00000050359 AACCAAGGATCCCTGCAAC CATGGCTCAGGAACAACTGG 
Gsta3 ENSMUSG00000025934 GCCAAGATCAAGGACAAAGC GTCCAGCTCTTCCACATGGT 
Hmox1 ENSMUSG00000005413 CCTAAAGCGGACAGAACCAG ACCTGGCCCTTCTGAAAGTT 
Psap ENSMUSG00000004207 CTGTCCAAGACCCGAAGGTA TTTCAGCAAGTTCCCAGCTT 
Clu ENSMUSG00000022037 AAATTCAAAATGCCGTCCAG CCATCATGGTCTCATTGCAC 
Ces1f ENSMUSG00000031725 TTGGAGAGTCAGCAGGAGGT CAGATGTGGTGGTTTTGCAC 
Serpinf1 ENSMUSG00000000753 TCAAGGTCCCGGTAAACAAG GGTGCTATGGATGTCCGAGT 
Txnip ENSMUSG00000038393 CAGTGCAAACAGACCTTGGA AAGGAAAGCCTTCACCCAGT 
Sqstm1 ENSMUSG00000015837 CTACACAGGGAGCACAGCAA ATCCCCTGCTCTAGGAGGAC 
Nucb2 ENSMUSG00000030659 CTCAGTGGCCTCATCTGTGA TCCTGGTGGGTCTATCCTTG 
Trp53inp1 ENSMUSG00000028211 TTTCCAATTCCCATGCAGAT AGGACGGAGCAAAATAGCAA 
Stau2 ENSMUSG00000025920 GAGAGCCTGCCATCTACAGG CATTGTGTCTGGCAGCTTGT 
Lcp1 ENSMUSG00000021998 ATGCCCTGATCATCTTCCAG TGATTCTTCCCCAGATCCAC 
CD36 ENSMUSG00000002944 CCATCTACGCTGTGTTTGGA TGTTTGCATTTGCTGATGTCT 
actin ENSMUSG00000029580 GTCGTACCACTGGCATTGTG AGGGCAACATAGCACAGCTT 
BSD N.A. ATGCAGATCGAGAAGCACCT ATCAACAGCATCCCCATCTC 
EGFP N.A. ACGTAAACGGCCACAAGTTC AAGTCGTGCTGCTTCATGTG 
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6.3.5 Isolation of Chinese Hamster Promoter 
A fragment of approximately 1000 bp containing part of the putative 5’ UTR and 
the upstream region of each of the following genes, Mmp12, Txnip, and Serpinf1, was 
isolated.  Genomic DNA isolated from Chinese hamster liver with the DNeasy Blood and 
Tissue kit (Qiagen, Valencia, CA) was used as the PCR template.  The forward and 
reverse primers included restriction sites of AatII and EcoRI, respectively, to facilitate 
cloning of the PCR product into the expression vector (Table 10). 
Table 10: List of PCR primers used for isolating promoters of Mmp12, Txnip, and Serpinf1 from Chinese 
hamster (CH) liver genomic DNA. 
Letters in regular format represent DNA sequences complement to the template.  Underlined letters represent 
restriction sites used for cloning.  Italic letters represent random sequences needed to make the restriction sites 
“internal”. 
Gene symbol Mmp12 Txnip Serpinf1 
Left primer TCAGGACGTCGGTGG
GAGTGTGTGTTCCTT 
CGTAGACGTCCCAATG
CTGAAGAACCCTTG 
TCGAGACGTCCACCTC
ACTGGCCACTTTTT 
Right primer TCAGGAATTCTGTGAC
CAGATCTCTCAGCAG 
TCAGGAATTCTCAGCG
GGTTCCAGATAAAC 
TCGAGAATTCCTCTAG
CAAGCAGGGGAGTG 
Coordinate in Chinese 
hamster scaffolds (Jacob et 
al.) 
1274477..1275388, 
scaffold 8  
1623404..1624318, 
scaffold 122 
60652..61866, scaffold 
942 
Coordinate in CHO-K1 
scaffolds (Xu et al. 2011) 
709505..710405, scaffold 
370 
846522..845735, scaffold 
297 
56467..57667, scaffold 
16294 
 
A 50 L PCR reaction mixture contained 1 unit of the Phusion High Fidelity 
DNA Polymerase (Finnzymes, Vantaa, Finland), 100 ng of the liver genomic DNA 
template, 0.5 M of each primer, and 200 M of dNTPs (Invitrogen, Carlsbad, CA).  The 
reaction was performed under the following conditions: initial denaturation at 98
o
C for 30 
sec, 30 cycles of 98
o
C for 10 sec, 57
o
C for 30 sec, and 72
o
C for 30 sec prior to final 
extension of 72
o
C for 10 min.  The products were separated on a 0.8% agarose gel. The 
expected band of approximately 1000 bp was excised and purified using the Zymoclean 
Gel DNA Recovery kit (Zymo Research, Irvine, CA).  A representation of the Txnip 
promoter fragment is shown in Figure 37a. 
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Figure 37: Cloning of promoter fragments from Chinese hamster liver genomic DNA. 
a) Representation of Txnip promoter fragment (black horizontal line) with approximate locations of 
putative transcription start site (TSS); general transcription factor binding sites (TFBSs) such as 
TATA box and CAT box; and other specific transcription factor binding sites such as FOXO binding 
site and carbohydrate response element (ChoRE).  The start codon (ATG) was shown for reference. 
b) Plasmid map of p_BSD_EGFP.  The isolated promoter was used to drive the expression of a fusion 
gene composed of a blasticidin resistance marker (BSD) and an enhanced fluorescent protein (EGFP) 
gene.  Each plasmid was linearized with restriction enzymes prior to transfection in two different ways: 
single digest with ScaI, or triple digest with ScaI, AatII, and XhoI.  Thus the resulting stable pools and 
clones are labeled as A_B_C, where A stands for the promoter (M for pMmp12, T for pTxnip, and S 
for pSerpinf1), B stands for the type of restriction digest (S for single digest and T for triple digest), 
and C stands for the pool (P) or the clone ID (numeric value). 
c) Integration of plasmid into the host cells’ genome was verified using gel electrophoresis of the PCR 
product of genomic DNA isolated from transfected cells.  The left and right primers used for PCR 
flank the BSD and the EGFP genes, respectively. 
 
6.3.6 Construction of Expression Vector 
A fusion gene of a blasticidin resistance marker (BSD) and an enhanced green 
fluorescence protein (EGFP) was excised from the CSII_BSD_EGFP plasmid (courtesy 
of Dr. Nikunj Somia) using NotI and EcoRI.  The pTRE-Tight plasmid (Clontech, 
Mountain View, CA) was also digested using the same combination of restriction 
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enzymes.  Each restriction digest mix contained 1 g of plasmid, 10 units of NotI and 20 
units of EcoRI (New England BioLabs, Ipswich, MA).  The digest was performed at 
37
o
C for 2 hr following by heat inactivation at 65
o
C for 20 min.  The digested products 
were separated in a 0.8% agarose gel, and purified using the Zymoclean Gel DNA 
Recovery kit (Zymo Research, Irvine, CA). 
The fusion gene was inserted into the multiple cloning site of pTRE_Tight to 
generate a new vector, pTet_BSD_EGFP.  About 50 ng of the BSD_EGFP insert and 50 
ng of the pTRE_Tight backbone were ligated overnight at 16
o
C in a 20 L ligation mix 
with 0.5 unit of T4 DNA Ligase (Invitrogen, Carlsbad, CA).  A negative control was 
performed in parallel without the insert to assess the extent of self-ligation of the 
backbone.  Two L of this ligation mix was used to transform chemically competent 
E.coli cells OneShot TOP10 (Invitrogen, Carlsbad, CA) following the manufacturer’s 
protocol.  Twelve single colonies were randomly selected and subjected to PCR 
amplification using two primers: EGFP_N (CGTCGCCGTCCAGCTCGACCAG) and 
BSD_R1 (ATCAACAGCATCCCCATCTC) to identify colonies with the correct insert 
direction.  Two of them were chosen to inoculate overnight cultures in 5 mL of LB 
medium.  The amplified plasmids were purified from 4.5 mL of the overnight culture 
using the Qiaprep Spin Miniprep kit (Qiagen, Valencia, CA).  The pTet_BSD_EGFP 
plasmid sequence in each colony was verified using Sanger sequencing with the EGFP-N 
primer. 
The tetracycline inducible promoter in this plasmid was subsequently replaced by 
each of the three Chinese hamster promoters isolated above via the restriction sites of 
AatII and EcoRI in a similar cloning process.  These plasmids were named after the 
corresponding promoters: pMmp12_BSD_EGFP, pTxnip_BSD_EGFP, and 
pSerpinf1_BSD_EGFP (Figure 37b). 
6.3.7 Generation and Characterization of Stable Pools and Clones 
The plasmids constructed above were linearized prior to transfection into the host 
cells.  Two types of restriction digest were used: one with ScaI (single digest), which cuts 
inside the ampicillin resistance gene; and the other with ScaI, AatII, and XhoI (triple 
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digest) to remove all bacterial components.  The products of the triple digest were 
separated on a 0.8% agarose gel, and the expected band was excised and purified using 
the Zymoclean Gel DNA Recovery kit (Zymo Research, Irvine, CA). 
CHO cells were seeded in duplicated wells at 5 x 10
5
 cells/mL in 2 mL of 
DMEM-F12 medium in a 6-well plate 24 hr prior to transfection.  A DNA – cation lipid 
complex containing 4 g of linearized plasmid, 10 L of Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA), and 500 L of Opti-MEM (Invitrogen, Carlsbad, CA) was generated 
according to the manufacturer’s protocol   After an incubation of    min at room 
temperature, the complex was added drop by drop into the cells.  The transfected cells 
were centrifuged at 700 rpm for 5 min at room temperature 6 hr after transfection and re-
suspended in 2 mL of fresh DMEM-F12 medium. 
Twenty-four hours following transfection, the cells were diluted in 96-well plates 
at 1000 cells/well in 0.2 mL of the selective medium comprising DMEM-F12 
supplemented with 5 g/mL Blasticidin S (InvivoGen, San Diego, CA), 5% (v/v) fetal 
bovine serum (Atlas Biologicals, Fort Collins, CO), and 20% (v/v) conditioned medium.  
The conditioned medium was collected during the mid-exponential growth phase of the 
non-transfected cells in a batch culture in DMEM-F12, and was filtered through a 0.45 
m pore size filter (Fisher Scientific, Pittsburgh, PA).  In parallel, the pools were also 
diluted at 5 x 10
5
 cells/mL in the same selective medium in 6-well plates and passaged 
every three days.  The plates were incubated for approximately two weeks in a 37
o
C, 5% 
CO2 environment.  Single clones in 96-well plates were picked and transferred to a new 
well containing 150 L of fresh selective medium.  Upon reaching high cell density, the 
total volume of 200 L was expanded gradually to 1 mL in 24-well plates, 4 mL in 6-
well plates, 8 mL in T-25 flasks, and 25 mL in T-75 flasks for cryopreservation and 
subsequent characterization in the selective medium. 
Stable clones and pools were characterized for the mRNA levels of the transgenes 
(BSD and EGFP) and the endogenous genes across different stages of fed-batch cultures 
via qRT-PCR.  A simple flowchart describing the process of generating and 
characterizing stable pools and clones is presented in Figure 38. 
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Figure 38: Flowchart for clone generation and characterization process. 
The plasmids were linearized before transfection either by single digest with ScaI or triple digest with ScaI, 
AatII, and XhoI.  The digested products were separated and purified prior to transfection.  Transfected cells 
were selected for two weeks in blasticidin.  Stable pools and single clones were isolated and used to run fed-batch 
cultures.  Samples were collected over time to characterize mRNA levels of the transgenes (BSD, EGFP and the 
endogenous genes. 
 
6.4 RESULTS 
6.4.1 Identification of Genes with Dynamic Expression Profiles 
Historical time-series microarray data obtained from multiple fed-batch culture 
conditions were used to identify genes with reproducible dynamic behaviors in a typical 
fed-batch culture.  Among the 23020 probe sets available on the Affymetrix microarray, 
10256 represented genes which were expressed at varying levels across time as evaluated 
by a coefficient of variation (CV) of greater than 0.2.  Principal component analysis was 
performed on each of these genes (Figure 39a).  Over 3000 genes with similar expression 
trends across culture conditions were grouped into six clusters using k-means clustering. 
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Figure 39: Identification of genes with dynamic expression profiles using historical time-course microarray data. 
a) Principal component analysis (PCA) was performed on each of the genes with a coefficient of variance 
(CV) across time greater than 20%.  For genes with PC 1 captured more than 80% of the total 
variance, k-means clustering (k=6 in this case) was used to identify clusters of genes with similar major 
expression trends.  Genes in each cluster follow a distinct expression profile and span a wide range of 
intensity. 
b) Expression profiles of three genes in the 5th cluster in the 12 historical fed-batch cultures are shown, 
each in a different color.  Each gene represents one of the three intensity categories: high, mid, and low 
with the maximum intensity greater than 10000, between 10000 and 5000, and lower than 5000, 
respectively. 
 
Of those, clusters 3, 5, and 6, comprising 1581 genes with low expression level at 
mid-exponential phase and significantly higher expression level at late-stationary phase, 
were of special interest.  Members of each cluster were further categorized into sub-
clusters based on their maximum intensity values (Imax): high intensity with Imax greater 
than 10000, mid intensity with Imax between 10000 and 5000, and low intensity with Imax 
less than 5000.  Examples of three genes representing these three sub-clusters are shown 
in Figure 39b.  Despite spanning a wide intensity range, all three genes displayed similar 
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expression trends across culture conditions, demonstrating the effectiveness of our time-
series transcriptome data mining scheme. 
A number of functional classes were significantly enriched in these clusters as 
determined using gene ontology enrichment analysis (Table 11).  Of note, the activity of 
cell cycle, mRNA processing, ribosome biogenesis, and lipid biosynthesis appeared to 
decrease gradually over time; whereas apoptosis, protein secretion, redox balance, and 
fatty acid metabolism displayed increasing trends as the cultures progressed from the 
mid-exponential phase to the late-stationary phase. 
Table 11: Enriched gene ontology classes in the six clusters of dynamic genes. 
k-means 
cluster 
Number of 
genes 
Enriched gene ontology classes 
1 683 DNA binding, cytoskeleton, cell cycle, mRNA transport and 
processing, lipid biosynthesis 
2 697 Ribosome biogenesis, cell cycle, amine metabolism, mRNA 
processing 
3 429 Actin cytoskeleton, vacuole, vesicle-mediated transport, fatty acid 
metabolism, sphingolipid metabolism 
4 54 No significantly enriched classes 
5 757 Glutathione transferase activity, cation transporter, positive 
regulation of apoptosis 
6 395 Apoptosis 
 
6.4.2 Verification of Dynamic Expression Profiles 
Among the 1581 genes in clusters 3, 5, and 6, only 901 were annotated with high 
confidence levels by similarity in nucleotide sequence with mouse, human, or rat 
homologs.  We further selected 15 genes based on the availability of full-length mRNA 
sequence in Chinese hamster; availability of genomic DNA sequence surrounding the 
coding region and approximately 1000 bp upstream of the putative transcription start site 
in Chinese hamster; and validity of protein function of homologs in other species (Table 
10).  As shown in Figure 40a, in a representative historical culture, these 15 genes 
displayed similar increasing trends over time with diverse intensity ranges.  Thus they 
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represented ideal candidates for which promoters could be used to drive the expression of 
transgenes following the desired dynamic trend above. 
                                                    
 
Figure 40: Expression time profiles of the 15 final candidate genes in three categories: high, mid, and low 
intensity. 
a) Intensity time profiles of these genes in a representative historical fed-batch culture of an industrial 
CHO cell line were shown, each in a different color.  The viable cell concentration in this culture was 
also shown for reference. 
b) Difference in qRT-PCR cycle number (Ct value), or – log2 fold-change, of each gene with respect to -
actin in a typical fed-batch culture of a second CHO cell line (host).  The same color code is used for 
each gene.  The viable cell concentration of this culture was also shown for reference. 
 
In order to check whether these 15 candidate genes are expressed in the second 
CHO cell line following the dynamic trends observed in historical data, qRT-PCR 
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analysis was performed using samples from a typical fed-batch culture of these cells.  
Surprisingly, only three of them exhibited significant increases in their expression over 
time as expected, namely Matrix metallopeptidase 12 (Mmp12), Thioredoxin interacting 
protein (Txnip), and Serine (or cysteine) peptidase inhibitor, clade F, member 1 
(Serpinf1).  As shown in Figure 40b, when -actin was used as a baseline for comparison 
across samples, the expression levels of three genes increased 4- to 28-fold when the cells 
progressed from the mid-exponential phase to the late-stationary phase.  The other genes 
remained relatively constant during the entire culture duration. 
6.4.3 Isolation of Promoters from Dynamic Genes 
For each of the three genes identified above (Mmp12, Txnip, and Serpinf1), a 
fragment of approximate 1000 bp was isolated from Chinese hamster liver genomic 
DNA.  These fragments contain part of the 5’ UTR and part of the upstream region of the 
putative transcription start site (TSS).  A representation of the Txnip promoter fragment 
is shown in Figure 37a.  The upstream region of Txnip promoter contains a number of 
classic elements such as a TATA box and two inverted CAT boxes.  In addition, it also 
contains other regulatory elements including a carbohydrate response element (ChoRE) 
and binding sites of FOXO and several other transcription factors. 
These promoter fragments were cloned upstream of a fusion gene composed of a 
blasticidin resistance (BSD) marker and an enhanced green fluorescent protein (EGFP) 
gene as shown in Figure 37b.  The resulting plasmids were digested with either ScaI 
(single digest) or a combination of ScaI, AatII, and XhoI (triple digest) prior to 
transfection.  The triple digest was designed such that the DNA molecule used for 
transfection contained no elements other than the promoter of interest, the fusion 
transgene, and the polyadenylation signal.  This design prevented any possible cryptic 
transcriptional regulatory elements from having unwanted effects on the expression of the 
transgenes.  Stable pools and clones were isolated following transfection and selection in 
blasticidin. 
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6.4.4 Characterization of Expression Profiles of Transgenes Driven by Txnip 
Promoter 
The presence of the transgenes in the genomes of stable pools and clones was 
subsequently confirmed by genomic DNA PCR with primers flanking both BSD and 
EGFP genes.  A 421-bp PCR product was found in all selected pools and clones as well 
as the positive control (pTet_BSD_EGFP plasmid) but not in the negative control (non-
transfected cells’ genomic DNA)   Figure 37c shows an example of stable pools and 
clones harboring the pTxnip_BSD_EGFP plasmid. 
Fed-batch cultures were performed on the isolated stable pool and three randomly 
chosen clones for each plasmid construct.  Samples were collected over different culture 
times for characterization of the expression trends of the transgenes.  As shown in Figure 
41a, the pool and all three randomly selected clones of singly digested 
pTxnip_BSD_EGFP consistently displayed the expected dynamic expression profiles of 
both BSD and EGFP.  The BSD gene was expressed 4- to 16-fold higher in the late-
stationary phase compared to the mid-exponential phase.  The increase in the EGFP 
expression level was somewhat less significant; ranging from 2- to 8-fold in the pool and 
clones.  As expected, the endogenous Txnip gene was highly dynamic, with expression 
increasing between 4- and 16-fold. 
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Figure 41: Expression time profiles of the transgenes (BSD in black and EGFP in green) and the endogenous 
gene (Txnip in blue) in fed-batch cultures of stable pools and clones harboring pTxnip_BSD_EGFP. 
a) pTxnip_BSD_EGFP was digested with ScaI prior to transfection 
b) pTxnip_BSD_EGFP was digested with ScaI, AatII, and XhoI prior to transfection 
The viable cell concentration in each culture was also shown in red for reference. 
 
Although both transgenes demonstrated the expected dynamic trend, they were 
not expressed at the same level.  In most cases, EGFP expression level was lower than 
that of BSD.  In some clones, the difference between BSD and EGFP expression levels 
was almost negligible (T_S_61, T_S_100, and T_T_238) whereas in other clones, this 
difference could be over 4-fold. 
Furthermore, both transgenes was expressed at lower levels relative to the 
endogenous gene Txnip.  In one clone (T_S_225), the expression of the BSD gene was 
only slightly lower than that of Txnip.  However, in another clone (T_S_61), this 
difference increased to as much as 64-fold. 
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In the pool and all three randomly selected clones harboring the triply digested 
pTxnip_BSD_EGFP, both transgenes and the endogenous gene also exhibited expression 
dynamics (Figure 41b).  As the cells entered the late-stationary phase, they expressed 
BSD 4- to 16-fold and EGFP 4- to 8-fold higher compared to the mid-exponential phase.  
Despite having the same expression trend, a difference of up to 8-fold between BSD and 
EGFP expression levels was observed.  Furthermore, BSD was expressed at slightly 
lower levels than Txnip (less than 3-fold difference). 
6.4.5 Characterization of Expression Profiles of Transgenes Driven by Mmp12 
Promoter 
When the promoter fragment of Mmp12 gene was used to drive the expression of 
the transgenes, virtually no dynamic trend was observed in stable pools regardless of the 
restriction digest type (Figure 42).  Among the three randomly selected clones for each 
type of restriction digest, only one appeared to express BSD and EGFP in the expected 
dynamic manner over the course of the fed-batch cultures.  In clone M_S_245 of the 
single digest, both transgenes were expressed 4-fold higher in the late stationary phase 
relative to the mid exponential phase.  In clone M_T_54 of the triple digest, this increase 
was up to 16-fold. 
Similar to the clones harboring pTxnip_BSD_EGFP plasmid, most clones 
expressing BSD_EGFP under the control of an Mmp12 promoter also displayed a 
difference in BSD and EGFP expression levels.  In most cases, this difference could be 
up to 4-fold.  However, in clone M_S_245, the expression of EGFP was slightly higher 
than that of BSD. 
Interestingly, the expression levels of the transgenes were not always lower than 
that of the endogenous gene Mmp12 in all clones.  In two clones M_S_235 and M_T_54, 
BSD was expressed from 4- to 64-fold higher than Mmp12.  This trend was reverted in 
other clones.  These opposite trends in the clones could explain the cross-over between 
BSD and Mmp12 expression levels in the pools, which were supposedly an unbiased 
mixture of the clones. 
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Figure 42: Expression time profiles of the transgenes (BSD in black and EGFP in green) and the endogenous 
gene (Mmp12 in blue) in fed-batch cultures of stable pools and clones harboring pMmp12_BSD_EGFP. 
a) pMmp12_BSD_EGFP was digested with ScaI prior to transfection 
b) pMmp12_BSD_EGFP was digested with ScaI, AatII, and XhoI prior to transfection 
The viable cell concentration in each culture was also shown in red for reference. 
 
6.4.6 Characterization of Expression Profiles of Transgenes Driven by Serpinf1 
Promoter 
Among all stable pools and clones harboring the pSerpinf1_BSD_EGFP plasmid, 
only one clone displayed the expected dynamic trend of the transgenes (S_T_72) (Figure 
43).  In this clone, both BSD and EGFP genes were expressed nearly16 fold higher in the 
stationary phase compared to the mid-exponential phase.  In other clones and pools, BSD 
and EGFP expression levels were relatively unchanged, or even decreasing, with time. 
Even though both transgenes were expressed with similar trends, there was still a 
difference between their expression levels.  In most cases, EGFP was expressed at much 
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lower levels with respect to BSD.  Typically, a difference of up to 4-fold could be 
observed. 
It was surprising to see that the endogenous gene, Serpinf1, was expressed at 
various levels in different clones and pools.  The log2 fold-change of Serpinf1 relative to 
-Actin ranged from 12 to 8.  Furthermore, the difference between Serpinf1 and BSD 
expression levels also varied significantly across clones.  In some cases, Serpinf1 was 
expressed up to 30-fold lower than was BSD (S_S_194) whereas in others, Serpinf1 was 
expressed up to 16-fold higher (S_T_P). 
 
Figure 43: Expression time profiles of the transgenes (BSD in black and EGFP in green) and the endogenous 
gene (Serpinf1 in blue) in fed-batch cultures of stable pools and clones harboring pSerpinf1_BSD_EGFP. 
a) pSerpinf1_BSD_EGFP was digested with ScaI prior to transfection 
b) pSerpinf1_BSD_EGFP was digested with ScaI, AatII, and XhoI prior to transfection 
The viable cell concentration in each culture was also shown in red for reference. 
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6.5 DISCUSSION 
To our knowledge, this is the first study which presents the novel concept of 
dynamic cell engineering.  A historical data set from 72 time-course microarrays was 
mined to uncover thousands of genes with various expression trends over the course of a 
typical fed-batch culture of an industrial CHO cell line.  These genes encompass a wide 
range of normalized intensities, from a few hundred to tens of thousands.  The large 
number of combinations of trends and intensities can arguably create a rich repertoire of 
expression dynamics.  If promoter regions of these genes are identified and isolated, they 
can potentially be used to drive the expression of transgenes following the desired 
dynamic trends and levels. 
Time-dependent expression dynamics has also been discussed in a few previously 
published reports.  In a study of transcriptional responses in CHO cells under the effect of 
temperature shift and sodium buryrate treatment, hundreds to thousands of genes were 
either up- or down-regulated in the late stage of the fed-batch culture relative to the 
exponential phase (Kantardjieff et al. 2010).  A slightly smaller number of genes were 
identified in the untreated culture at 37
o
C.  Among the genes most strongly induced by 
butyrate treatment at 33
o
C, Txnip was expressed at more than 23-fold increase over the 
course of the culture.  In another study, the time dynamics of regulatory motifs that 
control growth arrest and differentiation of a human monocytic cell line were investigated 
(Suzuki et al. 2009).  At least 30 of such motifs have been identified and clustered into 9 
groups with similar time dynamics: three of up-regulated trend, three of down-regulated 
trend, and three of mixed transient dynamics. 
Analysis in a functional context revealed distinct cellular functions which are 
enriched within each of the six dynamic clusters identified in our study.  Genes involved 
in regulation of apoptosis, redox balance, and protein secretion appear to be expressed at 
increasing levels over the course of a typical fed-batch culture.  In contrast, the 
expression of genes related to cell cycle, mRNA processing, and ribosome biosynthesis 
gradually decreases over the same time period.  Among genes with increasing expression 
trends, a small number of genes (15) with sufficient genomic resources were further 
analyzed.  Only three of them, namely Mmp12, Txnip, and Serpinf1, demonstrated 
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expected dynamic trends in a second CHO cell line, possibly due to variability among 
different cell lines and culture conditions. 
A Txnip promoter fragment of approximately 800 bp was successfully isolated 
and used to drive the expression of a fusion gene of BSD and EGFP.  In stable pools and 
clones, this promoter was shown to be capable of driving the expression of this fusion 
gene following the expected trend.  However, the fusion gene was expressed at lower 
levels compared to the endogenous gene of Txnip in most cases.  This result indicates 
that the isolated promoter fragment, albeit capable of conferring essential transcriptional 
activities, may not harbor all necessary regulatory elements to fully mimic the 
endogenous expression.  Furthermore, the expression levels of the fusion gene varied 
significantly across different clones.  This is likely due to the influence of chromosomal 
integration site as elaborated in literature (Dorer and Henikoff 1994; Festenstein et al. 
1996; Kleinjan and van Heyningen 1998). 
The next step following this proof-of-concept study would be using this promoter 
to control the dynamics of target genes with significant cellular functions.  Potential 
targets for dynamic control include a number of cellular processes which are known to be 
critical for the production of secretory protein products, such as apoptosis and energy 
metabolism.  Apoptosis is one of the major contributors to cell death upon exposure to 
the high-stress environment in bioreactors experienced by most industrial cell lines 
(Arden 2004).  Inhibition of apoptosis has been shown to prolong culture duration, 
resulting in higher product titer (Figueroa et al. 2007).  In addition, energy metabolism is 
known to impose profound effects on cell growth and productivity as reviewed recently 
(Mulukutla et al. 2010).  Modulating energy metabolism to reduce lactate production has 
been shown to significantly increase product titer (Zhou et al. 2011).  Ideally, 
implementation of such strategies would be desirable in the late stages of the culture, 
when environmental stresses including lactate concentration approach critical levels.  
This aim could be achieved using a dynamic endogenous promoter with low activity in 
the mid-exponential phase and gradually increasing activity towards the late-stationary 
phase, such as that of Txnip.  Thus the results in this study have demonstrated the 
feasibility of modulating cellular behaviors in a dynamic manner. 
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The increasing availability of mammalian genome sequences in recent years is 
opening up a remarkable opportunity to explore and gain better understanding of 
transcription regulation.  In the past few years, various ENCODE and FANTOM projects 
have shed light on previously unknown complexities of mammalian transcription 
networks (The ENCODE Consortium 2007; The FANTOM Consortium 2005).  More 
regulatory mechanisms with a multitude of cis- and trans-acting elements continue to be 
uncovered.  Although substantial efforts need to be invested to fully understand the depth 
and breadth of gene regulation, harnessing this knowledge will ultimately lead to the 
ability to modulate gene expression in unimaginable ways. 
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7 CONCLUSION AND FUTURE DIRECTIONS 
High-throughput genomic and process analytical technologies hold the potential 
to bring fundamental understanding of cellular changes occurring at each and every step 
along a cell culture process.  This thesis describes the application of advanced 
multivariate approaches in uncovering valuable information from the immense volume of 
data generated by these technologies.  The insights gained through this analysis continue 
to broaden our understanding of multiple facets of mammalian cell culture.  Furthermore, 
they offer great opportunities for enhancement of process performance. 
Ceaseless efforts have been made by the entire scientific community to develop 
genomic resources for a large number of mammalian species as well as required analysis 
approaches.  The results yielded by these fundamental studies will accelerate the product 
development pipeline in the pharmaceutical industry.  Furthermore, as more data of 
multiple types are accumulating, we could anticipate a swift move from the current 
exploratory phase to more rigorous evidence-based intervention.  Integrating these 
conclusions will certainly increase our capability to discover novel means to transform 
the current model of pharmaceutical research and development.  Such transformational 
changes are certainly needed to bring back the innovation level that prevailed in the era 
of blockbusters. 
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9 APPENDIX 
The following sections provide the sequences of the three genes from which 
promoters were isolated as described in Chapter 6.  These sequences were derived from 
the Chinese hamster genome scaffolds, which were assembled in our laboratory in March 
2011.  Briefly, genomic DNA from the liver of a highly inbred 17A/GY female Chinese 
hamster was used for sequencing.  Over 275 giga base pairs of sequences were generated 
using the Illumina paired-end technology.  About 10% of the reads of low quality, homo-
polymers, and short tandem repeats, were removed.  The remaining sequences were 
assembled de novo using Assembly by short sequences (ABySS), a parallelized sequence 
assembler.  The assembled contiguous sequences (contigs) were further linked using the 
SSPACE scaffolder.  About 32,590 scaffolds with a minimum length of 1 Kbp and an 
N50 of 2.2 Mbp were obtained.  The estimated size of this draft version of the Chinese 
genome is approximately 2.52 Gbp.  More than 32,000 putative genes were predicted in 
these scaffolds using ab initio prediction by Augustus and BLASTing against our 
annotated transcript sequences.  More details about the sequencing, assembly, and 
analysis of the Chinese hamster genome can be found in (Jacob et al.). 
The sequence formats are as follows: 
 Red letters: untranslated regions (UTRs), identified by BLASTing against 
the mouse genome, version mm9 (http://genome.ucsc.edu/) 
 Blue letters: exons, identified by BLASTing against the mouse genome, 
version mm9 (http://genome.ucsc.edu/) 
 Underscored letters: supported by our transcript sequences (S5.1) 
 Highlighted in grey: supported when genomic reads were used to extend 
exonic regions 
9.1 TXNIP GENE SEQUENCE IN CHINESE HAMSTER GENOME 
1622000..1629000, scaffold 122 
GTCAACACCCTGGGACCCGGTAACAGCCACCTCTCCTCCTGTCTTCTGATCTCCTCAAA
TCTTAAACAACAACAACAATAATTGTTTACATTTCACTTATTTTGTGTTCTCTGGGAGT
GAGCAGTCGGGTGGTCGGGGAGGTCAGGGTTGGTTCTCTCCTACTTGGGGGATTCTGGG
161 
GGTTGAACATACCACACTAGTTAACAATATCGATATATACACTTTTTGGTAAACATTTT
GATGTTTTATAACAACAAGTTATTTTTTTTTCCAAGATGCCTACTACAGTTTGGAACTA
AAATTAGTGAGAGTCCCACCTCCTTTGTTCTTAATCAATACTGTTAACTCAAGCCTAGT
TACCTTTCTGGAACAAACACACACACCCTAAGGATCAACATGTTCCTAGGCTTTGGTGT
TGTGTGTATGTTTTTCAATCCTGTGATGTCTAACTCTGAGCTTGCTTAACATTGAGGTT
GAGTTGCAACTTGTTAGCCTTAGGATGTCAACCCAGTTAAGGCATGTGAGCAAGGGGAG
GGTGCTGTTAAGAGCAGTGAACAGGTTACTAATTGTGCAGAAGGCAGAATTTCATATAT
GCAAAGGCTTTTTGCTTCCCCATCTTAAATTCAGGACCATTGTCTTCATTTTCCAGCAC
AAGGAACAAAACAACAATCTCCTAGTAACTCTGCCTAAATATGGAAGGAGTCTAGCATT
CAAAGACAAGGCGGGGCGGGGGTGGGGGGGTGATCCCTCTTCTACACAAACATTTTCTT
AGCACATTCAAGAGTTATTTCTTGAGTCAGCACCTGGAGGCACCTCTGTCAGTTTGGTT
TACCAGATAGCCAAGTGAAGCCAATACAACCTGGGCAACAGGCTTAGGGATATGCATTT
CATTTAGTGAGTCTGGAGAGATGATGAAGACAAAAAAAAAAAGTGACAGGAACTCTGGA
ACAAAGTCAGGAGTGATGGATCTTTTCCTTCTTTCCTTCCTTTATTTATTTATTGTACC
CACCCCTTGTTTCCTGGAGAAACAGGGACGGAGGGAGACCTCAGTGTGAAGTACACACC
TCATTAAAGCAGCTATGAGGTAAATGAGGGAACATATACAAAGTGTTCCCCAATTTCAC
AGGTAGACTGAAGAGACTTGGGGAAAAGCAACAGGATGTGGACACTCCCTTACTGCTTC
CGTTCTAGAGAACAGAGAACAGAAGAGAGTGCACACGGGTGAGGGACAGTCCATAGGGG
CGTGAGGGGAAGGGGGCACCCCAGAACAAGGTCTCGGCTTTCCCATGAGGACTTCTGAA
AGGGGGCTTAAAATATCTGACACACGCGTTTTGTTCTTCAGTAGACATGCAACGGGAAG
ACACCGGGTGGGCTTTCTCTAACACAGCCGCACCCTCACCCTCCACCCAATGCTGAAGA
ACCCTTGGGGCAATGGGATTGTTTTTCACAGACTTGGCGAATTTGGAAGCCAGGAATAA
ACAGTCGCCTCGAAATGAATTGCGCTGGCTAAGAGGGGGCATGAAATCCTCTCCTAAGC
ACATTTTCCTTCTCCTAAAAAAAGAAAAAAAAAAAAATCACACNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCACGCGCCCCTGCGGCC
GCGCGGATTGGTCGGAGGCCTGGTAAACAAGGGCCAGGCAGCCAATGGGAGGACTGTGC
ACGAGGGCTGCACGAGCCTCTGAGCCAGGGCTCGCGTGGGGCTCCTAGCCCGGCAGCTA
TATAAAGGCGTTTCCGGCTCCCGATTGACACTCGCCACCCCTCATCTCGTGGGTTTCCT
GGGCTCATCCGGCTGCTGGAGCAAAGAGACAGCCGCCGCTGCTTTCCTCTTGAAAGCCT
TGGGCACAGCCAGCAGGGTCGAAGCTCTCAGGCACCGTTTCGAGAAGTTGTTGGGGTTT
TGTTAAAGGGCTCCTTTAGCTTTTCGTTTGGGTTTTTTCAAGCCCTGTCTGCCTTCCGG
AGAGTGAACTCTTCATCTGCTGTGAAGGGCTCTTACGAGTTTTCTCTCCCGCCTCCGTT
TATCTGGAACCCGCTGAACCCAATCATGGTGATGTTCAAGAAGATCAAGTCTTTTGAGG
TGGTCTTCAACGACCCCGAGAAGGTGTACGGCAGCGGGGAGAAGGTGGCCGGCCGGGTG
ATAGTGGAAGTGTGTGAAGTTACTCGGATCAAAGCCGTCAGGATCCTGGCTTGCGGAGT
GGCCAAGGTCCTGTGGATGCAAGGGTCTCAGCAGTGCAAACAGACCTTGGACTACCTGC
GTTATGAAGACACGCTCCTCCTAGAAGACCAGCCAACAGGTACAGACACAGATAGCTCC
AGCTGTTCTTCCTCGCACGGGCGCTTTGACAAGGGGAGGCACGGGAGCCTCCAGCAAGG
GTTTGGAGTTGAGTCGTTCGTTTAATAGTTTGAATTGTGTTGGTTCCGATACTTTTAAG
TTTTAATTTGCAAGTATTTCACCAACCCCTCCCCCACCCCCGCAGGGGTGATTTGTAGT
TTCTGAGGTGCTGTTTGCTAAGGTGAAGCCTTAGCTACTTAAAGATTAATGTATTCGCG
GTCTGTACCCGATTCCTGGGGCAACCGTGCTGGATGGGCCTTTTCGTAGTTGTGGGCTT
162 
GGCTCTGCAACTTTCTGTCCAAGAAAGTGCACTGGAATCTTTTATTCCACCGTGCAAGA
GATGGACGTGGAAGTAAAATAACCTTGTCTGCTGCCCAGTTTTCACAGATGCCTTTGAA
ATGTAATAGGGAACCTAATGGACCCTTGCCTTTGTTTCCCCGCAGGTGAGAACGAGATG
GTGATCATGAGACCTGGAAACAAATACGAGTACAAGTTTGGCTTTGAACTTCCTCAAGG
GTAGGCATCTACCAAATGCACCTTGGACTCTGTTTCTAAAAGCCCCACCCCCATTGACC
TCTTACTGTTCTTAGAGAGCATTAATTTTTTTTTCATTGTTTTGTCACAGGCCCCTGGG
AACATCTTTCAAAGGAAAATACGGTTGTGTCGACTACTGGGTGAAGGCTTTCCTTGATC
GCCCCAGCCAGCCGACTCAGGAGGCAAAGAAAAACTTTGAAGTGATGGATCTAGTGGAT
GTCAATACCCCTGATTTAATGGTGAGATTTAGTTCTCCTTGTTTGGGGATAACAAATTA
GATGCTTGGGGCATGGAAATAACTCAAAACATTGTGTCCTCCTACACAGGCACCGGTAT
CCGCTAAAAAGGAGAAGAAAGTTTCCTGCATGTTCATCCCTGATGGGCGTGTGTCCGTC
TCTGCTCGAATTGAAAGGAAAGGATTCTGTGAAGGTAATATCCTCATGCTTAAAATGTA
GCCAGGGTGGCCAGAGCCGTGGGCTTGGAGGGGGGCATGGAGGAGAGGAAGTGCCGTTA
AGTAAACGGATGTTCATCCCTCTTCATCTTGAATCCCAGGTGATGACATCTCCATCCAT
GCCGACTTCGAGAACACATGTTCCCGGATTGTGGTCCCCAAAGCAGCTATTGTGGCTCG
GCACACTTACCTTGCCAATGGCCAGACCAAAGTGTTAACGCAGAAGCTATCCTCAGTCA
GAGGCAATCACATCATCTCGGGGACCTGCGCCTCGTGGCGAGGCAAGAGCCTCCGTGTG
CAGAAGATCAGGCCATCCATCCTGGGCTGCCACATCCTGCGCGTGGAGTATTCCCTGCT
GGTGAGTGTCATGGCGGCTTGGTCCTAGAAGAGAAACAATTCTTGTGTTACAAATTGAG
TGCTTTCTCTACACAACCCTTCTGACAAACTGCCACCTTGCTTTACAGATCTATGTTAG
TGTTCCTGGCTCCAAGAAAGTCATCCTTGACCTTCCCCTGGTGATTGGCAGCAGGTCAG
GTCTGAGCAGCAGGACTTCCAGCATGGCCAGCCGAACGAGCTCTGAAATGAGCTGGATA
GATCTAAACATCCCAGATACCCCAGAAGGTGGGTATCTTGCTTTCTTTGGGCCTGACGG
GGCTTTGTGAAATTGTGGTGATCTGGCAGGTTTTGGCTGACTTTGTCATCCATTTTCTT
TGTAGCCCCTCCTTGCTATATGGACATCATTCCTGAAGACCACCGACTAGAGAGCCCCA
CCACGCCTCTGCTAGATGACATGGACGGTGCTCAGGACAGCCCTATCTTTATGTATGCC
CCCGAGTTCCAGTTCATGCCTCCACCCACCTACACTGAGGTGAGATGTGCGATTTTTTT
TTTTTTTTTTTGACAGTTTGTCTCAGTTTGTCCTGAAGGAAGAAAGAGTTATTAAACTC
ATGGCTTTTCTACTACTTAACCTAAAAAACTAAAATGCTGTTTTCCCTCTTCCTCCCCC
AGGTGGATCCCTGCACTGTTAACAATAACAACAACAACAACAACAACAACAACGTGCAG
TGAGCCCGTGGGAGAAGAGATGCGTCTATACTCACTCATTTCTTTCCCCTCTCTGCTTG
GACGCCAGTGTTTCAGAGACTTAGTCTGAAAGTGGAGAACGGGTTCACCCCAGCCTCTG
ACTCCACATCTGGGTGATCAACAGGCGGGTCCCTGGCTTCAAGTGGCGCAGACACAGCC
AGTGCCCGCCCTGTGGTGTAGGAGCGTTTGCTGGGTGGATAGAAGAACACTCTAAAAAA
TTCAGACCCCGTCCACTTTCTCTCAGATCTTGGAAATGAAGACATTGTCCGCAGTTTTT
GAGTCGGTGTGAATGACCTTCTGGCATGGTCTTTACAAGGTTTTTTTTTATTTGGAGGA
GTTACAGGTTAACAGCAGACCATGCATTTCTGTGCCATGGGGGACAGAATCAGCTTCAC
ATACTAGATAATCATGGCCAAAGTTTGGAAGAGGTGTTTTTTTATTAGTAATATTTTTT
TAATCAGTGTTCCCTTTTTATAACCTTAAAAGGAAAATGAAAATCTTCCAAGGCTGTGT
GGTTTAGGCTTGGGTGATGGTGGCCACCCTGTGACTTACAGGGTAGCTGCTCCCAGTGA
ACTTTAACCTAGGCTCAGAGCAGTCGTGGCTGCACCCACCAACAGCCATAAAAGCCATT
TTACAGCCAGTTGCACTGTGTTCTCTTACAAACTTAATCAAATGGGAGAATCTGTTATT
TCCGTGTGACTCCTTGGAATTGATTCTAAGGTGATGTTCTTAGCACTTTAGCTCCTGTC
AATTTTGTTTTAATCTCGATTGCAGATGTAAACTCTACTACTATGTGTCTTAAGGGTTA
AGCCCAATGACAGGGCAAAATGGATTTTTGTGTTTGGGTTTTTTTTTTTTTTTTTGAGA
TGGGGTCTCTCTATCCTTTGTTAGCCTGGAACTCTACATAGACCAGGCTGGCCTCGGAG
163 
ATCCCTCTGTCTCTGCCTCCTGAGCGCTGAGATTGAAGGCTCATCTTGGTTATTACTTT
TTGAGACTTTGTCCCAGTGTGCAAAATTGTGTAATTCTGATTCGAATATGAAGGGTTGC
CGCCCTGTGTGTAAGCCTCTGCATTGAGATACCGCAGCGCTGATCAGGGTCTCCATGCG
TTGCAATGAGAACTGCAGGTTTTCACGAAAGCCCCCAGACCCATGTTCTGCCCAGTGTT
AGGAGAAAGGACTCTTAACTGCTTTCACTGTGGCCACTAGCACCTGATCAGTCACTTTC
AGCCATAGCACTTTGTCCATTGTCCTGTGTCAGCACTGAGTTCCACCCTTTTCTGAGAA
CTATGCAATCAGAAAGCATGTGAGCTGATGGTGGTTTCATTTTTGTTGTTTTTGTATTT
TGTGTATCCTTTTTGTATGACAAAAACTATATTTTGTACTTATCCAAATATATTTTCAC
CCCAAGGTGGGGATATCCTTTGTAAAAAAATAAAATAAAAATAAAGTTTTTTAATGGCA
AAAATGTTTTTTTTTCTTGTCTGAAATATTAGAGAAGTTACTAGAAAACAGGTGTGCAT
ACTAGTTTTCCCCTGCGTCACAATGCTGAAAACCCTGTGGAGAGAGCAGTCCCTATAGA
CCCTAAGTGACACTGGAGTTGAAGGGGAACAGCAGTCCGTCAGCTGTTTTGGCCTCCAT
CAAGGCTACATTGGTGGCATCTGGTGATGAAAGCTAATTAACCACATCCTGAAAATTCT
TCAGACCTCCTCCGGTAGCTAAGGATTGGTTCAAGGTGCTGGGATCAAAGGCATATATT
ACCATACCCAGGTTTTTCTTTTAGAGCCTGCCTTGCAAGAGTGTGGGACCCGGAGACCA
GGTCCTCGGGGTTTAAAGAAAGTCTACCAGCTGAGCCTTCTCAACATACAGTTCTCCAT
GCTCACTCAGTTTTATGAATTCTTGAAGAAATAGCCTTGAGGGGATTTGGAAAGGAAAG
AGTGAGTTTCCTTTGTGTATTTATCTTTTAAACTGTGTGAGCAGCTTTTATTTACACAA
AGGCGGCAGGAGGATCTGGGGAGAAGGGACTGGAGACTAACGTGAGGGAAATTAAATAG
GTGTGACTCGGGTGGGAGGAAATCAATACTGGAGCCCAATGGATCCCCTTATGGTCCGT
AATGTTCATCGGACACTGTAAATACAGAATGAGAATGGGTCAGGACTGGTAGAGGCCTC
CATCCACCTACCCCAAGGATGGTTTGTGGGGATGGAGTTTTGGTTTTGTTTTGTTGAGA
CAAGTTCTCTGTAGCTCAGGCTAGCCTCAGCCTCCCAGACACTGGGGTCAGAATCATAT
ACTACCATTCCTGACTGACATTCTTTCTTTCTTTCTTTC 
9.2 MMP12 GENE SEQUENCE IN CHINESE HAMSTER GENOME 
1272000..1288500, scaffold 8 
ATCCATTATTGCAGGAAATTCAAGCAATTGAAGTTTTCTTCCTGCATGAGCAAGCCAGT
GGTGTGTGAAAGGTCAGTGAAAGCATGCATTTCTTTGTGCATTTTTGGAGCATAGCTCC
TTCCTGGTCCTTCCTGGAAACCAGTTTGCCTCTGGATTCCCGGGGAATGGCACTACAAA
TGGTTTTGGGTATCATTGATACACTCAACTGTCCTGATGTCTGTCTGAGGATGCAGCAA
TGTCTAAATTCTTGTACTTTTGGAGACTTTATGTTATAAAATATGCCTTCTACTTAAGG
AAATTCTGATGAGTACCCATCATTTTGTGTATGAAGAACTCAGGCAGTGGCTGGTTTCT
GCATTTCCATAAAGGTGCTGTTTGTGTTGAGCATCATTGAAGGGCATTTGATTCTCAAT
CCCCATGGTGGCTCTTCTGGGATCCTCAGCTTTAAATCAGGACCTGGGTCAGGAGCTTC
CTGTAGTTCTTTCTGTAAAGAGAGCTGAGCAGTAGTCAATCTTCCTCTTCATTCTCATT
ACCAACTTAAAAAAAAAATTACCTTACATGGGAGTGCAGAAAGAAAGCATGAAGGAATA
TTGCAATCATGGAATTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTAAA
AGAGAGAGAGAGAGAGAGAGAGAGAGAGAGNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAGAGAGAGAGAGAGAGAGAGAGAGAGA
GAGATTTTACTGAGTCCATTTAGCATACAGTTTTGCTTCTGTGTGTATGTTTTAGGGGG
CTGTTTTGTTTTGTTTTTAGAGACTGGGTTCTCTGTGTAGCTTTTGCAGTCAGTCCTGG
164 
AACTCATTCTGTAGACCAGGCTGGCCTCAAACCCATGGAGATCTGCCTGCCTCTGCCTC
CTGAGTGCTAGGATTAAAGTTGTGCTCCACCATAACCCAGCCTCTGTATGTTTCTAAGG
CTGATCACTTGGAGTTGGATAAGATATCAAGGGGGCTTATCCGCTTAGCCCCAGAAAAA
AACTGATTCTTTTTCTCTCAGCCACCATTGACTGCTTGTAGCTTTCATTCAGGAGCCTT
GTAATATGCACCCCATCCATGTTGACAAGTTAACTGGTATTGCAATTACACAGGCCTTG
CTTAAGTGAGCGTATTGTTGAATTTTCATGGGTGCAACATCCCTGTCATATCTAGAAGA
CACTATCTCACATCAGGGTCCTGGACCTTTGTTGCTTGTAATCCTTTCACCACCTCTTC
TCTGATTTTCTCTGAGCTGTACGTGTAGGGTTGCATTGTAGGTGACCTTTAAGCTGTGC
CAGGCCATTGGCTCACTACTTTTCCCTATTATTTATAACCATCCCTGGTGTAGAAACAA
TTTTTACTTCAACTTTACAAGTGGAAAACTCATCTTGAAGGTCATAAAACACCAGACTA
AGATCCTTAATCAGGTCAGCTTTAGTCTAGGAATTAACTTGACAACCTCGGAAGTGCCT
GTAGCTACCCATGTAGTCTTTCTCTCCTTACACTTGACTAATTTGGAGCAACTGGTGAG
TTGAGACACAAGAGAACCAAAACGTGTTCACCTACTCTCATTTCTGTTTAGGGCACTCT
CACTTCTTAGTATCTCTGTTATCCTCTTGCGTCTTGCATCCTACATGCACGAGAAATTT
CCTGCAAATCTTCCAAGAACTGAATTCTGTCTTGCTGTGGATGAGACCAGTTCTTGCTT
TCAGTGGATCAGGAACACACCCTCCTGGTAGTGATTGCTCCCACCTGTGAGGTTCATTT
CCAATGTCCTTAATGTTCTCCAACCAGACTCAGTGGTACTGAGTGTCTACTACCCTCAA
GGTACTTTTCAGCACCAGGAATACACAACAAACAGACAAACAAAAAACCTCCATTTTCC
CACTTTGTAGCCCAACCCAGTTCTGTTCCTCTTACGATTATTGAGTTAGATTCGGTATT
TGAAAGGATTTCCTTACAATGTTCAACACATGATCATTCTCTTTCTGAACCCTTGAGCT
TCTTCTGCTTTCCAATTCAATGCTTGATAATCCCTGTTAAGGACAAAGGGAATTGACTG
GGTAACAGTGGGGAACTTCCTGTCACTAGAGTGCTTAACTCACTGTCTCATTTAATTGT
CACAATAGCATAAGTAGGTTAAAGCATATTGTCCCCATTCCAAGTGGGTCACCTAGAAA
TCAAGCCACAGAATATGAAAGAGGTAGGGTAAGGATACGGGATAGTGTGGTGGCAGGGG
TGGGAGTGTGTGTTCCTTCTCTTCCTGTCTGAAACTTCTAAAATCGTTAGAAAAGGGGA
ACAAAGGAGAACAAAGCATAGGACACATGTGTATGAAGAAGCCATACTGGATCTGTTGT
TTTGCATGATAACCGAAACATCAATATTCATTCATTTGTTTATTATATATGTCTCTCTG
TGTGCATGCATGCCATAATAGGCTTGTGAAGGCTAGCGGACAACTTCCAAACATGTGTC
CTCACCTTCCACTCACTATGTGGGTTCCTGGAGATCCAACTCAGGTCATGAAGTTTTGG
AGGAAGTATCTTTGTCTGCTAAATCATCTAATAGGCCCCTAAAATTCATTAAAATTAAC
ATTAGGAAGTAGCCAGCATGTCCCATCTCAGAGAGATTGGAGAGAGTAGCCCACTTGTA
CACCCATACCCTAGACTATTCATCTAGAAGATGCTTGTGATGGGATTAAAGGGGTTAGA
CAGAGTTCTGTCCACACAGCATATTCTAGCAAAAGTATTTTCTCCACACATTCTTTTAA
AATCTCCTTTAAAGCACTTCTTCTGTAATGAGTATAAGGAAAGCATTGTAAGGAGAATG
GACAACACCAAGCTTTCCAAAACTCTACTGGCAGAGTTTTGGTAGATTTGTTGTTGTGT
CTTACCTATGCTTATAAGTAAGTAGAAGCTCAGGCTCACTGGTCATTTTGAAGAAATAC
TCTAGACATGATTAGGTGAGTGATGACTTGTATGGCACTTTGACCCACTGTCCATTCAC
ATGCTTCTGAAGTACAGTAAGAGATGATATCAACTGTGAGTCACTCAGAGGATTTCACG
TTCACAGATCCGGACTAAAGTGTTATATAAAGCGGACTTTAAGGGAACTTAGAGAGCAG
AGCTCTGCTGAGAGATCTGGTCACAATGAAGTTCCTCATGCTCCTCGTGGTCTTGCAGG
TGTCTGCCTGTGGGGCCATTCCTATAAATGAAACCGAATTTGCTGAAGTGAGTATGACA
GGGCTGAACTGGCCTAGCCTGTGTCTTTAATATCTACTGAATTTGTAAGTTTTATTTTG
AACAGTATGATTTGATTGGAAAAATCAGCATAGGTAGCTGTTTTCTTTTCAGCATGTTT
GGTTTTCCATCGAGGAATATCCAAATGAAGTTATGATTTTGAAAGAATGTTATTAAATT
GGTGAATAATTGTGCTATCTACAAAAACCTATGGGTAAATAGTTTAGCTCAATATAATT
GAATTACATGTCTAATAGAGTGCTGTCTTTTGGTCTCCCACCCCCATTTTGTCTTTTAT
165 
TTGTATTAGTAATTTAATGTCCATTAATAATGTGAGATTTGGACAAGGTGTAATTGATG
TAATAGCTTCAAATTTTCATGATAGTTACAGCATTCTCCCTCCATGTTCATTTACCTCA
GATATTTATTCATTTCATAAGTGTTTTTAAAATCTTACCTTTTCTAATTTAAAAGATGA
CCTCCTATTTTCTAAAATTACCTACATTCCTTTTTGAGAACGGGTCAGCTGTGTTGTCC
TGTCTGGCCTTGAACTTGTGAACTCAGATGGCCCTTCTGTATTGTCCTCATCAGGAGCT
GGCTCTATTTTCTAACATTATTTTTACTTTGAATTTATCCAAGTCTTCTGCTATGTCAA
GATTTTTCCCAATGCTGGGGATCAAATCCAGATCTTCGAGCATGCTAGGCAAGTGTCCC
ATCACTAAGCTACCTTTGCCGGTTAAGTCAAGTTTTGATGCAACCTAAATGGCTTAAGC
ACCCTGAAAATAAAGATTTTGCCACTTACAATGTGTCCTTCTATAGTCAATGTTAAAAT
AGCTTCTAAAAACCCAGAAGCAAACCTGAAGACACAGAATAACAAGTAGTTTTCCACCG
GTCTTTGGTGAGTCTGACTATGACATGTTTAAATAGCATAGGAAGTTAATTTTTTTCTT
CCTTGTAGTTGGTGTCTAAATAGTAATAATGTAGGCTGTGATTGAAATACCTAGTTCAG
GGAAATCATCATGTTGCTGGCCATGTTTGCAGGGCTCCCAACAGAACCCTGGCCGTGTA
CAGCATGTACAGTATAACTGAGTATGTTACTTGTGTTTTGTCCAGAGGTACTTGACAAA
ATTTTATGACCTTAAAGAGGACAGAATTCAAAAAACAAAATGGAAAGCCAAGAGAAACC
TCCTTGAAGAAAAAATCCAGGAAATGCAGCAGTTCTTTGGGCTCAAAGCAACTGGGCAA
CTGGACAGCCAGACTCTGATGATAATGCACACACCTCGATGTGGAGTTCCTGATGTGGA
GAATCTCAGAGAATTGCCGGGGATGCAAAAATGGACGAAGCATCACCTCACCTACAGGT
AATGTTCGTATACACCCTAGTGAATTCTACTTTCCCATGGGTGTGGCTTCTAGAAACCT
GAAACATTTAGCCACAACAAAGTTTTAAATCTAAGAGTAGCCTCTGTATGCTGTTAAGG
TGATGGCTCAATGGAGAAAGTGCTTGTCATACGTGGGAGTCAGAGTTCAGATCCCAAGA
GTCCATGGGAACACCATTACAGGCATGGTGGCTGTCTGTAATCCCAGCACATGGAAGGC
AGAGATAAGAGATGCCTAGGGCAAGCTGGCTAGGGAGACTAGCAGAATCAAGGTCTCTG
GTATGGTTGAGAGATTCTGCCTCAATAAATAAAGTGGAGCATGATTGAGAAGACACCTG
AGTCTACTTCAGGGCTCTACATGCATGCATGCGCACACAACACACATACCTACCCAGGC
ACATCCCCCTACACACACAATTCATTATCTCTATAAGGACAGTTGTTCACTGAAGGAAG
ACTTGCAGTCATTCTCTTGTCAGTCAGTCCAGTGCAGAACAGAAAAACTGCAAGCAAAC
CAAACAAAACTGAATCGAATACAAATAAAAGACAGAAGTCTGCAGAATATTAAAGATGG
ACAAATGTGGAGTTTGGGCACAATGCCTATTTGTTTTTATGAAAGCAAATCCTCTTCTA
TGAGGTTTCAACTGAAGAATCGATAAAGAAAATGTGGTACATTTATACAACAGAGTACT
ACTCAGCTGTAAGAAACAATGATATACTAAAATTTACAGGCAAATGGACAGAACTAGAA
AACAAACCATCCTAAGTGAGGTAACCCAAAACCTCACTCATAAGTGGACACCAGAAATA
AAGCAAAAGATACCCAGCATACAATCTACAACCCCAGAGAAGCTTGAACCCTCTTCCAG
AAACAGATGGAAGAAGATGAAGAAATCCACAACTAACCATTGAGCCAAGCTCAATTGAA
GTGAGGGAGGAGCAAAAATATGAACAAAGAAGTCAAGACGATGATGGGGAAACCCACAT
AATCACCTGACCTGAGCTAGTGAGAGATCACTGACTCAGGGAACCTCCATAAGACCAAA
CTAGACTCTCTAAATATAGGTAACAATGGTGTGACTGGGACGATGTATGAGGTCAATGG
CAGTGGGTGCAAGATCTAACACTAATGCACAAATTGACTTAGTGGAACCCATTCTATAT
GGAGAGAACCTTGCCCAGCCTAGACACAAGGGTGTGGGGATGGAGAGGTGCCTTGCTCC
TGCCTCAACTAGATGATGGGACAGACTTCACAAACTTCCTAGGGAAGACCTTACCCTCT
CCATGGAGCAGATGGGAGAAGGTGGGTTGTAGGGGGAGCAGGAGGAGAGGAGTGAGGGG
GAACTGCGATTGGAATGTAAAAAATAAATTAATAAAAAAGAAAGTGAATCCTTCACAAT
AATTACTAGTAACTTATAAATAAGAAGAAATTAAATTACATTTTGATTGATAAAGGTTT
TCCAAAGAAAAAAATGGTTTGAAGTTCAACATTTTTTTAACATGGACTGTCCGTACGTG
GGGAAGTTCTTCTGGCAGGCGTGGGTGCAGAACTAAGAGACTAGAAGAGATGAAATTAA
CCAATAATGTCATGTTTGTTTCCCTCTTTCTCTAACACAGGATCTATAATTACACCCCT
166 
GACATGAAGCGTGAGGACGTTGACAGGGCATTTCAGAAAGCTTTTCGAGTCTGGAGTGA
TGTGACCCCGTTGAGATTCAGGAAGATTTATACAGGCCAGGCGGACATTATGATACTGT
TTGCATCTGGAGGTACACAGCTTCACCTGTGTCATTTGTCAGGCTGTGTGACGGCATCA
TTCAACACACCCATGATGCCACCAAGTGTTGTGCTCTGTGATGGCATACCTTCTGACAG
ATGTAGCTGACTAATGACTTTCTTTGTTTTAAAAAGCTCATGGAGACTTCAGTGCTTTT
GATGGCAGAGGTGGCACAATAGCACATGCTTTTTACCCTGGACCCGGTATCCAAGGAGA
CGCACATTTTGATGAGGCAGAGACCTGGAGTAAAGGTTCTCGAGGTAGGAGAGTTTTCT
TTCTTTTTTTTAATGAAAACTAACCATAACTAAATTTAACATAGGCCCTGATCTTGAAA
GAATACATTTTGATGAAATATTATAGTCTTAAATGTTAAATTTTGATTGTTTACCTCTA
AATCAAATTTAAGATTTTATATATTTAGTCCAATGTTTCCTCATTGCAAACTGGGGTAT
TGGGTGTGATTACGTTAGTGATCCTATGAGCAAGTTCTGTACAGTAAACTCTTGGAAAG
GGTTTTGCCAGTAAAATCTATAAACTTAAAAGCAAACGCTAATTCTGTGATTGATTGTA
TAGTGACAATTTCTTAGATTCATGATGACGTGGCAAGATATTTATAGAAAATTTACAGA
TCCCTATGGATAAGCTCTTAGGTAGTCTGGGAGCCTTGCTTGATCTTGGGATACCATTT
TCAGAATGTCCAATCAATCAATTGGAACAGGAACTCACTATACCACTCAGATAATGGGG
AATGAGGTTAACTTATTATTAATTTATTATTATTATTAGAGGCCATCCCTAGGAAAAGA
AAATTTAAGCCATCATTTCAGTTGCTTTTCTAATATCTCTTGGAAGTTCTCAATTATAC
AGTTCATTCATGTGGAAAACATAGGGAGACATTCAAGAATGTGGTCTCTCTACCCTGAA
TCTCCCTTCTCTGACTGATTTTTCATATGATGTATAGCTATATTTTTACAAATAGAAAG
GTAGACACATAGACTACTGCTTTGACACAGCTTTGATAAAGGCATTTTGAAGGCTGAAA
GGTAGATCATGTATGATTTGGCACTTGCTGAACTACACGTTCTCAACCAAATATGGTCC
ATGTGTGAGATTTTCTCTAGGGTCATTTGGGGGCTGGTTGCAAGTTCTTCACCAAGTGA
CAATGCTTTGGAATTCTAATGGACCGTAGAAACGTAAATCAGTGCAGTTGCTCTCACCT
GAGGAGAACAAGCAAAAGTCAGTAGCAAGTTTGTGTATGACTAGAACATGTACTATTGG
CTCCTGACCTTCTCCCCCTGCCAAGACAGGGTTTCTCTGTGTAGCTTTGTAGACCAGGC
TGGACTTGAACTCACAGAGATTCTCCTGACTCTGCCTTCCAAGTGCTGGGATTAAAGGT
ATGTGCCACCACCACCTGGCTATTCCTGGTCTTAATTTAAAAATTGATTTGACTTTATA
TTTTAAAAAGGGTGTTTTTGAAAATTCTATCTGTGTGGCCCAGGCTGACCTTGAACTCA
TGTTCCCCCTACACCATCTTTCTGAGTTGGGATATGGGCATATAGTACCATACCCAGTA
TTGATGTATTGTTTTGAACCAGTAATGAAGATTCTGATAGGTGCTTGATGAGTTTCTGT
TACAGTGTTGAGTGACATTTTTGATTCAGAGACAAAAAGGACAAATCCTCCCCAGGAGC
ATGCAACTTAACAGAAAACCAGACAAACAGAAAGTCCCTGTTTGCAGATGAACATTGAT
GGGAGTTAATTTTACAAAACCTTATGAACTTGAATTTCTAGACTTATCCAATCCCCCTG
TTTCAGTCTCCTGAGTGGCTTGGACAACAGACACATGCAATTGTCCCAGCTTTAAGAAA
GAATTTGAAGCAATGTGAGCTATCAAACATACCTGTGATTTATGTTAGGAAGAATCATG
CCAGAATGTTTCACTTATCTGGCAATGAGATGGTCCATAACTATAGACAATTTTGGCTC
CAAAGGGACATTTTCAGTTAAAAACAGAAGTGGGGATTCATACTTCCACAGAGTGGTGC
AACTAGAGATCTCTAAATATCTGTAATAGAGGATGGCTCTGGCAGTACTTACCTAGCCT
ATAATGACAACACTATTGAGGCTGAGAAAAGCTATTTGAAAGAGCTGGGAAACAAGCAA
AGGAGCCTCAAACATCCCCTCTACTGTGTTAGATGTTGTATTATTTCCTTCCAAATGGC
AAGGCAATGGGGTGGAAAGATGGCTCAGAGTGTACCTAGCTGGTAGAGGGCCCTCTTTC
TAGTTCTATTCCCAGTACCCAGGTTGGACAGCTCACAACTGCCCAACTGTGGCCTCTGC
AGGCACCTGCACTCACATGGCACAGCATAGTCACAGGGGGATGACATTCAGCCACTAAA
GGATTGGCTCCCATCCCTTGAATGGAACTGGGTTTTCTGTAAAAAGGTCAGGCATAAGA
AGATGAGCACCCTATTATCTCATTCATATTGAGACATGAGAAAAGTTAGTCTCACAAAT
GTTACAACAGAATGGTGGTTCCCAGTGGCTGAGGAGAAAGGGGCGATGGATGGGTGATG
167 
GCTGAGCCCTTGGTGCTAAGTCACAGTTAGGAGCATGGAGCCATAGTCTTGACACTGTG
GTGCATCAATACAACTATAGACAATAGTAGTGTACTATTGATTTCAAAAGGCTGGAAAG
AAAGGATTTTGAGTGCTTTCACCACAAAAAAGTGGTACATATTTGAAAAGATATATTTA
TCTTGTCTTGAACATTATGCAATGAGTGTAGCCATCAAAATATCACATAATATCCTGTA
AACATGTACAATTTCATGTGTGAGTTAAATAAAAAGTGATAATCCATTTCACAGATTTA
TTCTTTTACCTCCTTGCTTCTCAGGCACAAACCTGTTCCTCGTTGCTGTTCATGAACTT
GGCCATTCCTTGGGGCTGCGGCATTCCAACAATCCAAACTCAGTAATGTACCCTAGCTA
TAGTTATGTTAACCCCAACACATTCCGCCTTCCTGCTGATGACATACAAAGTATTCAGT
CTCTCTATGGTAAGCTGAACCTCATAATTTGCCATACTATACCCTGTGTTCTTATGAAT
AATCTCATTTGTATATTTAGAAGATTTTAGTAATTTAAATGTCATGTGATAGGCTGCAA
ACACTATCGTAATTTCGCCTCATATTTGGAATGTGTTCTAACAATGGCATCACTGATCT
GTTGATGGGGCCTCCGGAGAAAAGAAATTCAATTATTCTCATCTGTGATGCTGCCACTA
AGTGGGACAAAGTCCTCAGGGCAGGCTTCTTATGAATTTCATTGGAAGCATGACTGTTT
TGTATTTTCTTTTAAGAAACAGAATATTTAAAAAGAATAGCCTTTCCTCTTACAAAATT
TCCCCAAATGAACATCAAAATGTATTTTCAGGATCCCCAGTGAAAAACCCACCCTTGAG
AAATCCTGTCATTCCATCAGCAGCAACTATCTGTCAGCAAAGCTTGAGCTTTGATGCCG
TCACAACAGTGGGAGACAAAATCCTTTTCTTTAAAGACAGGTATGGTCATTTTCATAGC
TAATGAATGCTACAGGATATGTCGCTAAATCTGCTAGTTTTTTATTTGTTTGTTTTTTG
TCAGAAGATATTTGAAAGGATGTAGATCAAATTTGTAAGGTAAATTTGTAGAACTTGAT
TCCCAAGTTTTAGAGAGATCTTAGATTTTTTTTTTTTAAATAGTGAATTGGTGTGATGC
CATTTGTGTTGACTAGGAAGCTAGTGTGTGAAAAAAATTGCTTTGTAGTAGGAATCTGG
CTGGGGAATTAAAAGACAGGAAGTGGAGAAGCCCAGGTAAAAATGATGAGGTCTCAGAG
GTTGAGGAGATGGTTCGGTTGGCAAAGTATGCAGTGTTCAAAGAAAGCCTGATATTAGT
CCCCAGCCCCACACAGAAATGCCCAGGGGCAGCTGCATGGACTAGGAATCCCAGTGCAG
GGAAGGAGGGCAGGGTTGCTGGGGCTTGTGGAGTCTAACCCAGTCTAACTGAACCCAAA
AATCCAGGCTCAATGAGAACATATGTCTCAAAAGATAGAGGGTGTGGAGTGATTGAGGA
AGACACTTGTGGTCTCCACATACATGTTCACAAACACATATACATATACATGAAGACCT
TCCCCCCAACACACACACACACACTCACGAACTCTTGAAGAAGATCATGTGTAGGCTTC
CTTGTACGTGGAGAATTCCAGAATGACTCTAGTTTCTGTTTTGGAGCAGAGATGTAAAC
AGATGCTGGCTAGCAGGGAGAGCAGTGGGGAGGGCTAATGCGTGGGACAGAGGATGGAT
TCCTGCTTTTGAGATTATAAAACAGTAATTTCTTCAAAACCAGATAACCTTACAACCTT
GTGAAGCCACACCAGAATCTTAGATCCCTGGAGTCCAGACCCTGGGTGTTTTTTTGGGG
GGGGTTCCTATTTAAGTCAGGTTTTCTTTCAAGGTGCTCGCACACAGAAATCCCTGGAA
TAGAATGTGCAAGAAAAAAATACTGAATCATTTCACAAGTTCTCATTTGTGTTTTTGAA
GAATACAAATCTACAGCAGTTTTTCACATTTATGAAATGCGTTTCCCACCAGGTTCGTC
TGGTGGATGTTGCCTGGGAGTCCAGCCACCGTCACTTCAATTTCTTCCATGTGGCCAAC
CATCCCATCTGGTATTCAAGCTGCTTATGAAATCAAAGGCAGAAATCAACTCTTTCTTT
TTAAAGGTAACTCCAATGCTTGGTTCTGCCACTGAGAACACTTTAAGGAGGAGAGAAGT
AAAGGGAAGGGTATCAATTCTGTTATCAGAGATCTGATTGATAAGTTCTGGGATAGGTG
TATAAAAGATGAGTCAATGGCACTTAACACATCCAAACCATAGAACCAGGGAGGTAAAC
CAATGATTGAGAACAAAAAAGACTGGGGTGACAATTTCTCAGTGACAGAGAACCTATTT
ACTATGGATGGAGTCTCAGGTTTGCCTCCCACCCCCAAGCACAAATAAAATAAAATTAA
TTTTAGAATTCTGCACAAGAGAGATGTTTTATAGTAAGTCAGTATTTGTATTATTCTTT
GGTGTGATTTTGTTGTGTTCTTTGTCTTTGTCCTTATAGATGACAAGTACTGGTTAATA
AACAACTTAGTAGCACAGCCACACTATCCCAGAAACATATCCTCTCTGGGCTTCCCTGC
GTTTGTGAAAAACATTGATGCAGCCATCTTTGACCCATCTCATCATAAGGTCTACTTCT
168 
TCTCGGATAGACGATATTGGAGGTGAGGTCCAATGGCAGGCACTTTGTCCACAAAGATT
TGAGAAGCAGGCACATCTTGGAATTTTCAAGAAGTCAGCTTTCGTTTGTTTGTTTGCTT
TTTAATGATCATCTGCATATTTAAAATTTTTATTTTATTGGAGTTTTTGCCTACAGGCA
TGACTGTGTGAGGGCACTGGATACAGAAGGCAGCTTTTCTATGAAGGTTTCTAATTTCT
TTGCCTAGGGATAGGCAGCAAGAGAACACAGGTCTGAAACAGTCACTATCGACCTGGTT
CTTTACTCTGGGCCTTTGGTTTTTATTTAATTTCATTTTGGAGAGTGTTTGGACTCCAG
GACTCCTTCTCATAACCAGTGGACCCAGAAGACAACATGAGTAGCCTGCCCTTTGTGTG
ACAAGAGAGCCACAAGGAAACCAGGGCCTGGTTATCTTACTCACCTAATGTTGAAAGAG
GGAGGGATCATCCCTACGTTCTTCTGAAGAAAACAGTTTGCATACTTGGCATAAGACAT
TAACAGGTTATACTAAGATAATAAAGCCTCTATGTTTTCTTGAATACTTAAAATTCAAT
ATCTAATTTCAACTGAATGCCATATATTTGTGACATGAATTGGTTTGACAACTTTAGCC
TTGTTTGAGAAATAGGACTTGTGATTTCACCAAATAAGACTTTCTGAATAGGTGACAAA
CAGGTGCAGTTTATTGTAATCCAACATTCTTTATTTTGTTGTTATTGATGATTGATTGA
TTTTTCAAGACAGGGTTTCTCTGTGAAACAGTCTTGGCTGTCCTGGAACTCACTCTGCA
GACCAGGCTAGCCTCAAACTTACAGAGATCTGCCTGCCTCTGCCTCCTGAGGGCTGGGA
TTAAAGCTGTGTATCACCACCACCCAGAGTAATCTAACATTCTTAGAAATTTGTCTGAC
TACTGGTTCCCCCTTTATACTTCCAACTGACAGGGGAATTCCTTTTCCTAAATTCCAGA
GGGACAGTGTCAAGCAAACAATGGTTGGAGAACTAAACTGAATGAAAAATAAGACAACT
ATGTTTCAACTGTCATGTGGAAGTCTAAAGAAAAATTGACTCTTTTCACTCAGTGGTAA
AAGAGACTTTATGGAAATACTAGGGCCCCCCCACTCTCCAGTGTGGACATGACTTGTTT
TACTTTTAGTTTTTCTTTAACATGGATGTTCGAAACCCATTGGTTCCATGACTCTTAAG
TACCCCTTCTCTTCACTGTGGGAAAAAATCATTGATATGTGTCTTGCTAGAAAAGATTT
GCAAAAAATGGTGATAGACAACTAAGTCATTGGGCCACTGAGGAATGTCGCATATCAAG
CCCTCTTCAATGCCAGGCTGTGTGGGAAGGGACTAAGCAGTGGGGAAAGCACTGTGAGA
ATGGAAAGAGATTTGACTAGAGTCAAGGTTCAAGTTTTGACCCTTGTAGTTACTTAGGG
AAAACCAACCAACTGTTTATGTCTTTGCATTTTTCATCAGTACATTTAAAACTCTCTCA
GGAAAGACCAACGTGGGCTTCATGTTATGAAGCCCATTTTCTCATTGTGTTCCTGCTGT
TTCCTCCTACAGATACGATGTGAGGAAGCAGTCCATGGACCCTACTTATCCCAAACTTA
TTTCCTTGCACTTCTCAGGAATTAAGCCTAAAATTGATGCAGGCTTCTCTTTCAAAGGT
AAATAGAGTGGGAAAATATTGGAAATCACATTTTAAAGTGTGATACCACAGACTGGGAT
CCAGGGTGGGTATAAGATGCTTGTGTTTGTGGTGTGAATATGTTCCACTTCAGCCTGAG
CAAACTTGCCTATCAGTGTCACATAGCAACAATACAACCCACATTGTGTGAGATGAGCT
GCATGACACGTTTAACAAGAATGGGAACCTCATTTTATTCCTTCTCCTCTCCTGTTGAG
TGGACCAAGATTCAAAAACAAATTTGAGTTTTCTCTAGCCTTTTCCTCCTTCCAGATCA
CTGTATGCCTGACCTAGATCCTAGTCTTGAGACCTCCACCCAGAGAGTGACTTGCTCAG
GGGGGAACATCAGAGCAGGGTGCACTGCCAAGGGTCCCCGATATTGACATCTCAGTCAC
ACCTTTTGTAGTCTAGATAACCTATAAAATTAACTCTATGTTTTAAAGGAAGACACGAT
AAGAATTAAAGAATTGAATTTGTTTCCATTTTAGGACACTACTACTTCTTCCAAGGAGC
CAATCAATTGGAATATGACCCCCTGTCGAATCGTGTCACCAAAAGGCTCAAAAGTACGA
GCTGGTTTGTTTGTTTGAAATGATGCAGTTGAGGATCTTCGCTAGTTCTTCAGTTTAAT
AAGTATTTATCACATCTGCACTTTATGCTCATTATGCATATAATGTAACATGAGATAAG
GTGAAGTGTACAGGCCACAGATAAATATTTACACCGAAAAATGCTTTGACAAAATTTAT
CCTCTTCTGGTAAGCTTTTTCACTTGACTCCTTTCTTACTTTTGAAAGCGGGTACCTGC
CAAGTCTGCCAGGTTTCTTTCTAAGTTGTTTTCTAAGAACCTTCAAGTGCACCAATACG
AATTACTTCCCTGTCTTTACTAATATTTAATGTGTATTATTTTGTCAAATAAAATGTAA
AGAATTTAGCTTTTGATTTTTTTCTTTAAAAATTGTGTGTGTGTGTGTGTGTNNNNNNN
169 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTGTGTGTGTGTGTGTGTGTGTGT
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTGACTGCATGTAA
GTATGTACACCACATGTGTGCAATGCTGGTAGAGGCCAGAAGAGAACATCAGATCCCTA
GAAACTAAAGTTACAGATGGTTATGGGCAGACTTGTGGGCCTTGGGGATTGAACCTGGA
TCCTCAGGAAAAGCAGCTTGTGCTCTTAATGTCTGTGTCATCTCTCTGGTCCTGTTTTT
TGTTTGTTTGTCTGTTTTTGTTTTTCTTACTATTTTTCTTGAGGAACAGAATGAATTTT
GAAAAAACTCTGGCTTCTAAATAAAGTCTTTCTGTGACTGTATCAAAGAGTCAATAGAG
ACGTGATAGCTACAAAAATATTGAAGCTTGAAGTCCTTTTGATCAGTTGTATAAGGACA
CCTGTTTAATCCTATGACAAGAAAGCATCCTCTAGCCTGCACATGACCCCAAGAATAAC
TGCAGCATGTGACCACAAGACTTGAGAGGAGAGAGGATGAAATGGGATTTCCATTCTTG
ATAGATATGTTGTGTGGCTCATTGCACATCAGAGAGTGGGCTGTGCCATTGCTGTGGAG
CCTTACAGGGTATTAAATCTATGACTCCTTAAAAATAGGAGGAAATATGAGTAGCACAC
ACCTCTAAGTTTGTTGTGGAAGAAAAACACAACATGGTGATCCCCTCACACCTGTGTCA
TGGCCTTCTAGCAGTTTCCCGCATTGCCCTGACATTTAGGCCCCTATCCTCTGCATTGT
GTGTGCTGTAGTGCTCTCATTTAAAGCTATGGATTTGGGAAATGTGTCCAATATTAAAA
CTGACTGATGTATTGACCCAGATACAGAAAGCCCTCCATAGCAGATGAACATCTGGTCA
TTTTTGAAGAGTGAAATGAACTGAAGGTGGAGAGATGTGGGGAAGGGGCCCTCCAGCTT
TGATGTCTCTGACATTGTGAGTGATGATATTCACCATCAACTTGATGGGATCTGGGGTC
ATATAACAGACAGACACCTGAGGACTATCCAAAGAAGGTGGACTGTGGGAGGAATTCCC
TCTTTCAGAGTGGTGGCGGGTTGACAGCATTAGAACACATCCATCATGGAAAGGGCAGC
ACTTTGTCCTTACAAGGATAGATGCTTGAATTCTGGTTATGAGTTTGTACTTCATGTAC
AGAAGCTTCTGCTCAAACTGTTGCCCAGGGACTTGCAGAACACCTTATCCACCGCCATG
CCTTACTGCACTGCATTGTTTCTGACCAGGGAACTCATTGCACAGCCAAAGCAGAGTAG
CAGTAGGCTCATGTTCATGTTCTTGGAATTCACTAGTCAGATCATATTCCACACAGTCC
CGACACATTCAGCTTGATGGAACACTTGCTGTCTAGGCTGCTGTAAGCCTTTGATTATT
TTCTAGATTTTTTTTCTTTTTGGTGTTAGAGATGAACCCAGGGCCATGTGTATGTTAAA
AAAGCACTGTCCCTTTAAGCTATACCCTGCCTGTTAGGATTCTAAAAATGTTGACTTTG
CCATTAACAGCTAGTTGTTGCTTTTCCGAAAAAGGTATTTTGGTTGACCTTATTCTATT
ACCCTAGGTGACATGGCTCTGAATTAATTTTAGTGTTGACAGCAAAAAGAGATTTAAAG
CCCTAAATTGGTGCTCACAGTAACTGTCAAAATAGTTATTTTGAAAGCCATATTATTTA
TTTTTTATTTCAATTGTATTTATTAATACCATATAGTGAT 
9.3 SERPINF1 GENE SEQUENCE IN CHINESE HAMSTER GENOME 
55000..80000, scaffold 942, reverse complement 
GGAACTAGCTCTTGTAGACCAAGTTGGTCTCGAACTCACTGAGATCCGCCTGCCTCTGC
CTCCCAAGTATTGGGATTAAAGGATTGTGCCACCACGGACTGGCTTCCCTAACTTAAAA
AAAATTAATTTTTAATTATATGTAGGAGTGTGTGGATATGTGTCCATGAGTGCAGTTGC
CCTCAGGGGACAGAGGAGGGTGTGGAACACCATGGAGATGGATTTACAGGCAGTTGTGA
AGCACTTGATGGGGTGCTGAGAACAATACTCCGGTCCTCTGTAAGAGCAGTACATTAAC
TACTGAGCCATTTCTCCAGCCCCCTATCGTGTGTATGTTTTAATTTTAACATTTATTTA
TTTTGTTCATTTGATTTTTGAGTTTTGGTGTTTTTTGTTTGTTTTGTTTTGTATTTGAG
ACTAGGTCTCACTATATGTAGCCTTAGCTGGCCTGGAACTCATTATGTAGACCAGGCTG
TCCTCAAACTCACAGAGATCTGCTGACCTCAACCTCCCAAGTGCTGGGATTAAAGATGG
GAGCCACCACGCCTAGCAGTTTACTGACTGACTTACTTATGACTCTGTGTGCCACAGTG
170 
CACAAGTAGAGCTGACAGTCAACTTGCTGGTTTTAGCTCTTTCCTTCTACCATATGGGT
TTCAGGGATCAAACCTGGGCCCTCAGGATGGCAGCAGACTCCTTCACCTGCTTAGCCAT
CTTGCTGGCCCTTTCCCCTGGCTTTTAATTTTCTATAAATGAATCATAAAGTCTTCTCC
TCTGTTGGGTGCCCTGCCCTGGCCTGGCAGTGCTGGGGATTGAACCCAAGGTCTTACCT
ATGAGGCAAACACCCCACCATTGAGCTGTTTCTACCTCAATTTGTATTCTCTGTCGGGT
TTCTTGCACTCAGCCCCGTGTGTTGGAGACTTGCCTGTGTTGTGCCCAGCAATGCCCCT
TCACCTGGAGGCCTTGGGCTTGGAGGTTACTGCTGGATCTGAGTTCTGTGGCTTCTGGA
TGGAAAGGGATGAGGTGGGAATAAGAAGCTGGTTGGCTGGCCCACCCAGGGTGCAGATC
AAAGCCATAGAATTCTTCTTGGGAGGGAGGAGAAGGAAGTACTCAGGGCAATGGTATTT
GGCATTGCCATTCCTAGGGTTTCTTTGTAAAGGAACGGGTAGGGGTGGTCCCTTTGGCT
GATCTGGGAAGCAGAAAGACTATGGAGTGGATGGGGGATTTGCAATTTAAACTCGTTAT
AATGGAAATGTTATGCTAATCCAGGCCAATCACACGTCCCTTTTTGACTGGAAAAATTA
GGACTATTCCTGTCATTTGAACTAATTAGTAGCATTCAGTCTTGCTGTTGGAAGTGTCC
TATAAATTCATTCCTGGGCTACCATGTGGATCTGGTAGGCATGGAATTGCTAATGATGG
TTTTGAAGGTAGCCATTTTAAATGTCAAGGGATTGACTGAATGCTTTGGTAAGGGGTGG
GAGTGTATACTTGACACATAGAGATGCTTTAAGTCATGGAACTAGGGGCTGCATGGGGC
TCCTGCTTAACTCCTGCAAGGGCCTGGGTTTCATCCCTAGTGGTGTGGGGAAGACACTG
AACAGGAAGAAATCCCTTAAGGGGAAGACAATGTAACAGGAATGAAAAGGGTCCCAGAT
CAAGCAAGCAGAGACAGAGATGGGAGGACATGGGAACTGTAGAGAGAATGGGCTTCAAG
AAGGAGGAACACTGCTTTGCTGCCTGCCGCTGAGATTGGAGTTTCCATGTGGTAGGGAA
CACCAGTCACCCAGGTGATGGCGGCAGTGTTAGAGAAGGTGGGCGCAGAGGCACAGAGG
GGAGGAGGAAGCGGGAGCAGAAACTATGTAGACACGAGAGCAAACAGCTCTTTCCATCA
TGGCTGTGAGGGAAATGGGCAGTGACCTTAGGGGATGTAGCATAAAAAGGAGACTTTCA
GATAATAAAAGTTTTTCTTTCTTTCTTTTTTTTTTCTTTCTTTTTCTCAATGTTCAGAT
TGAACCCAGGGTCTTGTATGTGCTGGGGAAGTTTGCTCTACACCAGGCTATACCCCAGT
CCTAGGAGATGTCTTTAAATTTTTTTTATTTGCACATTCTTGTAGGTTTATGTTTGCAT
GTGAGTACATGTGCCTTAACACACAAGTAGAGGTCAGAGGACATCTTCTGGCTGTGGAC
TCTTTCTGGCTTGGCAGCAAGTGCTAACAGCTGTGCCCTGGGAGTGCAGACCTGTTTTG
AAGCCTTGAGTAACTTCTTGTAGCAGACACTAAAAGAAGAGGCTGAGAGTCTGTTGGGT
GAACTTTGGATGTTGTCTAATTTCCGGGAATCCCACAGAACCAAGAATGAAACAATGAG
CTTTCTCCACTCTTCCAGTAGAGGGCGCACTCTTGCCAGAGCCTTTGGCAGCCAGTTGC
ATCCAGCATGCTTTCCCATCATGCATCTGTGATGGTTGGCTTGGTGGGAGCTACGATGT
AGAGAGCCCTCTTTACCAATCCCCTTCTTCAGGTGCAGCCTGGGGAGGCACTGGCAGTG
GAGTAGAGCAACTGGATTGAGGTCACACTAGAAGCTTTCTTTAAAAAATCAAGCAAACG
CAACACTGGAAACAATGCAGCTATACTCCCTGCGAATAATTCCTTGTTTGCATATGCTC
GTTTTATTCTTTGGTGGAATCGGGGATGGGATCTAGGACCTCATGCATGCCAGGCAAGC
ACCCTTTCAGAGCTTTATCTCCAGTCCTGTGGGAGGCTTTTGGTGCAGGACTTGTAGAA
GTAGAATATTGAGGCTGGGCAGTGGTGACTCACTCCTTTAATCTCAGCGCTTGGGAGGC
AGAGGCAGGCGGATCTCTGTGAGTTCGAAGCCAGCCAGCCTGGTCTACAGAGTGAGTTC
CAGGACAGCCAGTGCTACACAAAGAAACCCTGTCTCGAAAACAGACAAACAAACAAACA
AAAAGAATAATATTGGAAGTCAGCTTCGGGCTTGTCCATTTTTTTTTGTTTTGCTTTTT
GTTTTTTTTGTTTTTTGAGACAGGGTTTCTCTGTAGCTTTGGAGGCTGTCCTGGAACTA
GCTCTTGTAGTCCAGGCTGGTCTCGAAGTCACAGAGATCCATCTTCCTCTGCCTCCCGA
GCCCTGGGATTAAAGGCGTGCGCCACCAGCACCCGACGTCTCTTACTTTTNTTTTTTTT
TTTTATTTAAAACTTGTTGTTAGATTTATTTTATGAGTGTTTTGCCTGAGTGTGTATCT
ATGCACCACATGCGATCCTGGTGCTCACAGAAGTCAGAAGAGGGCATTGGATCCCCTAG
171 
AACTGGGGTTATGGAGTTGTGAGCCACCCCGTGGGTGCTTGGAAATTTGCTAAGCCAAA
TCCTCTGCAAGACTAAAAAATGCTCTTAACTAATGAGCCATCTCTCAATGCCTTTTCCT
TTTTGTTTTTGGTTTTCTCATTACTTTACAATGTTTTGGTGTGGTTGTGTTTTCTCTTT
GGTTTTTTGTTTGCTTTTTTTTTTTTTTTTTGGACAGAGTTTCTCTGTGTAACAGCTCT
GGCTGTCCTGGAATTAGCTTTGTAGACCAGGCTGGCCTCAGACTCACAGAGATCTGTCT
GCCTCTGCTGGGATTAAAGGCATGTGTTACCACTGCCAGGCGTTTCTTTGTTTTATGAT
ATCTTTGTTTGAAAAGAGAAATTGCTAACTTTAATGCCACATTCATCATCAACCTTTTA
CCTTACAGTTTGCACTTCTTTGGGCATTATTTATTTTATTTTAATTTTTAGAGATGGAG
TCTCACTGTGTATTCCTGGTTGGCACGGAATTCTTTATGCAGGTCCCTAATCTTAAGTT
TCCAGCACTTTTCCTTCTGTCTCCTGAATCCTGGAATCACATGTGTGCTACCACACCCA
GCTATTTATTTATTATTGTTTGTTTTACCTACTTGGATGTATATGTGTACGCCATGGAG
AATGCATGTGGAGATCAGAAAATCACCCGAGGAAATCATTTCTCTCCTTCCACCAAGTG
AGTCCTGGGGAATCCACCGGTTGTCATCAATCATGCTTAGTGTCAAGTACTTTTGTTTG
CTCAGCCATCTCATAGGCCCCATATTTTTCTTTCTGAGATAGGGTCTTATGTATCCCAG
GTTGGCCTCCAACTCTTTTTTTTTTAAGGTTTATTTATTTAATTTATGTATGAGGACTC
TATCTTCATGTATGCCTTTATGTCAGAAGAGAGCATCAGACTCTATTATAGAGCCACCA
TGTGGGTGCTGGGAATTGAACTCAGAACTCTGGAAAAGCAGCCAGTGCTCTTAACCAGT
GAGTCATCTTTCCACCACCGGCCTCCAACTCTTACATGGAGGATTGCCTTAAAGTCTTG
ATTGCCCTTCCTCTACTCTTCAAGAACTAGGATTACAGGTGTTTACCATCCTGTCCTGC
CTGGATTTGCTTTTTAGAGCATGGTATTGCTTAAAGAATATGCTGGGCGTGATAGGGCA
CACCTTAAATCACAACACTGGGAAGGCAGAAGCAAGAGGATCACTGTGAGTTCCAGACC
AGCCAGGGCTACATAGTGAGGTCTGGTCCCAAACCAACCAACCAGGGAAGATATCAAAG
TCAGCTGTGCTCAGAATGTGACACCCCTGGGTGATATGGGAGATTAACTGAGAAATTTT
CACGGGATAGTTTTTGACTCTCTCTCTCTCTCTCTCTCCCCCTCCCCCCCCAGTGCGTG
CGTGCGTGCGTGCGTGCGTGTGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG
TGTGTGTGTAGGTCAGAGGGCGACTTTGTGGAGTAGGCACTCTTCTTCCACCTAGGATT
GAGCTCACATCACCAGGCTTAGACTGCAAGTGCCTTTACCCGCTAACACTAGCACTTTG
CCTAGAGTCACACAGCAGTTTTTCTTTATTGAAAGGACCTGGACTCTGACTGTTGACAC
TCTCCTTCCTATGAAGTTGAACCTTGCCCACTGCAAAATCTCACTGGTCCCAGCTCTGC
TTTCTGGGCTTCCTCGAGAATGCCAGCAGAGTCTCCTACATTTTCTCTCTTTTGAGCCT
TTTCCTCTTTTCTTCTCTGAATGGCTATCAGGCTTTCTTAGTCAGACTAAAAAACATTT
GCTATATAGGTCTAGAGAGCAACATTTTAAACCAGAGCAGCTGTGGAATACGAAGCATT
CCACAACCTTCAGCTCTCTGGAGCAGATCCCATGCTACACCGTTGACAGTTCAATGTGA
TGAACTTTGTCCATGAGCAAGAGTAACAAAAATATTGTTCTTTAAAAAAAATCATTACA
TTTATTTATTTTGTGTGTGTGTGTATGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG
TGTGTGAGAGAGAGAGAGAGAGAGAGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAG
CCATGGCACACACAAGAAAGTCAGAGAAACACATGTCAAAGTTGGTTCTCTCCTTCCTT
ATGGGTACTGTGGATAGAACTCAGGTTTTCCTAGTGACTACTGAGACACCTCACTGGCC
ACTTTTTCTTTTCTTTATATTTTATGACACAGGGTTTCATGTAGCCCAGGCTAGCCTCA
AATCTACTGTGTAGCTAAGGCTGGCCTTGAACTTCTGCCACCACTTTCTAAGTGTTGGG
ATTATAGACACCATACCAGTTACACAAATACTACCTTCAGGCTGTGTGTATTAAGAGTT
ATATGAAGGAGGTGAATTTCAAATTTAGAATTTCAAGTTTCATTCCCAAGATCTTTCAT
GTAGATGCAAATACTCCAGATCCCCAATTCAAAACTGTTTACTTTGGATCCTAGGTGTT
TCAGATAAGGGGATTCAGCTTGGAGTCTCTAGTTGTCACTTGTTGACCTTTAGTTTTGA
172 
AATTCTGTTACAAGTTCTAATACCCCAGGGCAAACTGAATGCAAGTGTTCCCCTGTGCA
GCAAACCTGTAGCGTGGGCCTCCTCTAGTGACAGGTGTCCTGTACACCTCATTTATTCC
TCTGCTCAGATGTTTCCCCCACTGTCCCTTCTATTCTTCTTAAAGGTTTTAGTGTGTGT
GTGTGTGTGTGTGTGTGTCTGTATGTGTGTGGTACCTGAGGAAGCCAGAAGAGGGTATC
AGATTCTCTGGAGCTGGAGTTACAGGCAGTTGTGAGTTCCTGGTGTGGGTGCTGGACAC
AGAACTAAGGTCTTTTCTAAGAGCAGCCAGTGCTCTTAACCACGGAGCATCTCTCCAGC
CCCCACCATCCTCTGTAATCTTCAGAGAACACGGAACTCCAGAACAGACAGTCCCAGTC
CATCCTTTTGCTTTCCAGGACAGGGAGAATTATCTTTCTCCTCTACTGCAGGCAGAGGC
AAAGCTAACCACTTGGAAGAACCCAATGTCTCCATGCAGCCCACCTCTCAGCCAATCCT
TTCTGATGTTCAGGTTCAGATTCATGACCTACCCCAGGCTGCCTCAAGTGCCCTGTGAC
GTTAGCCATCATGTGGAGGGTCCCACTGAGGAGGGATGAAGGCCCAAGGAAGATGTGGT
GGGAGAGGAGGGTGACATGAATGTGTGGTCTTGGAGACATAGGATGGATGGGCAGCAGT
GGGTTAAAGTTAACACCAGACAATGATGCAATCACAGACTCCAAATTGAGTCAGGTCAC
TTTAAGAAAGGAGTAGCTGTAATCTGAAGCCTGCTGGACGCTGGGTTGGGAGGCAGTTA
TTCACTCCCCTGCTTGCTAGAGCCCCCTCAGGGTGCAGGCTGAGAGGGACCTAAACTCA
GAGAGGAGCTGCTGTGGACAACAGGTAAGGCAGTTCCTGGTCTAGGCTGGAGAAGACAG
ACGGGACAGGCCCCTTGGCCAGAGGGACAGGGAAGAGCAGGGGCACCCCAGAGAGCAGA
AAAGAGGGGTACAAGGAGGTAGAGGTAGGGATATAGTAGCCTCTGTACTTTAGGGACAA
AGGTAAACAGATGAGAGGAAAGAAGAGAATTGGGGGGCGGAGGGCCGGGATACTGTTAT
CCCCTACATTATCCCACTGCAACAGAAGGAGAGGCTGCATGGGGGTTTAAATGGGGTGG
AAAACAATGTGGGGGTATGGTGGTGGGCAGTGGGGAGGGCAGCTCTGGTCTGGTCTGAA
CAGTATCCCAAAGGGGTTATCATCTCACAGGCAGGGCTCTCCCTGGAGTTGCTTCCACC
AGCAGTGAGCAAGGAAGGTGGTCTTCCTGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCTGCCTGAGTCCTG
CTGGGATGGGATGCCTGCTAGGTCCTCTCTCCAGCTCCCACCCATTCTGTTACCAAGTG
AATGGGAGACAAATGAGGTCATGGCCTCTTGCAAACAATAAGCACCATTTAGCCTAGCT
GGTGTGTGGGGTCTGGCTGCCCTTCTGCAGTCTTTTTACCTCTCGAGGAAGCCACAGCA
GGGAGTGGTCTGGGTCAAAGAAAAGAGACAAGCTTTCCAAGTGCCAACCACTATCTGGA
CTTTAGCTGCCCCCATCAGTTCAGCCTCCAGGCTGAGGGGGATGGGTGGGGACCAAGGA
GTTCTGGCTCCAGGGAGTTCTGGCTTTTCTGGGGTGCTGGGAGGTGCAACTATGGGGTG
TTTCAGGTTCCAAGATTTCAGAAAAAACCAAACCAAACCAAACCAACAAAACTCTCACA
AAACTTCCCCAGAGGTGAGTGGTGTAGCCTTGAGCCAGCAGAGAGGGAGGTGTCCTCCC
CTGCTCTGTCCACATGTCCACTGCTGTGTGGCCTGAAGGCGGCTTGGTTCTGGGAGGAG
GAAGCAGTGGAGGAGGAGCAACATGTTTGTCTCCCAGCTGGGTTTAATCTGAAACACAT
GTACTGGCTCCCGTTTGTCTTCCCAGCTTGGATTTGAGACCACAACATCCCAGTTTCTG
TGCCTCTTGATTTGGGGCAGACCTTGGCTCAGAGGGGACAATCTTGACCCTTTCCCATG
CCCTCCCCAACCTGTAGCCCAGGAATCTGGCTTGGACGCTGCTCTTTGGACAGAATGGC
ATCACTGTCCCAGTTCCCCTGGCTAGTCAGTAGCTGCCTACCCAACCCAGTTATAGCTC
CCAGGGCACTGTATGTGTCCTGGGGCCCCTCTTGCAGACCCTTACTTCCTGCCTTTCAG
GGTCTCCACTTCCTTGATTCCTGTGGCTTCAGGTGAAGATTTCACACTTCCATTAACAC
TTGCCCTGCTTATAGCTCTTGGGCTAGCACTGGACTCCCATGTCTCCCCATGCCCACCA
GGTTCACTACCTCAGCTTCAGTTCTCAGCCTACCCATGTGGTGGTGACAGTGATCTGTG
ACTTAGACCCTGGAGGAACTCTGGCAGGCCCCTTCTGCAAGTGTATCTCACTTACTTCC
TGCAATAGGAGCCAAGGGTGACCGTTTTCTCTCAGTCGATACCCACCCAGAGGGACCAG
AGGGGGCTTTCTGTGCATCTTTGATAAATCAGCCTGCTGAGGCTCAGCAGGGGGAGGGT
173 
TCTGCCTGTGATGGGTGAGGCTGGGAGGGGAGGGCTATAATCTGTATCACTTTTCTGTT
GTTCCAATGGTTTTTTTCCCCCACGAAGCTGGGAGGCAGTGCCCTGGGTGAGAACACAG
GGGTCCCTAGAATTCCCACTGGGAGATCTGCCATAGATGAGGGGTTAGAACAAGGGAGG
CTGGTTTCTGCTGGTGCTGCTGCTGGAAGCAGAGGAAACTTTGTCTTGTTTCCCCTCAT
GGGCTACAGTTGTCTAGTGGATTATCTGACTTAATTCTAAGAACTTAGCCAATGACTGC
AGATTGCACTCCAAATTTTTCAGATCCAATTTGTTCTGGGAAGTCAGAAGAGTTGATGG
TGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGGTGGGGGAGGGCAAGTGTATGTGAC
AGGATAATGATGGAGCTGAGGGAGCATTTCTGGGTATGTGTGCTGTAGGATGGGCGGAG
GACACGCCATGCCACGACAGACAGTGGTCTTTTCCGTCTCTAGAATAAACTTTTCTGTG
GACCTCGTACCCCAACCCTAGACCTGACTCCAGGAGCACAGGAATTTTGCTTTGTGTTC
CAAGTGCCAGACCAGAGTCTGGGCAGAAAGGTCGCTGCTTCGGGAGGTGATAGGAGGTC
CCACCAAAACTTAGTGTTGTTTAACCTGAAGGAAGGAAGGAAGGAGGGTAGGAAGGAAG
GAAGTTAGGAAGGAAGGCAGGCTGACAGGCAGGCTTTGGGGTTAAGAGCTGTTTCCTTA
AAGTGGGGGAGAAGACATAGCCCTTCAGAAGAGATGCCAGTGGAAGGGACAGCTGAGAT
CTTCCCAACCCCTGGCACTGCTAAGGGCTGCTAAGATACTATCTAGGCAGATGTGGTTG
TGCACATTTAGGAGGCAGAGACAGGAGGACCACACATTCAAGGCCAGCTTACATATAGC
AAGACTGCTTCAAAAAAGAAAAGAGAGCGAGAGGTTATATAATATAACGCTCATAACAG
TAAGTAAATACTACTATATATGGAGGGGTTTGTTCTTTGGACAGCTATGAAGTTGGGGT
TTGATCCCAGGCAGTGTGGGCCTAGTTTGCACCCTCTTAACTGAGTAAGCAACTGCTAT
TGAGATGGGACACTGTGGTCAAGCCAGGCACAGTGGGTGTCAAACAGTGGGATTCCAGC
ACTCAGCAGGCAGATGGAGGAGGGGAGGAGGGTAGCTGCAAGTTCAAGGCTAGCCTGGG
CTACACAGGCAAGATCCTATCTAAAAAANNNNNNNNNNNNNNNNNNNNNNNAAAAGGAG
AGAGGGGCGAATAGACTGAGTGTCCTTATCGTGAGCTGCTTTTGGCCAGAAAACTTTTG
GTGGATAGCAGGGCTAGCCCAAGGTTCTGTGAGTCTCTGAGCCCCACCAAATGAGCTGG
CTGTATGCCTCCATGAAAAAACCTGGGTGTGTGTTTATTTTCTTGGGGCCAGAAGAGTC
CACTGCTGGGTCTTCACTGCTCTGGCCCATTCTGGCCCTTAGGCTAGAAGGTGGGTCTT
CCTATAGGAACTATTGTGGAGGCACAGCTCACGCTAAAGAGGAGGCAGGTGTGGGTGGG
GACAGCAAACCTTAAGCTTCGAGTCCTTTTGGGGGCTGAGAGCTGGAGGGAAAGCTCTC
ATCCTGTCTGACTCTTGTCCCTATGAAGGGTGGGGTGGCAGCACAGGCGGTGGGAAGGG
GAGTCACTTGCCCTCTTGTTTCTCCCAGGATGCAGGCCCTGGTGCTACTCCTCTGGACA
GGAGCCCTGCTTGGGCATGGCAGCAGCCAGAATGTCGCCAGCAGCTCTGAGGTCAGTAG
GGTGGGCAGCAGGAGTTCTAGCTCCTCTTCGGAGCCAGCAAAGGGAGGCAGCGCTGGGT
CCGGGGTGGGCTCTGGCTTTCATTCCTTTAGTTGGTTTCTCCAGTGGCAAGACAAATAT
TTGCCTTACCATTCAGGCTATGGAGAAGCCTCTCCTGTGCAGAGGAAGTAGGGATAGGG
TCTTGTCACACAAGGCACAAGCCAGTTGGGTATATTTAGTCTGTTTCCTAACAAGGCCA
CTATGGCCATTCACTTATTCCTTATCTAGTAACCACCTGCCTCAAAACGCAGGACCTTT
CACATGCTACACAAGTGCTGTATTAGCCCTGCCCATGAACACTTATTCTGTGGTTGGTA
GGTATGGATAGAAATATAAAAATCCCAGCATTCAGGTGGGCAGTGGTGGCACTCGTCTT
TAATCCCAGCACTCAGGAGGAAGAAGCAGGTGGATCTCTGTGAGTTTGAGGCCAGCCTG
GTCTACAGAGTGAGTTCCAGGACAGCTAGGGATACACAGAGAAACCCTGTCTTGAAAAA
CCTAAACAAACAAACAAAAATAAATGAGGCTAATTTTGCTTTTAATTAAAATATGTGTT
TGTTATTCTTTTTTATGGCTCTTGTCATTTTTTTTTATGATTTTATTTAGTTATTATGT
ATACAACATTCTGCCTCCATTCTGCACACCAGAAGAGGGCACCAGATCTCATAACGGAT
GGTTGTGAGTCACCATGTGGTTGCTGGGAATTGAACTCAGGACCTCTGGAAGAACAGTC
CGTGCTCTTAACCTCTGAGCCATTTCTCCAGCCCCGTGTTTGTTATTCTTATTATTATT
ATCATTATTTTGTTTTTGTTTTTCAAGACAGGGTTTCTCTGTGTAACATTCCTGGCTGT
174 
CCTGGAACTCACTCTGTAGACCAGGCTAGTCTTGAGATCTGAGATCTGCCTGCCTCTGC
CTCCTGAGTGCTGAGATTAAAGGTGTGCACCATGACCACCAGCATATTTATTATTCTTG
TGTGTGGGCACCTGTGGCACAGCATGTATGTGGAGACTAAGAGCAACTCTGCAGTCAAT
TCTTTCCTTCAGCCTTCACATGGGCTCTGGGAATCAAACTCAGGTCCCCAGGCTTGAGT
GGCAAGCTCCTTTGCCTGATGAGTTCTATCACCAGCTCCTCAGATTTTACTTTTAAAGA
ACTCAATTCCTGAGCTTGCTGTGATGGTGCACGTCTTTAATCCCAGCACTCGGGAGGCA
GAGGCAGTGGTTTGATGATGCCAGCCTGATTTACAGAGTGAGTTCCAGGACAGCCAGAG
TCACGTCTTACCACCCTCCTATACCCCCAAACAGCATCAGGAATGGGAGATGTAGCTAA
GTGTCAAATCACTTGTCCAACATATGCAAGAGCCTGGGCTTGATCCCTAGCCCTAGAAA
CAAAACAAAAACTAGCAGAGTCCCTCACATAGCAGCTAGCTAATAAGGAAGTGGTTGAC
ACTGGAAAAGGAACCTAGGCAGACTCAGAACAGTCTGAAAGGGTGAGCAGGAGTGTGGT
ATGGCCTGAGGACAGGTTTCTTTGGTGGTGGTGGTGGTAGTGAGGTCTCCTGCCGAGAG
ACAGATTGTGTTTGTAGGCCAGAAGTCAATCCACAGGACCCCTCACTGGTCTGGAATAC
ACTGACTTCTCCAGGACCTGCCCATTTCTTCCTCCCCAGTGCTGGGATTACAAGCATGC
CCAGCCTTTTTTGTGTGCCTTCTGGGGATTGAATCCAGGTCCTCATGCTGACAGGCTGG
CACTTTCCCAACTGCGCTAGTTCCCCAGCCCTGCCATTTTTATTTTAAAGTAGGCCAGG
CTCCCTGCTCTCAGGTCACAGTTCAAGCTCGGTGGACCCTCTTGGTTGTCTCTTCCCAG
CACAGAGGTTATGTACAGTCAGAGTGCACATGCTCACTCCAACCTTAGACTAATGGACC
CCAGGCACCAGAGGACAACCCCAACCTGGAGGTGTTGCCATTCACTGTGTCTTCCCCAC
TGGTCCTTGTATTCTGACCCAGGGTTCCCCAGCCCCTGACAGCACAGGGGAGCCAGTGG
AGGAGGAGGAGGACCCCTTCTTCAAGGTCCCGGTAAACAAGCTGGCAGCAGCAGTCTCC
AACTTCGGCTATGACCTGTACCGCCTGAGATCCAGTGCCAGCCCAACTGCCAACGTTCT
GCTGTCTCCACTCAGTGTGGCCACAGCCCTCTCTGCTCTTTCTCTGGGTGAGTGTCAGC
CGAAGGAGGCTGCAAGTGAACCTGAATTTTCCCACGGAGTCTCTATGCATATGCTGCCG
GGAGAGCAGGAAAGGGACAGTGGGGGCTACACCTCTGGCCAGGCACTGGCCACACACAC
ACAATCCCTACCACTTTATGAAAGTGACACTCAATTCTTGGTTCCTAAGTGGACTCCTA
TTGTGTGTTAGTCATTTATCCAGGTTCTAGGGGTACTGCCACGAGCAGGCCCAGGTTCC
TCCTCAGAATAGTGTAGGTAGCAAAGGGAAAACTTCAGGGACTGCACCCCACTCTTCTC
TCTCTGTAGGTCTGATGGCCTTGGCCTATTTTAGAAATTTTTCCTAGCAATGCAGTTAT
ATTTTCCTTGAAGCTCTCATTCACTTATATAGAATGTCTGCAATGTCAGCCTCCTTGGG
CTCTCAGAAGACAACAGACTAGGTGTACACTATCCCTGTCCTGCTCTGGGTCCCATGGA
TAGCCATGAAGCCTGCCATCCTTTTCTCCCTGGCAGGAGCTGAACAACGAACAGAGTCC
ATCATTCACCGGGCTCTTTACTACGACTTGATCAGCAACTCGGACATCCATAGCACCTA
CAAGGAACTCCTTGCCTCTGTTACTGCCCCAGAGAAGAGCCTCAAGAGTGCTTCCAGAA
TTGTGTTTGAGAGAAGTCAGTAGCCCACCCACCCCACTCCTGAGTCTGTGTAGTCCAAG
CTAGTCCCTGACTCATAGTGCTGCTCCTGCTTTCAAGTGCAGGCATGAGCCATCATGCC
TGACACATGGTTGCTTTTCTGGTCTGGGTTGTCTGTGTGCTTCATGCTGAGGGTTCTGT
CTAAACAATGGACTGTGTGTGCTCAGGCCAGGCCTGGTGCTGGTGGGCAGGAAAGGGCC
TGTGAGAGCACAGAAGATCGGAAAGAGGAAGTGGACTGTGGGAGACAGCAGGAGGGTCC
AGGAGGGCTGTGACATGAAGGGGAAGGCAATGGGTGGAATCCATTGTTCCTTGTCCAGG
GTTTGGGCAAGTAGGCAGATGCCCCAGCAAGTCAGGGGAAGATGCTGAGCAGGAAGCTG
GGGTCTGGAATGCTTTCAAAGTAAGGGTGCTTGTTGAGCTCTCACACACTGATCTTTGA
TCTGCTTCCTCTCAAGAACTTCGAGTAAGATCCAGCTTTGTTGCACCTCTGGAGAAATC
ATATGGGACCAGGCCCAGAATCCTCACTGGCAACCCTCGGATAGACCTCCAGGAAATTA
ACAACTGGATACAGGCCCAGATGAAAGGGAAACTTGCTCGGTCTACAAGGGAAATGCCC
AGTGCCATCAGCATCCTCCTCCTCGGTGTGGCTTACTTCAAGGGTGAGGGCTTCCCCAC
175 
TTCTCTTGGATGGCAGGTGTGTGGTGGTGGTGGTGAACACAATGCAGGTGCAAGGCCAG
AGGAGGGTATGGAGCCATGTGTGCTTGTTCATCTCATCATCTACCAAGTGTTCCTGCTC
CATGTGACACGTGAATGGCTGGGTGGGACTGGGCACAGATCTCTGACCAGGTTTAATCC
TGGCTGTGCCCTGTCTCCTCAGCTTTCCTGTGAGGACTACATATCCACTTCACTGTACA
ATACGGGCTGTCTCATTCTCACAGAGACCCTGTCCTGCTCCAAGGATTCCACCTGTGCT
CAGGACAATGCTTCCAGTTTCCTGCCAACACTCTTCTAGGCAGTAGTAACGTGTCAGGA
GACCCTTCCACAGGCCTCATACAAGGTCTGTTTTCTTCAGAAAAGGGCTTGCAGCAGGA
ATGCTTTGACCAACTTCCCTCTGAAGATGTGACTGCCTTACTGAGTAGCAGCAAGAGTG
GACCACCTAACCGAGTAGGAAGCCCCTGGAGCTTCCTACTCGGTACACAGGGGATAGGA
GAGCAAGCACAACCCAGCATATTAAAAGCCACCTTAAACAAAAGGCCAAAGTGAGAACA
CCCACTCACTTCCAACTGAGTTTGCCAGGGGAAGAGTGTCAGCACCTGTGGACCACGGA
TCCTGTGGTCTACACCACACATGCTGGGACCCAGAAGCTCCTGTGTCCATGCTACTGAC
AGCTCAGGTCCCCTGGCCTTTCCGGTGGCATTGGCTCAGGAAGCTCCATATGTTTCCTT
CCAGGGCAGTGGGTGACAAAGTTTGACTCGAGAAAGACGAGCCTCCAGGACTTCCACTT
GGATGAGGACAGGACTGTGAAAGTCCCCATGATGTCAGAACCCAAGGCCATCCTACGAT
ATGGCTTGGACTCTGATCTCAACTGCAAGGTGTGGGAGCATGGGGGGTGGGAGGGGTCA
GAGAGGGGCAGGGTGGTATGGAATGGATGGCTGCTGAGATGGGTCAGCTATCTGAATTT
TGCTGTTGTGACTTTGGGCAAGTTAGTAATGTTTCTGGGCCTTTCCTTTTCCTCCTCCT
CCTCCTTTGTTTTTTTTTTTTTTTAAGATTTTATTTATTTATTATGTATACAGTTATCT
GCATGCATGCTTGTACACTAGAAGAGGGTACTAGATCTCATTACAGATGGTTGTGAGCC
ACCATGTGGTTGCTGGGACCTCTGGAAGAGCAGTCAGTGCTCTTAACCTCTGAGCCATC
TCTCCAGCCCCCCTCCTTTGGTTTTTAGAGACAGGTTTCTCTATTTAGCTTGGGAGCCT
GTCCCAGAACTTGCTCTGTAGACCAGGTTAGCCTGGAACTCAGGGATCCACCTGCCTCT
GCCTCCCAAGTGCTGGGATTAAAGGTGTATGCCACCACTGCCTGGTATCTTTCCTTTTC
TTGAATCTAAGGAGTGAAAAGTAGTTATCAGAACTTATTCTCTAGGATTTGTTGTAAGG
ATCAGAGCCATAAAACACAGGTTTTTAAGACCTGGCATTCAGAGTTGGGGATGGAGACA
CACACCTGTAGTCAGTCTCAGGAGTCAGGAGCCTGAGGTAGGGTGACCAAGAGCCCAGT
CTGAGCTGTACTTTGAGACCATCTCAACAAACAGAGATGGGCTGGAACAATGACTCAGT
GGTTAAGAGCACTAGCTGCTTTTTCAGGGGAGACAGGTCTGATTCTCCAGCACCCAAAT
GGCAGCTCACACCTGTTTGTAACTCCAGTTCCAAGGGATCCAACACCCTCTTCTGGACT
CTGTAGACACCAGGCATGTCTGTGGTGCACAGACAGACATGCAGGCTATCACCCATACA
TATAAAAACAAACAAACAAACAAACAAACAAACAAATGCTGGGGTGTACCACAATGGTG
GAGCACGTGCCCAGTACGAGCAAGTTTAATCCTTAGTACTGCCAAAAACAAAACAAAGA
AAAAGACTTGACACTCAAATGTTGATTTATTTATTCATTTCTTTCCTTTTTTATTTTTG
AGACAGAGCCTCAAACTTACTAGCTGAGGATGACCTTGAACTCCTGATTTTCTTGCCTC
TACCTCTCAAATGCGGCCTTGTAGGCATGAGCTACCACCCTGGTTAAAGCAGTGCTGGG
GATCAACCCACAGCTTCATGCATGTTAGGCAAGAGCTCTACCAAGTGCACACAGCCCCA
GCCCAAAGCTGTCTTTCCTGACAGCTCTTCTTTTAGAATTTAGACTCAAATTCTGACAG
CTTGTCACAAACACCACACAATGACATTCTAAGGCTCTCAGTGAGCTTGACTTCTTTGT
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CTGCCTCCCGAGTGCTGGGATTAAAGGCGTGCGCCACCACTGCCCGGCTCTACTGTTCC
TTTCTAGTCCAGGGATCTGAACAAAGCAAATGGTCAGTAAATGCTGCCAGGGAGATTCT
GGGAGGATATCCAGTTTCAGCTCCTAGGAACCAGGTCCCGGACAGTGTTACCAATTTGA
CACAAGTTAGAGTCTTTGGAACAGCAGCTCAGAACCAGGCTGGCCTCTGGGCACACCTG
TGGGGCATTTTCTTGACTAAGGATTGATGTGGGAGGGCCTAGCCCACTACAGACTATGC
CATTTCTGAGCATGTGGTTCATGGCTGGTCTGAAAGGGCAGGCTAAGGAGCCCGGGGAA
GTAAGCCAGAAGCAGCGTTCCACTTTGGTCTCTGTTTCAACTCCTGCCCTGAGTTCCCC
GTGGTGATGAGCTTGACCTGAGAGTTCTAAGATAAAATAAACCCTTTCCTCCCCAAGTT
GCTTTTGGTTACATTTTATCACAGCAATGGAAACCCCAAGTAAGATAAACTATAAGCTA
ACCATTTTCCATCAAACTTCTGAGAAGAAAAGTGCTTACTCCTGGAAGGACTTCCAGAG
ACCCGCAGAAGGCAACTGCTGCACTGGCTGGGGGTGGGGCCTGCCTCAGGGGAGGGGAA
AGCAAGTCTTAAGGTCTGGGGTTTTGGCTCCAGACTAACTCACGTGCTTCTCTGTTGTT
AGATTGCTCAGCTGCCCCTGACAGGAAAACTGAGCATCATCTTCTTCCTGCCCTTGACG
GTAACCCAGAACTTGACCATGATAGAGGAGAGCCTCACTTCTGAGTTTGTTCATGACAT
AGATCGAGAGCTGAAGACCATCCAGGCTGTGCTGTCTGTCCCCAAGCTGAAGCTGAGCT
ATGAAGGGGAAGTTACCAAGTCTCTGCAGGAGATGAGTATGTTCTCAAGACCACTCTAC
TCCAGGGGCTGGACATAAGGCTGAGTCTGTGAGCCTGCCTTCTGCCTTGCTGACAGAAC
TTTTGGGTGGCTCTGGGCACTTGCTACACTGTTATGGGGGAGAGGAATATAGAACCACC
TTCCCATCAGACTCAGTCCTAGGTCCNNNNNNNGCACACGTCCTGTAACAGCCCAGAAT
ATTGTCTCAGGCCAGGTCTGTTTCCCTTGCTGGCTCTATGCTCTCAGGTAGGTCACTGA
GCCTGCAGTGGCTTAGAGAACCTCCTACCTCACAGGGAAAGTTTGCTTGCTTTCCTGAG
AATCAGCTTACACAAACCAGGATTGTGTGTGTGTGTGTGTGTGTGGTGTGTGTGTGTGT
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TCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTGTGTGTGTGTGTGTGTGTGTGT
TTGCTTAGGAGTATGCATGCATCTGTGTAATTGAGTATGGGTGCCCATGTAGGCCAGAT
GTGTTGGGTCCCATGAAGCTGGGAGTTACAGGTGGCTGTGAGCCACTCAGTGTGGGTGC
TGAGAACTGGACTGAGGTCCTCTTCAAAAGCAGTATGTGCTCTTAACTGCTGAAACACC
TCTTCAGCCCTTTTATTTTATTATTTTTGTTTTGTTTTGTTTTCTGAAACAGGGTTTCT
CTGTGCAGCCCCGCTGTCCTGGAATGTGCTTTGTAGAACAGGCTGGCCTAGAACTCAGA
GATCTGCCTGCCTCAGCCTCTTAAGTGCTGAGACTAAAGTTGTGCACCACCATGCCTGG
CTTAGCTGTTTTATTTTTGAGACAAGATCTTTTGTAGCCCAGACTGCCCTCTAACTCTT
GACCATCTTGTCTTGGCCTCCTGAGGGTTGAGATTATAAGTGTGCTGCTACCATGGCCA
ACCTATGCTAGATTTTAATGCAAGCACAAACATTCTCAAGCTAAGGTCACATGAGACAA
TTAGAGATTTCTTCTTTGATTTTTATTTCATGTGTGTGCGTGTTTTGCCTGCATTTATA
TCTGCGCACCATGTGCACACAGTGCCCACAGAGACCAGAAGAGGGCAATGGGCTCCCAG
AACTGGAATTACAGAGAGATGTTGGCTGCCATTTGGGTACTGGAAATCAAACTCAGGAC
CTTCAGAAGAGCAATACATACTCTTAGCCACTTAGCCATCTCTCCAGCCCTGAGAGACA
TACTTCATAACTTCAGGAAATAATTCTTTATTTTGGACCGGGATAACAAAAGAGTTGTC
TGCAGGACTAAACTTTTTTCCTGAGGAAACTCTATCAAAAAAACCTTACAGGTTGGACT
GGAGAAATGGTTCAGAGGTTAAGATGACTGGCTGCTCTTGCAGAGGTCCTGAATTCAAT
GCTAGCGACCATCTATAATGAGATCTGGTGCCCTCTTCTGGCATGCAGGCACACATGCA
AGCATAATATGCTATACATAATAAAACAAAACAAAACAAAACAAAACAAAACAAAACAA
AACAAAACAAAAAAACCCAAACACCTTACATGTCACCTCTTTGTAATACTACATTAATA
GACAGCAGGAGAATCAAATTCGGCCCACTTTCCATTCCACAAATGTTGGAATGCTATCT
TCCATCACCCAGCTTCTTGGAAAGATGCTGTCAGGCATCTTCAGGACTATTTATTTCTT
GATTGTAATGCCATGGCAACTAACAGCCACTTCTTGGGCACAGCCAGGGTGGGTAAGTT
CCTAAAAGCAGTGTATAACTCATCTGACCAAATTGGTCACCAGTAATAATGTAATAAGG
ATCAGTCAGAAAATCCCACAGTTTCTGACCTTGGGGGTCTGGACCACCACTACACATCC
TTGAGGAAAGGGGAAGCCATCCCTCCCTTCTGTCTCACTTTGAAACCATAAGCAGCAAT
178 
ATCTACAACCTCAGCACTTGGGGGTGGGGGGCATTTGGGTATCAACCATGAGCCTCACA
CTCTACCAGTGAGCTACACCCCCAGCTCCTTGTGGAATGTTTGTCGGACTCTTGATTCT
CTTTGTACACAGAACTTTTAAACCTAGTACTTGGAAGGCTGAGGCAGGAGGATGATATG
TTTAAGGATAGACTGGCTTACAGAATGAGGTCCTGTCTTCAAATAAAAAAAACCTGAGT
AGTTTATTTTCAGGTTTGCTAACATATAACTCAGAAAGGAGGCATATGTGCTATAAAGT
CATCCATCCCTTCAAGTTTGAGTTTTATTAGTGCCTGGACAATGAATCTGTCAAAAAGA
TTTAGTGAAAGCCAGAAAATAAAATAAAAAACTGGGGGCTAGAGAGATGGCTTAGTGGT
TAACAGCACTGGTTGCTCTTCCGGAGGACCCAAGTTCAATTCCTAGCACTCACATGGCA
GCTCACACCCGTTTGTAACTCCAGTTTCAGTGCTTCTGACACTCTCACACAGACATACA
TGTAGGCAAAACACCAATGAAATTAAAAACAAAAAGAATTAGAAAACCAGCAGGAAACA
AATACAGAGTTGCCATCCCAGGAAGAAACTACCCAAGAGTAATATAGCCCCATGTTTAT
TTCTCTACTCACAAATTATACACCACCAATTTTATTGAAGAATTTAAGGAAGCAGAATA
TTGTAAGTATAATTGTGTGTCTCTTGAAGTAGAAAGTCAACCAATTTCTTGCTGTATAC
TGTTTTTTAATTACAATACAAGACTAAGAACTGAAGTTCCTCCTGGAGTGGTACACAGC
ACTTCATTGCTACCAGAAACCATAGGGATGTCCCAGGGAAACAGACTCTCACATTTAGT
GAGATGAAATCAGACTCTCACATTTAGTGAGATGAAATCAAGTTGAAACCCTAGGCTAG
TCTCAGCTGCCTGCAGACCAGCGGCGACCTTTAAAGCACTGGGTTTCCACAAATACTGG
TCTAAGTCTTTTCTGGGGATGGGGAGTTTCTATCAGAGGGCAGTTAGTTTCTGCAAGCA
ACAGCCATCAGGACAGTGCCTCTCAACCATTGTTTCCCAAGTGCTCCCTGCCATCAAGA
CACAGCTTAGGACAGCTGGGTAGGTCCTGTTCTTTCTGATGACAACTTCAAACCAACAT
AGCTTCTTTACCTCATCTGCCAGAGTTCCCTTCTTGTGAGCTGGAATGTACATTCTACA
CCAAAGGCCCCACAGGGATGAATGATGAGCCTAATAAACAGGATTTCATCTCCCGGAGC
TCCTGGACCTCATCGCTCTCAGGGCCACAGTGAACCAACAGGATCTTTTCTGCTTTCCA
TATGGCATTCAGAGCTTCAGGCACTGCCAACCTGAACCAAGGGAGGAAAGCTGGTCAGT
TCACTCATTCAGTCAAAATGAAAGCTGGCTCCTTTCTGGACAGAGGACACAAAGGATCA
AGTTTAATTCCATCCTCCACAATCTACAGAGGGCACAAAGGGTTCACCATACCCTCCAG
AATCTGATCTTACCATCTAAAGGGGTAGATAAGAAACTTCACAAGCACACTGCAAAGCA
GAGTTTGAGGAAAGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGAGAGA
GAGAGAGAGAGAGAGAGAGAGAGANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAG
AGAGAGAGAGTGTGTGTGTGTTAGACTCCAGGATCCTGAGAAAAGTGGGCAAATTTATG
AAAGCTTTATACAGAGTTGTTCATTTTAGGGCATCCATGTCCCACCTGACTGACTTTGT
GTTTCCATGTCTGGTAATTAGGTCTAAGCTTCAAACACTTTCCCTTAGCAATGCACACT
AATGAGTTTTTAATACAGGCTGGAGGTATGGTATCCACACAGGAACACTACAATTGGGG
ACTCTTTCATTTCAAGTGATCACAGTAGCAAAATTGGGTGTAGGACCAGCTAGTTCATC
AACTCTGCTCTTGTCTTTTTTTTTTTTTCCCTTCCTCTTCTTCTGTGCAGTGCCAGGGA
CGGAACCCAGGGCCTTGTGCATGCTAGGCAAGTGGGCTACAACTGAACCATTCCCCCAG
CTTCCTTTTTTAACCTTTAAAGCAGCAATTCTTAACCTTGACGTAACTACTTGGTAACT
CTACTGTTGAGGGTGTCCTGTGCACTCAGGGTTAGCCTTTACCCACTAGGATGCTGGCA
GTACCCTCCCTCGGTCCATAACAACCAAAACTGTCTCCAGACATTGGCCAATGCTATCT
GAAGGCAGAATTTCTTCTGCTTGAAAACAACTGCTTTAAAAGGAATAGGACGCAAACTT
GGGAAAAGGCAGAGGCCCTGGAGTTGAGAATGCTGGGAATGAGTAAGCCAAGGGGGTGT
GATTAAGCCCAGAGGAATGCTAGAGGGCGGGTGAGGCTGCCTGGAAGCCCTCCCTGGGA
AACTCAATTGAGAACTAAGAGCTTTCTTCACATCTCTCAGGAGAAAATTCAAAGCTTAA
AGCCTGTCAGTGAAACAGAGGGCAACGATCTGTCCTAAGGAGGAGACAGAAGGAAAGGT
TTCAACATCTGAAAATCACTGTAGCAAAGTCATCCACAAAAGCA 
